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ABSTRACT
At a cellular level, neurogenesis relies on homeostasis in the brain, allowing neural stem
cell (NSC) populations to maintain their pool throughout life, while remaining capable of
re-entering the cell cycle during periods of time when there is a demand for cells to be
repopulated. The cell cycle lies at the center of these decisions and alterations to the cell
cycle prove costly. The cyclin-like protein Spy1 can bind and activate cyclin dependent
kinases (CDKs) 1 and 2 in a unique manner to promote cell cycle progression. Spy1 can
target p27 for degradation and overcomes checkpoints introduced by DNA damage, thus
leading to enhanced cell proliferation. Previous data implicates Spy1 in the brain tumour
initiating CD133+ population of aggressive glioblastoma multiforme (GBM). This
suggests a role for Spy1 in normal NSCs as well impairments in cognitive functions and
potentially development of tumourigenesis. This work describes the development and
characterization of a novel transgenic mouse model to study Spy1 in the Nestin-positive
NSCs of neurogenic regions of the brain. Using this newly generated NTA-Spy1 mouse
we have shown that elevated levels of Spy1 in NSCs increases proliferation, decreases
differentiation capacity, increases self-renewal leading to impaired memory recognition.
We demonstrate that when cultured in vitro and damaged by ultraviolet (UV) irradiation,
NSCs down-regulate and bypass class DNA damage repair pathways. Lastly, we link
mechanisms of Spy1 stem cell maintenance as potential regulators of reprogramming to
induce pluripotency. We demonstrate increased reprogramming efficiency as a result of
the role of Spy1 in epigenetic regulation. Collectively, these results may provide a better
understanding of molecular mechanisms that drive abnormal cell growth and division in
reprogramming and NSCs.
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CHAPTER ONE
GENERAL INTRODUCTION

1

INTRODUCTION
The Cell Cycle
The cell cycle is an intricate and comprehensive process that involves many regulatory
proteins which play unique roles in guiding the cell through a precise series of events that
conclude with mitosis and the creation of two daughter cells. Following mitosis, daughter
cells make critical decisions at the restriction point in Gap 1 (G1) phase as whether to
differentiate, re-enter the cell, or enter a reversible quiescent state, known as G0 (Schafer,
1998; Vermeulen, Van Bockstaele, & Berneman, 2003). If faced with a stressor or the cell
reaches the end of its lifespan, cells can undergo irreversible cellular senescence (Campisi
& d'Adda di Fagagna, 2007). In addition to the restriction point, checkpoints throughout
the cell cycle ensure that cell cycle events are maintained in a controlled order and occur
without error (Hartwell & Weinart, 1989). Pioneering work in yeast demonstrated that
cyclin –dependent kinases (CDKs) interact with regulatory subunits known as cyclins to
aid in the progression between different phases of the cell cycle–G1, Synthesis (S), and
Gap 2 (G2)/ Mitosis (M) (Beach, Durkacz, & Nurse, 1982; Nurse & Thuriaux, 1980). The
mammalian cell cycle has 5 distinct CDKs capable of regulating different cell cycle phases,
this diversity is thought to fulfil the requirements for greater control over a range of
different cell types (Malumbres & Barbacid, 2009). CDKs are a family of serine/threonine
protein kinases that are ubiquitously expressed and can be activated at different points
throughout the cell cycle. The inactive state of CDKs is relieved when they bind to cyclins,
allowing conformation changes to occur which make the catalytic cleft more available
(Morgan, 1997). In addition to the interaction between CDK and cyclin, the enzymatic
activation of CDKs requires post-translational modifications (Booher & Beach, 1986; Gu,
Rosenblatt, & Morgan, 1992; Solomon & Kaldis, 1998). Furthermore, the kinase activity
2

of cyclin-CDK protein complexes is constantly kept in check by CDK inhibitors (CKIs)
(Sherr & Roberts, 1999). The cell cycle remains the focal point of many cellular decisions
such as proliferation, differentiation, quiescence, self-renewal and apoptosis to maintain a
homeostatic environment (Figure 1).

Cell Cycle Regulation in Cellular Decisions
Active cyclin-CDK complexes allow for the phosphorylation of numerous substrates that
affect cell division. Currently, there are over 20 members of the CDK family (Malumbres
& Barbacid, 2009). Of these CDKs, five are active during the cell cycle: CDK1, CDK2,
CDK4, CDK5 and CDK6 (Vermeulen, et al., 2003). Each CDK contains a conserved
catalytic core, which includes the PSTAIRE-like cyclin-binding domain, an ATP-binding
site and a T-loop motif (Morgan, 1997; Pavletich, 1999). Once the cyclin binds, a
conformational change occurs, which triggers a cascade of post-translational modifications
leading to the activation of the cyclin-CDK complex. This begins with displacement of the
T-loop so that the phosphorylation site becomes available to relieve blocking of the
catalytic cleft (Jeffrey et al., 1995; Pavletich, 1999). The CDK activating kinase (CAK) is
responsible for further conformational changes through T-loop phosphorylation, which
occurs on a conserved Thr residue – Thr161 for CDK1 or Thr160 for CDK2 (AthertonFessler, Parker, Geahlen, & Piwnica-Worms, 1993; Jeffrey, et al., 1995; Pavletich, 1999;
Russo, Jeffrey, & Pavletich, 1996; Solomon, Lee, & Kirschner, 1992). For full activation
of the cyclin-CDK complex, inhibitory phosphorylation marks found at Thr14 and Tyr15,
which are positioned within the ATP-binding site need to be removed. MYT1 (F. Liu,
Stanton, Wu, & Piwnica-Worms, 1997; Mueller, Coleman, Kumagai, & Dunphy, 1995)
3

and WEE1 (Igarashi, Nagata, Jinno, Suto, & Okayama, 1991; Parker & Piwnica-Worms,
1992) kinases are responsible for the inhibitory phosphorylation on Thr14 and Tyr 15
residues. Cyclin-CDK complexes are activated once the CDC25 phosphatases dephosphorylate these residues (Dunphy & Kumagai, 1991). Once these critical posttranscriptional modifications have taken place can the cyclin-CDK complex carry out its
function.
Cyclins are a diverse group of proteins. Every cyclin contains a cyclin box domain
which is responsible for binding to CDKs (Gopinathan, Ratnacaram, & Kaldis, 2011).
Protein levels of cyclins, unlike CDKs, are transient and oscillate throughout the cell cycle.
Although cyclins were originally termed for their cell cycle-dependent expression (T.
Evans, Rosenthal, Youngblom, Distel, & Hunt, 1983; Pines, 1991), many of the recently
discovered members of the cyclin family of proteins do not oscillate (S. Lim & Kaldis,
2013). Nevertheless, oscillating cyclins are critical components in understanding the cell
cycle and mechanisms of regulation during cell growth. Cyclin D1, D2 and D3 share
significant homology and bind to CDK4 and CDK6, and are essential for entry and
progression into G1 phase of the cell cycle (Sherr, 1994). The binding of Cyclin D to
CDK4/6 allows for phosphorylation of the Retinoblastoma (RB) tumour suppressor,
essentially inactivating RB, and permitting the release of the transcription factor E2F from
RB (La Thangue, 1994; Sherr, 1996; Sherr & Roberts, 1995; R.A. Weinberg, 1995).
Downstream E2F transcriptional targets include CCNA, CCNE, and CDC25, which are
responsible for promoting cell cycle progression from G1 to S phase (Botz et al., 1996;
Buchkovich, Duffy, & Harlow, 1989; Kato, Matsushime, Hiebert, Ewen, & Sherr, 1993).
Another cyclin present in mammalian G1 is Cyclin E, which binds CDK2 and is critical in
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the progression from G1 into S phase (Ohtsubo, Theodoras, Schumacher, Roberts, &
Pagano, 1995). The Cyclin E-CDK2 complex helps maintain Rb in a hyper-phosphorylated
state (J. A. Knoblich et al., 1994). Cyclin E-CDK2 also targets the CKI P27 for proteasomedependent degradation by phosphorylating it on Thr-187 (Montagnoli et al., 1999; Sheaff,
Groudine, Gordon, Roberts, & Clurman, 1997). Cyclin A associates itself with CDK2
during S phase (Girard, Strausfeld, Fernandez, & Lamb, 1991; D. H. Walker & Maller,
1991). In G2 and early M, Cyclin A binds to CDK1 to help in mitosis entry. Progression
of mitosis is also regulated by the Cyclin B-CDK1 complex (Arellano & Moreno, 1997; R.
W. King, Jackson, & Kirschner, 1994). Other Cyclin-CDK substrates include WEE1,
CDC25 and cytoskeletal proteins that are essential for proper mitosis (Blangy et al., 1995;
Courvalin, Segil, Blobel, & Worman, 1992; Heald & McKeon, 1990; Hoffmann, Clarke,
Marcote, Karsenti, & Draetta, 1993). The degradation of cyclins is important in exiting
different phases of the cell cycle, especially mitosis and allowing the cell to re-enter into
the subsequent cell cycle. Degradation of cyclins A and B is mediated through their
destruction boxes (Glotzer, Murray, & Kirschner, 1991), and degradation of cyclins D and
E is mediated through their PEST sequences (Rechsteiner & Rogers, 1996), both of which
culminate in degradation of cyclins through ubiquitin-mediated proteolysis at the end of
each phase of the cell cycle.
CDK activity can be repressed or completely halted by cell cycle inhibitory proteins
known as CKIs in response to DNA damage or extrinsic stressors (Nakayama, 1998). CKIs
can either bind solely to CDKs or to a cyclin-CDK complex to inhibit CDK activity. There
are currently two different families of CKIs. The first is the INK4 family which includes
the proteins p15 (INK4B), p16 (INK4A), p18 (INK4C) and p19 (INK4D) (Sherr &

5

Roberts, 1995). The INK4 family of CKIs bind monomeric G1 CDKs (4/6) and render
them inactive by forming stable complexes with CDKs, preventing Cyclin D from binding
and thereby inhibiting its association with CDKs (Carnero & Hannon, 1998). The second
family of CKIs is the CIP/KIP family of inhibitors (Sherr & Roberts, 1995). The Cip/Kips
include p21 (WAF1, CIP1), p27 (CIP2) and p57 (KIP2). In contrast to the INK4 inhibitors,
the CIP/KIP inhibitors inactivate the entire cyclin-CDK complex (Harper et al., 1995; M.
H. Lee, Reynisdottir, & Massague, 1995; Polyak et al., 1994). When a CIP/KIP member
binds the cyclin-CDK complex, it induces conformational changes that prevent CDK
activity by inhibiting access to the catalytic cleft (Pavletich, 1999). This binding is
mediated by a conserved hydrophobic patch on the cyclin that contains the MRAIL motif,
a sequence that plays a role in substrate recognition (J. Chen, Saha, Kornbluth, Dynlacht,
& Dutta, 1996; Schulman, Lindstrom, & Harlow, 1998). The Cip/Kip CKIs predominantly
inhibit G1 cyclin-CDK complexes, but are also known to inhibit the cyclin B-CDK1
complex (Hengst & Reed, 1998). These protein family members have critical roles in
regulating cellular proliferation rates throughout development and are coordinated through
intrinsic and extrinsic mechanisms. The CKI p21 is transcriptionally activated by the
tumour suppressor p53 to promote cell cycle arrest by blocking CDK activity (el Deiry et
al., 1993). p21 can also inhibit DNA synthesis through inhibition of proliferating cell
nuclear antigen (PCNA) (Pan et al., 1995; Waga, Li, & Stillman, 1997). It has been
demonstrated that along with a role for p21 in cell cycle arrest, the protein can also trigger
cell cycle exit leading to differentiation (Steinman et al., 1994). Transforming growth
factor β (TGF-β) contributes to cell cycle arrest by increasing the expression and activation
of two other CKIs – p15 and p27 (Hannon & Beach, 1994; Reynisdottir, Polyak, &

6

Iavarone Massague, 1995). Crosstalk between the two different CKI families allows for
further control of CDK activity. p16 inhibits cell cycle progression through a p21-mediated
inhibition of CDK2 (Mitra et al., 1999). Additionally, the induction of p16 is correlated
with the relocation of p27 from CDK4 to CDK2, and this rearrangement leads to the
inhibition of the cyclin E-CDK2 complex by both p21 and p27 (B. B. McConnell, Gregory,
Stott, Hara, & Peters, 1999; Mitra, et al., 1999). It is evident that these regulators of the
cell cycle play crucial roles in development and that their dysregulation may cause a loss
of homeostasis through abnormal growth and proliferation of cells. A thorough and
comprehensive understanding of all the regulators of the cell cycle is essential to illuminate
which ones are critical for growth and development.
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Figure 1: Regulatory features of the eukaryotic cell cycle. The four distinct cell cycle
phases – Gap phase 1 (G1), DNA synthesis phase (S), Gap phase 2 (G2) and mitosis (M)
– are shown as an approximation of their relative duration. The reversible quiescent state
known as Gap phase 0 (G0) is also depicted. The periodicity of different cyclin-CDK
complexes and Rb phosphorylation (P) status are outlined. An intact restriction point that
occurs during G1 is demonstrated. The different cyclin-dependent kinase inhibitors (CKIs)
that act on different regulators of the cell cycle are also shown.
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Cell Cycle Control of Embryonic Stem Cells
Embryonic stem cells (ESCs) are unique cells that have the capacity for infinite cell
proliferation events while maintaining their ability to differentiate into any cell type of an
organism. ESCs demonstrate a rare cell cycle arrangement (Stead et al., 2002), with a
remarkably short G1 phase and the majority of cells found in S phase (Figure 2) (Faast et
al., 2004; Fujii-Yamamoto, Kim, Arai, & Masai, 2005; Savatier, Lapillonne, Jirmanova,
Vitelli, & Samarut, 2002; J. White et al., 2005). Many studies have implicated a number of
cell cycle regulators in mouse ESCs (mESC). High expression of cyclins D1, D3, E, A and
B have all been characterized in mESCs (Savatier, Lapillonne, van Grunsven, Rudkin, &
Samarut, 1996; Stead, et al., 2002; J. White, et al., 2005), while Cyclin D2 levels are very
low in these cells (J. White, et al., 2005; Wianny et al., 1998). All CDKs that are expressed
in somatic cell cycles have also been described in ESCs and bind with their known cyclin
partners, with the exception of CDK4 (Savatier, Huang, Szekely, Wiman, & Samarut,
1994; Stead, et al., 2002). Interestingly, the Cyclin D3-CDK6 complex shows much higher
activity than its G1 counterpart Cyclin D1-CDK4 complex in mESCs (J. White, et al.,
2005). While cyclin levels oscillate in a very strict manner during the somatic cell cycle,
they are expressed at constant levels during the ESC cell cycle, regardless of the phase
(Stead, et al., 2002). mESCs also lack cell-cycle regulated transcription (Savatier, et al.,
1996; Stead, et al., 2002; J. White, et al., 2005). It appears that cell-cycle mechanisms have
to make a switch from constantly elevated in pluripotent ESC to cell-cycle phasedependent expression during differentiation (J. White, et al., 2005). The numerous cyclins,
CKIs and CDKs need to be differentially expressed to allow for differentiation and linage
commitment (J. White & Dalton, 2005).
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Figure 2: Comparisons of cell cycle structures in ESCs and differentiated cells. The
constantly active cyclin-CDK complexes along with a continually hyper-phosphorylated
Rb help shorten the G1 phase in ESCs which ultimately leads to a shortened cell cycle. In
differentiated cells, the G1 phase undergoes a noticeable lengthening of the G1 phase
which contributes to an overall longer cell cycle.
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Cell Cycle Regulators, Immortalization and Stem Cell Self-Renewal
There are notable links between cell cycle machinery and stem cell self-renewal
mechanisms. First, the activity of cyclin-CDK complexes are frequently upregulated in
immortalized cells. These are thought to be due to mutations that can result in unrestricted
cell proliferation. For example, knockout studies in mice reveal that inactivation of Rb
results in immortalization of primary cells (Sage et al., 2000). These cells present with a
shortened G1 phase and proliferate at increased rates (Dannenberg, van Rossum, Schuijff,
& te Riele, 2000). This is complemented by a loss of contact-dependent inhibition, decrease
in necessity of external mitogenic signals and a reduction in cell size (Schratt et al., 2001),
all of which are characteristic ESC traits. Furthermore, experiments overexpressing cyclins
A or E concluded that this was a mechanism of overriding pRb-mediated growth arrest and
provided a path for cell transformation (Hinds et al., 1992). A number of other pathways
that have been implicated in self-renewal are also required for regulation of cell cycle
machinery, suggesting that there may in fact be connections between cellular proliferation
and self-renewal (Burdon, Smith, & Savatier, 2002; T. C. He et al., 1998; Liang &
Slingerland, 2003; Roussel, 1998). In total, the links between the cell cycle and stem cell
self-renewal establish a unique role for cell cycle regulation as an essential component for
the maintenance of the pluripotent state.

Adult Neurogenesis and the Discovery of NSCs
Neurogenesis is defined as the process of producing new functional neurons from neural
stem cells (NSCs) (G. L. Ming & Song, 2005). Until recently, this process was believed to
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only occur in embryonic and perinatal stages of the mammalian brain. This does not hold
true any longer. Studies conducted in the 1960’s were some of the first to provide evidence
for the presence of the production of new cells in the postnatal rat brain (J. Altman & Das,
1965). The generation of new neurons in the adult brain were first demonstrated in
songbirds (Paton & Nottebohm, 1984); however, the field did not gain momentum until
discoveries in the 1990s supporting a role for neurogenesis in the adult mammalian brain.
The technique of lineage tracing through the use of a thymine analog, bromodeoxyuridine
(BrdU), has aided the study of neurogenesis for decades (H. G. Kuhn, Dickinson-Anson,
& Gage, 1996). It was an important tool in proving that neurogenesis is a life-long and
continuous process in mammals (P. S. Eriksson et al., 1998). Advancements in techniques,
including microscopy enabled the co-labeling of neurons and proliferating cells in vivo,
experiments that were needed to demonstrate that rapidly dividing cells eventually became
neurons (Kempermann, Kuhn, & Gage, 1997; H. G. Kuhn, et al., 1996). Lastly, the
advancement in methods for the isolation, expansion and differentiation of NSCs was a
breakthrough that gave researchers the ability to study the cellular and molecular
characteristics of NSCs in more detail in vitro (Kilpatrick & Bartlett, 1993; T.D. Palmer,
Ray, & Gage, 1995; T. D. Palmer, Takahashi, & Gage, 1997; B. A. Reynolds & Weiss,
1992).
The ability to culture and observe adults NSCs in vitro led to experiments which
confirmed their identity as true stems cells. One fundamental property of stem cells is their
ability to self-renew indefinitely. Cells isolated from the striatum of adult mouse (between
3 to 18 month old mice) brains cultured in the presence of epidermal growth factors (EGF)
in serum-free media were able to proliferate indefinitely and were positive for the stem cell
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marker NESTIN. These cells grew in spheres, termed neurospheres, composed of
proliferating cells. When these spheres were dissociated and reseeded as single cells, they
formed secondary spheres which were also positive for NESTIN (B. A. Reynolds & Weiss,
1992). The second fundamental property of stem cells is their ability to differentiate and
give rise to committed cell populations. Spheres produced in the presence of EGF were
dissociated and plated onto a substrate that would test whether these cells could
differentiate into the main cell types of the CNS. Indeed, after 21 divisions, these cells were
positive for the intermediate filament GFAP and neuron specific enolase (NSE), indicating
the generation of astrocytes and neurons, respectively from NESTIN positive cells (B. A.
Reynolds & Weiss, 1992). Moreover, proliferative cell populations isolated from mice
older than 60 days and cultured in serum-free conditioned media in the absence of both
EGF and basic fibroblast growth factors (bFGF) were able to give rise to neuronal cells (L.
J. Richards, Kilpatrick, & Bartlett, 1992). Cells competent of long-term self-renewal as
well as differentiation were also identified in human brains. Through the use of electron
microscopy, immunocytochemistry and reverse transcriptase polymerase chain reaction
(RT-PCR) in surgical biopsies of adult humans (24-47 years), it was demonstrated that the
human brain contains a stem cell population which grow as neurospheres in vitro and give
rise to neurons, astrocytes and oligodendrocytes (Kukekov et al., 1999). In another study,
the dentate gyrus of adult human brains were isolated and transfected with a vector
containing a green fluorescence protein (GFP) placed under the transcriptional control of
the Nestin promoter. These cells were able to give rise to βIII tubulin and microtubuleassociated protein (MAP2) expressing neurons that demonstrated electrophysiological
function (Roy et al., 2000). The discovery of adult neurogenesis and the identification of
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NSCs in the adult brain are features that cannot be overlooked especially in terms of central
nervous system (CNS) development, neurological disorders and malignancies of the CNS.

The Neurogenic Niches of the Adult Mammalian Brain
The stem cell niche is a microenvironment in a tissue or organ that physically houses stem
cells and has the ability to control and maintain their development in vivo. First revealed
in the hematopoietic system (Schofield, 1978), niches have been described in many models
since then, including mammalian skin and intestine (Morrison & Spradling, 2008). In the
adult mammalian brain, two unique regions have been described as the neurogenic niches
that house NSCs (Ihrie & Alvarez-Buylla, 2011; Riquelme, Drapeau, & Doetsch, 2008).
These stem cell niches are found in the subventricular zone (SVZ) of the lateral ventricles
and the subgranular zone (SGZ) of the dentate gyrus. Specific cellular organization within
each of these neurogenic niches are required to maintain healthy stem cell populations,
guide cell fate decisions and control the regenerative capacity of the NSCs that are housed
within the them.
The SVZ niche is comprised of four different cell types including ependymal cells
(type E), slow proliferating cells (type B), transit amplifying progenitors (type C), and
neuroblasts (type A). The ependymal cells line the walls of the lateral ventricles and aid in
the circulation of cerebrospinal fluid. Slow proliferating B cells express Nestin, are found
adjacent to the ependymal cells and surround the newly generated neuroblasts. Neuroblasts
are proliferating cells that organize themselves into chains that eventually converge on the
rostral migratory stream. Finally, immature and highly proliferative transit amplifying cells
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also express NESTIN and are found scattered in between all the other aforementioned cell
types (F. Doetsch & Alvarez-Buylla, 1996; F. Doetsch, Caillé, Lim, García-Verdugo, &
Alvarez-Buylla, 1999; F. Doetsch, García-Verdugo, & Alvarez-Buylla, 1997; C. Lois,
Garcia-Verdugo, & Alvarez-Buylla, 1996; Luskin, 1993).
The SGZ niche is an anatomically smaller niche than its neighbour, the SVZ.
Similar cell types are found within the SGZ that are also found in the SVZ. The four cell
types found in the SGZ are the radial glial cells, transit amplifying progenitor cells,
neuroblasts, and postmitotic neurons (Seri et al., 2004). The radial glial cells are considered
the NSCs of the SGZ and also express NSC markers NESTIN and SOX2. Radial glial cells
have also give rise to new neurons in vitro (T. D. Palmer, et al., 1997). Transit amplifying
cells, similar to those found in the SVZ, are a pool of highly proliferative cells that represent
the beginning of fate-choice decisions. The neuroblasts characterize the latter stages of
fate-choice during NSC development which will eventually generate postmitotic neurons.
Finally, postmitotic neurons mature and eventually become part of the hippocampal
circuitry (Seri, Garcia-Verdugo, McEwen, & Alvarez-Buylla, 2001; Seri, et al., 2004; H.
J. Song, Stevens, & Gage, 2002).

Molecular Mechanisms that Regulate Neurogenesis
Many intrinsic and extrinsic mechanisms are required to coordinate the features of
neurogenesis. These may include niche-specific factors or receptors, cytoplasmic proteins,
transcriptional factors, cell cycle regulators and epigenetic regulators. Extrinsic growth
factors, cytokines and neurotrophins play and important role in neurogenesis (C. Zhao,
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Deng, & Gage, 2008). Notch and Sonic hedgehog (SHH) signaling are among the pathways
that play a significant role in the maintenance of NSC identity and fate-choice decisions
(Ahn & Joyner, 2005; Alexson, Hitoshi, Coles, Bernstein, & van der Kooy, 2006; Banerjee
et al., 2005; Hu et al., 2011; Palma et al., 2005). Notch signalling is important in the
maintenance of the quiescent radial glia-like cells in the SVZ (Imayoshi, Sakamoto,
Yamaguchi, Mori, & Kageyama, 2010; Pierfelice, Alberi, & Gaiano, 2011). SHH has been
implicated in the maintenance of radial glial-like NSCs in both the SVZ and the SGZ (Ahn
& Joyner, 2005; Balordi & Fishell, 2007; Y. G. Han et al., 2008).
Intrinsic regulators of neurogenesis include transcription factors, epigenetic
modulators, and cell cycle regulators (C. Zhao, et al., 2008). A major transcription factor,
SOX2, is a key regulator of the Notch signalling pathway to help maintain the NSC
population (Ehm et al., 2010). As expected, the depletion of SOX2 in mice led to the failure
of neurogenesis (Favaro et al., 2009). Many other transcription factors have been
implicated in the maintenance of NSCs including the inhibitor of DNA binding (ID) genes
and the forkhead transcription factor (FOXO) family members (Nam & Benezra, 2009;
Paik et al., 2009; Renault et al., 2009). Epigenetic mechanisms such as DNA methylation
and histone modifications preform crucial roles in neurogenesis (D. A. Lim et al., 2009; C.
Liu et al., 2010; Molofsky et al., 2003). Finally, cell cycle regulators including inhibitors
p16, p21 and p53 play major roles in the maintenance of the NSC population. The role of
the cell cycle and the inhibitory regulators will be discussed in further detail in the
following sections. A number of different factors regulate proliferation and fate
determination of NSCs and coordinate with each other to ensure this population is
maintained throughout life.
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Cell Cycle Regulation of NSCs
Neurogenesis is reliant on a reservoir of slow dividing, or quiescent (G0), NSC populations
(Codega et al., 2014; DeCarolis et al., 2013). If the pool of quiescent cells becomes
exacerbated or loses its genomic integrity, neurogenesis will fail to occur (T. E. Kippin,
Martens, & van der Kooy, 2005). CKIs, including p21 (T. E. Kippin, et al., 2005) and p57
(Furutachi, Matsumoto, Nakayama, & Gotoh, 2013; Furutachi et al., 2015) aid in the
maintenance of this quiescent state. Quiescent NSCs will re-enter the cell cycle to divide,
either symmetrically or asymmetrically, in the face of external cues or injury. Unlike the
CKIs, several oncogenes and other cell cycle related players are involved in activating
quiescent NSCs to re-enter the cell cycle (Geng et al., 2003; Y. Z. Wang, Plane, J.M., Jiang,
P., Zhou, C.J., Deng, W., 2011). Maintenance of adult NSCs relies on a number of cell
cycle-associated regulators, including G1 cyclins and CKIs, which play roles in division
symmetry and length of the G1 phase of the cell cycle, that ultimately direct the fate of this
cell population.

The Role of G1 Cyclins and CDKs in NSCs
Stem cell differentiation is correlated with a lengthening of the cell cycle, specifically a
longer G1 phase (Beukelaers et al., 2011; Calegari, Haubensak, Haffner, & Huttner, 2005;
Molofsky, Pardal, & Morrison, 2004). Neurogenesis begins at embryonic day 11 (E11) in
mice and by E16, the majority of NSCs have stopped proliferating and entered the state of
quiescence in which they will remain as the NSCs of the adult mouse brain (Gotz &
Huttner, 2005; A. Kriegstein & Alvarez-Buylla, 2009). BrdU labeling has demonstrated
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that the length of the cell cycle in the NSCs of the SVZ increases throughout development.
The NSC cell cycle is approximately 8 hours at E11 and by E16 it has reached 18 hours,
with G1 phase alone increasing in duration by nine hours (T. Takahashi, Nowakowski, &
Caviness, 1995a).
Mechanistically, G1 phase can be lengthened by inhibition of Cyclin E-CDK2,
prompting an induction of premature differentiation supporting that G1 phase lengthening
is adequate enough to prompt differentiation (Calegari & Huttner, 2003). Many studies
have verified this conclusion through observations made by genetic manipulation of G1
cyclin-CDK activity in vivo (Table 1). D-type cyclins help regulate the earlier portion of
G1 which is largely mitogen-dependent. Many studies have demonstrated that this early
portion of G1 is a critical time where important cell fate decisions are made (Calegari &
Huttner, 2003; Sherr, 2000; T. Takahashi, et al., 1995a). Knockout of Cyclin D1 in NSCs,
results in upregulation of Cyclin D2 which had a compensatory effect and no differences
were observed in G1 length as well as differentiation compared to controls (Glickstein,
Monaghan, Koeller, Jones, & Ross, 2009; Lange, Huttner, & Calegari, 2009; Ochiai et al.,
2009). On the other hand, knockout of Cyclin D2 in NSCs was not compensated by Cyclin
D1. Depletion of Cyclin D2 lead to lengthening of G1, an increase in differentiation and a
decrease in proliferation (Glickstein, et al., 2009). The use of in-utero electroporation to
manipulate genes in a tissue-specific manner has significantly improved the ability to study
CNS development in mammals. This technique was used to overexpress the Cyclin D1CDK4 complex. Analysis revealed that these animals showed an inhibition of neurogenesis
and a decrease in differentiation. As expected, when short interference RNA (siRNA) was
used against the Cyclin D1-CDK4 complex, the opposite occurred. These animals
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displayed a lengthening of the NSC G1 phase, increase in differentiation and a decrease in
proliferation (Lange, et al., 2009). Inhibition of the Cyclin E-CDK2 complex through
chemical means lengthened G1, induced neurogenesis, increased differentiation and
inhibited proliferation (Calegari & Huttner, 2003). Overexpression of Cyclin D1 or Cyclin
E1 decreased G1 length, decreased differentiation and neurogenesis (Lange, et al., 2009).
It is very evident that in the developing brain of mouse embryos, manipulation of G1 phase
cyclins, Cyclin D or Cyclin E, either alone or in conjunction with their CDK counterparts
greatly affects G1 length, neurogenesis ability, differentiation potential and proliferative
capacity in the NSC population. Hence, this suggests that G1 lengthening of NSC cell cycle
is a necessary component to induce differentiation
Adult NSCs resemble their embryonic counterparts in many ways. They express
similar molecular markers, such as NESTIN and SOX2, while continuing to produce
committed progenitors that eventually fully differentiate (A. Kriegstein & Alvarez-Buylla,
2009). However, while all three D-type cyclins are expressed in the developing embryonic
brain, only Cyclin D2 is expressed in NSCs of the adult brain (Kowalczyk et al., 2004).
Adult NSCs are crucially dependent on Cyclin D2 and the knockout results in a complete
block of the cell cycle and complete inhibition of neurogenesis (Kowalczyk, et al., 2004).
The olfactory bulb, a region where newly generated neurons are found, are significantly
reduced in size in the Cyclin D2 NSC knockouts (Kowalczyk, et al., 2004). Other than
Cyclin D2, there are no further reports showing the effects of manipulating any other
cyclins or CDKs in the adult mammalian brain. Experiments to fill these empty gaps will
be essential to determine if manipulating other cell cycle regulatory genes will have any
adverse effects on G1 length and how they may disturb either the expansion or
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differentiation of NSCs in the adult mammalian brain. Ultimately, experiments such as
these will contribute towards understanding adult neurogenesis and could have
implications in diseases and disorders of the CNS. In summary, G1 cell cycle regulation
plays an essential role in neurogenesis and NSC cell-fate determination, and modulation of
the G1 phase changes the cell’s ability to maintain its quiescent state.
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Table 1. Effects of G1 phase manipulations on developing and adult mouse brains.
Green arrows are indicative of an increase in cyclin-CDK levels or activity, an increase in
G1 phase length, increase in differentiation, and increase in proliferation. In contrast, red
arrows are indicative of a decrease in cyclin-CDK levels or activity, a decrease in G1 phase
length, decrease in differentiation, and decrease in proliferation. Ph. Inh represents the use
of a pharmacological inhibitor.
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Function of p53 in NSCs
The role of p53 has been characterized in NSCs and is implicated in the regulation of selfrenewal, modes of cell division, quiescence, survival and proliferation (K. Meletis et al.,
2006). Proper development of the CNS is reliant on a central process of neuronal death to
ensure that the proper neural connections are established in the brain (W. B. Jacobs,
Kaplan, & Miller, 2006). p53 plays a crucial role in this process, and consequently, a
proportion of p53 knockout mice develop exencephaly as a result of decreased apoptosis
in the developing CNS (Armstrong, Kaufman, Harrison, & Clarke, 1995; Sah et al., 1995).
Although the role of p53 in neuronal cells has been described extensively, little is known
regarding its role in other cell types in the brain including astrocytes, oligodendrocytes, as
well as their progenitors.
In NSCs, the loss of p53 leads to enhanced proliferation as was demonstrated by
p53 knockout mice (Tsukada et al., 1993). Overall, endogenous p53 expression is highest
in neurogenic regions of the mammalian brain and it is the cells housed within the SVZ
that display enhanced proliferative capacity in p53 knockout mice. p53 null cells produce
neurospheres that have increased self-renewal, increased cell proliferation, and decreased
apoptosis (A. Armesilla-Diaz et al., 2009; K. Meletis, et al., 2006). When further
characterized, p53 null NSCs transcriptomes reveal a decrease in both p21 and p27 (K.
Meletis, et al., 2006). In summary, p53 loss creates an advantage for NSCs and early
progenitor cells through increased self-renewal and decreased differentiation.

22

p21 in NSCs of the Adult Mammalian Brain
Adult stem cells found in various systems of an organism can be pushed to abandon their
quiescent state in vivo and remain proliferative through the suppression of specific CKIs.
A decrease or inactivation of p21 in NSC populations disrupts quiescence and results in a
hyperproliferative state that leads to ablation of this population later on in life (T. E. Kippin,
et al., 2005). In accordance, the loss of p21 through the use of a p21-/- mouse, initially
disrupts NSC quiescence and results in increased neurosphere formation and increased
proliferation in mice 2-8 months old. However, persistent and continued loss of p21
resulted in decreased neurosphere formation and decrease in BrdU+ cells in vivo,
demonstrating the ablation of the NSC population in older mice (>16 months) due to the
continued hyperproliferative state of these NSCs (T. E. Kippin, et al., 2005). In addition,
p21 transcriptionally represses Bmp2 in a cell cycle-independent manner. It was also shown
that the loss of p21 in the NSCs leads to their premature differentiation into astrocytes
(Porlan et al., 2013).
p21 can also act in a cell cycle-independent manner to maintain the NSC pool.
Particularly, p21 can act as a transcription factor at specific promoters. p21 binds to the
Sox2 regulatory enhancer region, which inhibits the expression of Sox2 in NSCs. The
deletion of p21 increased SOX2 levels, which led to replicative stress and culminated in
NSC growth arrest due to an activation of p53 and p19 (Marques-Torrejon et al., 2013).
The modulation of both the cell cycle, and factors, such as Sox2 and Bmp2, by p21 are
regulatory mechanisms that help maintain the NSC population by controlling their
proliferation and quiescence in the adult mammalian brain in vivo. This supports the idea
that the relative adult NSC quiescence is associated to their longevity and potentiality.
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p27 in NSCs
It’s been suggested that p27 inhibits proliferation during CNS development (Durand, Fero,
Roberts, & Raff, 1998; Durand, Gao, & Raff, 1997). Early studies on the role of p27 in the
CNS recognized its importance as part of the differentiation program required for
progenitor cells to properly give rise to committed cell types at specific developmental
times (Durand, et al., 1997). The overexpression of p27 in some brain precursor cells
results in decreased proliferative capacity during embryonic development. Lastly, the loss
of p27 resulted in an increase of the transit-amplifying progenitor population through
enhanced proliferation, and a decrease in differentiation to more committed cells of the
brain (F. Doetsch et al., 2002).
In the adult mammalian brain, deletion of p27 in the neural progenitor cells of the
SVZ results in increased proliferation (Lukaszewicz et al., 2005). Interestingly,
experiments that involved the overexpression of p27 in SVZ NSCs reported an increase in
G1 length without disruption of differentiation (Mitsuhashi et al., 2001). In another study,
the overexpression of p27 increased neural differentiation without changing the length of
G1 phase (Tarui et al., 2005). Recently, experiments revealed that p27, similarly to p21,
was able to transcriptionally repress Sox2 (H. Li et al., 2012). Consistent with the function
of p21, expression of p27 seems to also be important in the maintenance of NSC quiescence
downstream of Bmp (Andreu et al., 2015). Overall, p27 appears to play different roles
during neural development, including the promotion of proper differentiation and
preservation of quiescence.
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p16 in NSCs and Aging of the Adult Mammalian Brain
It is widely accepted that aging of the brain induces a significant decline in the proliferation
of cells found at neurogenic sites, this is mostly attributed to age-dependent cellular
senescence. The CKI p16 accumulates at proliferative neurogenic sites of the adult brain
as time progresses, which could provide a molecular basis for senescence in aging cells
(Molofsky et al., 2006). Supporting this theory, the increase of p16 levels contribute to the
decline in NSC replicative function with age (Sharpless & DePinho, 2007). p16 deficiency
rescues the aging decline of NSC neurosphere forming capacity which allows NSCs to
continue to self-renew throughout aging (Molofsky, et al., 2006). p16 is transcriptionally
regulated by BMI1. Studies using BMI1-/- mice showed that the decline in NSC selfrenewal was rescued through deletion of p16 (Bruggeman et al., 2005; Molofsky, He,
Bydon, Morrison, & Pardal, 2005). This evidence suggests that NSC maintenance in the
adult mammalian brain is dependent on the transcriptional regulators that repress p16
(Molofsky, et al., 2006). Evidently, p16 seems to play an important role in regulating the
senescence pathway of the aging brain.

NSC Mode of Division
Before neurogenesis initiates (~E9-E11), NSCs undergo symmetric cell division to selfrenew, thereby creating more daughter NSCs that have similar proliferative capacity (S. K.
McConnell, 1995; Rakic, 1995). Once neurogenesis begins, the mode of division shifts
from symmetric to predominantly asymmetric. This shift towards asymmetric cell division
is responsible for creating a large pool of the more mature radial glial-like and basal
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progenitor NSCs that will eventually generate the entire brain (Götz & Huttner, 2005).
These cells still retain vital NSC characteristics, including apical-basal polarity and the
expression of the stem cell marker Nestin (Gotz, 2003; A. R. Kriegstein & Gotz, 2003).
The basal progenitor cells will be responsible in forming the SVZ through symmetric
divisions that will result in two differentiated daughter neurons in order to increase the
number of cells in the SVZ (Götz & Huttner, 2005). Hence, the mode of NSC division is
important throughout embryonic and postnatal stages of CNS development. The shift
between symmetric to asymmetric division ultimately allows the upsurge of progenitor
populations, which will differentiate into the various cell types of the brain. NSC
asymmetric division is characterized by the distribution of cell fate determinant proteins in
a specific apical basal manner in the new daughter cells (Götz & Huttner, 2005; Tsunekawa
et al., 2012). A few of these cell fate determinants have been revealed and include Numb
and Par complex proteins (Wodarz & Huttner, 2003). Throughout progression of
development, cells that are dividing asymmetrically present with longer cell cycles, in large
part due to an increase in length of the G1 phase (T. Takahashi, Nowakowski, & Caviness,
1995b). It’s been suggested that cell cycle regulators that affect G1 length may also play
roles in the function of cell fate determinants (Caviness, Takahashi, & Nowakowski, 1995).
Ultimately, this suggests that cell cycle regulators, especially those involved in the G1
phase, may contribute to NSC mode of division.
G1 cyclin-CDKs play a key role in regulating the mode of division of NSCs. In
CDK2/4 double-knockout mice, neural progenitors increase the length of G1 phase and
have an increased differentiation capacity in vitro, as well as a decrease in basal progenitor
NSCs and increased differentiation in vivo (S. Lim & Kaldis, 2012b). Interestingly, radial
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glial-like NSCs that are asymmetrically dividing show preferential and biased separation
of Cyclin D2 into the new daughter cells (Tsunekawa, et al., 2012). This work illustrates
that both Cyclin D2 protein and mRNA are highly expressed at the initiation of
neurogenesis, however, only at the basal pole of the radial glial-like NSCs (Glickstein,
Alexander, & Ross, 2007; Tsunekawa, et al., 2012). Mechanistically, this preferential
segregation of cyclin D2 is thought to result from both transportation and local translation
of Cyclin D2 mRNA. When asymmetric division is occurring, Cyclin D2 is favourably
divided into the nucleus of the self-renewing daughter NSC. Here it will continue to
function as a fate determinant to promote NSC properties (Glickstein, et al., 2009;
Tsunekawa, et al., 2012).
The most comprehensive evidence regarding the role of Cyclin E in neural cell fate
determination and mode of division mechanisms arise from studies that have been
conducted in Drosophila. The NSCs of the Drosophila embryo have high Cyclin E
expression levels that localize favourably in a particular daughter cell versus another (C.
Berger, Pallavi, S.K., Prasad, M., Shashidhara, L.S., Technau, G.M., 2005). Differential
expression of Cyclin E in the resulting daughter cells maintain the NSC fate. Cyclin E binds
to Prospero, a cell-fate determinant protein, hinting that Cyclin E could play a role in
differential localization of fate determinants during asymmetric NSC division (C. Berger
et al., 2010). Unlike the NSCs of the Drosophila thoracic region, the NSCs found in the
abdominal segments mechanistically down regulate Cyclin E levels so that the cell can
undergo symmetric cell division, producing two identical differentiated glial cells (C.
Berger, Pallavi, S.K., Prasad, M., Shashidhara, L.S., Technau, G.M., 2005). The selfrenewing NSCs of the Drosophila CNS give rise to progeny known as ganglion mother
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cells (GMCs). These cells undergo asymmetric cell division (Thomas, Bastiani, Bate, &
Goodman, 1984; Wai, Truong, & Bhat, 1999). It was later revealed that biased segregation
of Cyclin E in GMCs maintains the self-renewing property of these cells (Bhat & Apsel,
2004).
The mechanisms that have been covered so far regarding G1 regulators in the
Drosophila CNS cell fate determination have yet to be implicated in vertebrates.
Nevertheless, Cyclin E has been implicated in cell fate determination in the mammalian
CNS. The effects of Cyclin E1 on cell fate was first demonstrated in ex vivo experiments.
Overexpression of Cyclin E in mice brains was responsible for the promotion of
asymmetric proliferative cell-fate decisions (Pilaz et al., 2009b).
In conclusion, G1 phase cell cycle regulators can alter the mode of division to
regulate cell fate, particularly, through affecting G1 phase length. Overall, the support for
cyclins in the role they play towards delaying terminal differentiation of post-mitotic cell
populations is undeniable. Notably, cyclin overexpression, especially D-type and E-type
cyclins, maintains the amplifying precursors in the cell cycle constantly so that they are
continually undergoing self-renewal. Therefore, it can be speculated that G1 phase cyclins
increase symmetric division due to the fact that they don’t allow cell fate determinants
enough time to properly segregate and complete their effects (Figure 3) (Calegari &
Huttner, 2003; Gotz & Huttner, 2005). The correlation between the length of G1 and mode
of division, provides a cell-cycle dependent mechanism through which cell cycle regulators
can regulate cell fate during neurogenesis. Ultimately, this supports the idea that cyclinCDK complexes can have roles in cell fate by exerting their effects on symmetry of
division.
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Cell Cycle-Independent Regulation of Self-Renewal by Cyclin/CDKs
Although cell cycle-dependent mechanisms of cyclins have been extensively reviewed, the
cell cycle-independent mechanisms are mostly unknown. The switch from one cell type to
another during differentiation requires extreme changes in gene expression. Cell cycle
regulators have been implicated by their ability to effectively induce global changes to
transcriptional programs. In NSCs, CDK activity is necessary for the hyperphosphorylation of Neurogenin 2 (NGN2), a proneural transcription factor that helps to
establish the committed neuronal program. The hyper-phosphorylation of NGN2 reduces
its ability to bind DNA to turn on neuronal genes, and therefore inhibits their expression
(Ali et al.). Furthermore, p27 negatively regulates self-renewal by binding and stabilizing
the NGN2 protein, allowing NGN2 to transcriptionally activate the expression of proneural
genes in committed cell types (Nguyen et al., 2006). The involvement of cyclins, CDKs
and CKIs in cell fate determination is extensive. Cell cycle regulation is restricted to not
only coordinating events that are responsible for the division of a cell, but also other
responsibilities, such as cell fate determination to ensure that appropriate cell types are
produced during neurogenesis in a timely manner. Surely, in due time, more will be
discovered regarding the continued association between cell cycle and self-renewal.
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Figure 3. G1 phase length and mode of division. G1 phase regulators can influence G1
phase length duration so that in the shortest time spent in G1 (far left) both daughter cells
maintain stem cell properties. As the G1 phase starts to increase in duration, the NSC can
shift to asymmetric cell division (middle) to that one daughter is starting to differentiate
into a more committed fate due to time that cell fate determinants have to act on the cell.
Further increase in G1 phase gives cell fate determinants ample time to act on the cell in
which both daughter cells will differentiate into more committed cells (far right).
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DNA Damage Response in NSCs
It is becoming increasingly apparent that the response to DNA damage in stem cells is quite
different than the response exhibited in differentiated cells. How cells respond to DNA
damage is crucial in tissue homeostasis. The canonical DNA damage response (DDR)
mechanism and downstream signalling pathway are functional in NSCs of the mammalian
brain (Schneider, Fumagalli, & d’Adda di Fagagna, 2012). In the rat brain, ionizing
radiation (IR) induced apoptosis in the SVZ (Bellinzona, Gobbel, Shinohara, & Fike,
1996a). Induction of DNA double-strand breaks (DSBs) by IR leads to cellular senescence
regardless of a decrease in gene expression of DDR genes such as ATM, CHK2, TP53 and
H2AX. Furthermore, DNA damage was demonstrated to induce astrocyte differentiation
through Bmp2 signaling (Schneider et al., 2013). Therefore, DNA damage seems to
withdraw the ability of NSCs to self-renew and induces them to differentiate. Moreover,
another study observed that post IR exposure, the transit-amplifying cell population had
decreased proliferation. Interestingly, it was also demonstrated that quiescent NSCs of the
SVZ were forced to exit dormancy following IR (Daynac et al., 2013). Most recently, in
vivo experiments following IR reveal that the response to DNA damage is cell typespecific, not proliferative status-specific. Progenitor cell populations activate apoptosis,
undergo cell cycle arrest and increased differentiation following IR. However, in this case,
the quiescent NSCs don’t undergo apoptosis following IR, instead they re-enter the cell
cycle to produce an increased amount of differentiated cells (Barazzuol, Ju, & Jeggo,
2017). The DDR in NSCs seems to be coordinated in a manner to remove damaged cells
in order to aid in repopulation and maintain tissue structure.
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NSCs; Implication in Psychiatric and Neurodegenerative Diseases
Studies regarding the brain and NSCs have shifted from neurogenesis alone towards
understanding the role of neurogenesis in brain health and disease. A number of studies
report correlations between NSCs, neurogenesis and neurological disorders (M. Han, Lee,
& Koh, 2016; H. Liu & Song, 2016). It has been suggested that these changes in
neurogenesis contribute to symptoms of brain disease as well as progression. Alterations
in neurogenesis resulting in a reduced size of the hippocampus have been implicated in
brain disorders including schizophrenia, depression and anxiety (Jun, Hussaini, Rigby, &
Jang, 2012). Patients with depression have cognitive defects that are attributed to decreased
SGZ neurogenesis (B. R. Miller & Hen, 2015). Moreover, evidence implies that
impairment of SGZ neurogenesis is part of the schizophrenic pathology (Duan et al., 2007;
Kvajo et al., 2008).
In addition to psychiatric disorders, some neurodegenerative diseases, such as
Parkinson’s disease (PD) and Alzheimer’s disease (AD), have aberrant changes in adult
neurogenesis (Crews, Rockenstein, & Masliah, 2010; Kohl et al., 2016; Rodriguez et al.,
2008; B. Sun et al., 2009). Neurogenesis is impaired in transgenic mouse models that
harbour mutations in PD-related genes that result in decreased proliferation and survival of
newly generated neurons, as well as decreased proliferation of the NSC population of the
SGZ (Marxreiter, Regensburger, & Winkler, 2013; Winner, Kohl, & Gage, 2011; Winner
et al., 2004; Winner et al., 2012). Studies related to AD and neurogenesis are much less
conclusive; AD mouse transgenic models have reported both increased and decreased
neurogenesis (Lazarov & Marr, 2010). These differences were in part due to variety of
experimental conditions, and the difficulty of delineating intrinsic and extrinsic effects of
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AD in the NSCs and the neurogenic niches (Lazarov & Marr, 2010; Marlatt & Lucassen,
2010; Mu, Lee, & Gage, 2010). The studies which reported decreased neurogenesis
attributed it to decreased proliferation and a significant inhibition of neuronal lineage
differentiation of the NSC populations (Choi et al., 2008; Rodriguez, et al., 2008).
Advancements in understanding adult neurogenesis will contribute to knowledge on
neurodegenerative disorders and may elucidate potential effective treatments for these
patients.

NSCs; Implications in Learning and Memory
Neurogenesis in the SGZ of the hippocampus is linked to memory formation, acquisition
and maintenance (Saxe et al., 2006; Shors, Townsend, Zhao, Kozorovitskiy, & Gould,
2002; Snyder, Hong, McDonald, & Wojtowicz, 2005; Winocur, Wojtowicz, Sekeres,
Snyder, & Wang, 2006; C. Zhao, et al., 2008). Most studies undertaken in neurogenesis of
the SGZ support the conclusion that promotion or inhibition of neurogenesis corresponds
to enhancement or diminished learning and memory performance, respectively. In a study
conducted on rats, enhanced neurogenesis correlates with an increase in spatial learning
performance through the maze water task (Nilsson, Perfilieva, Johansson, Orwar, &
Eriksson, 1999) and increased memory in the novel object recognition test (BruelJungerman, Laroche, & Rampon, 2005). Conversely, impaired neurogenesis was
associated with a decrease in novel object recognition and reference memory performance
(Bonnet et al., 2008; Graciarena, Depino, & Pitossi, 2010; Jaako-Movits & Zharkovsky,
2005). The influence of adult neurogenesis on learning new information and memory
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formation is strong and evidence supporting this is constantly emerging. Disruption of
normal adult neurogenesis by any means negatively affects learning and memory.

NSCs; Implications in Malignancies of the CNS
Malignant gliomas signify some of the hardest to treat cancers worldwide and remain some
of the most lethal (Louis et al., 2007). The similarities and parallels between normal NSCs
of the adult mammalian brain and cancer stem cells (CSCs) of malignant tumours have
been noted over the past decade. This is largely due to the magnitude of genes that are
commonly expressed in both NSCs and CSCs (Galli et al., 2004; Singh et al., 2003; Stiles
& Rowitch, 2008). Moreover, the fact that brain tumour CSCs are also characterized by
NSC properties suggest that NSCs could play an influential role in tumour development
(Stiles & Rowitch, 2008). Nevertheless, it is still unclear where these CSCs originate from;
there are two different hypothesis of how they may arise in malignant brain tumours. First,
CSCs can originate through transformation of normal NSCs (Hemmati et al., 2003b;
Nakano & Kornblum, 2009; Singh, Clarke, Hide, & Dirks, 2004), where usually the tumour
initiating CSC arises from the quiescent NSC located in the SVZ (Y. Wang et al., 2009).
Evidence in Drosophila supports the hypothesis that CSCs arise from transformed NSCs.
It has been suggested that asymmetric cell division may act as a tumour suppressor
mechanism. In Drosophila, the loss-of-function mutations in critical regulators of
asymmetric cell division (Gomez-Lopez, Lerner, & Petritsch, 2014), including Numb
(Bowman et al., 2008; C. Y. Lee et al., 2006; H. Wang et al., 2006), result in a
hyperproliferative state of the NSCs. In this case, Drosophila NSCs are presumed to switch
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to more symmetric cell division to generate progenitors that fail to differentiate, but instead
continue to proliferate indefinitely.
The second hypothesis is that the CSC may originate from the dedifferentiation of
transformed astrocytes and oligodendrocytes (Bachoo et al., 2002; Uhrbom et al., 2002),
where the loss of tumour suppressors such as p53 induce upregulation of stem cell markers
in mature astrocytes (Molina, Hayashi, Stephens, & Georgescu, 2010; Radke, Bortolussi,
& Pagenstecher, 2013). It seems that both loss of a tumour suppressor and the activation
of an oncogene are necessary to trigger malignancy that arises from astrocytes (Radke, et
al., 2013). This is not true for Nestin-positive NSCs that need only one oncogenic mutation
to induce malignancy (S. Alcantara Llaguno et al., 2009; S. R. Alcantara Llaguno, Chen,
& Parada, 2009). Indeed, it can be hypothesized that genetic altering of the Nestin-positive
NSCs of the brain may be one way in which malignancies of the brain arise.
Tumour initiation and progression and reprogramming to induced pluripotency are
very similar processes. Both processes need the overexpression and/or activation of
oncogenes, inactivation of tumour suppressor including p53 and RB (Hong et al., 2009;
Kawamura, Suzuki, Wang, Menendez, Morera, Raya, Wahl, & Izpisúa Belmonte, 2009; H.
Li et al., 2009), the ability to overcome senescence barriers as well as a number of
epigenetic changes that must occur (Iglesias, Gumuzio, & Martin, 2017). Understanding
of both processes and the mechanisms that regulate them could uncover new cancer
therapies
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The History of Cellular Reprogramming
The recent discovery of induced pluripotent stem cells (iPSCs) is the result of many
decades-worth of knowledge in stem cell principles, findings and developments. The first
breakthrough was the discovery that development enforces reversible epigenetic changes
instead of irreversible genetic changes during lineage commitment and differentiation.
Evidence for this was provided through the use of early stem cell nuclear transfer (SCNT)
techniques in tadpoles and amphibians (Briggs & King, 1952; Gurdon, 1962; Gurdon,
Laskey, & Reeves, 1975; T. J. King & Briggs, 1955). Similar experiments in mammals
revealed that adult cells, including fully differentiated cells have genomes that are
genetically capable of totipotency (Eggan et al., 2004; Hochedlinger & Jaenisch, 2002; K.
Inoue et al., 2005; J. Li, Feinstein, & Mombaerts, 2004). The second most influential step
towards iPSCs was the development of tools and methods that could be used to derive and
culture pluripotent cell lines in order to further study them. This was done through the
formation of pluripotent stem cell lines derived from teratocarcinomas, which were termed
embryonal carcinoma cells (ECCs) (Kleinsmith & Pierce, 1964; Stevens & Little, 1954).
Interestingly, when ECCs were experimentally fused with differentiated somatic cells, the
resulting cell attained properties of ECCs and erased many features of the somatic cell (R.
A. Miller & Ruddle, 1976). This ultimately suggested that there must be factors in ECCs
that can aid in establishing a pluripotent state in somatic cells. The ability to derive and
establish ECCs prompted scientists in the field to determine a method to isolate pluripotent
cells from an embryo. Eventually, ESCs were derived from the inner cell mass (ICM) of
the mouse and human blastocysts (Martin, 1981; Thomson et al., 1998). Finally, the
observation that lineage-associated transcription factors are critical determinants of cell

36

fate and when ectopically expressed and are able to switch one differentiated cell into
another, a process known as transdifferentiation (Davis, Weintraub, & Lassar, 1987; Xie,
Feng, & Graf, 2004), was important for the ultimate discovery of iPSCs.

Discovery and Initial Characterization of iPSCs
Yamanaka and Takahashi (Tokuzawa et al., 2003) created a sophisticated screen to
elucidate the identity of transcription factors that could have the potential to reprogram a
fully differentiated adult cell into a pluripotent cell. In a landmark study, they were able to
use this technique to definitively confirm the establishment of ESC-like colonies following
ectopic expression of retroviral vectors. This led to the identification of a core set of four
transcription factors – OCT4, SOX2, KLF4, C-MYC (OSKM), that in combination with
each other were able to give rise to mouse iPSCs from adult cells (K. Takahashi &
Yamanaka, 2006). These iPSCs expressed pluripotent stem cell markers and were able to
differentiate into cell types of all three germ lineages in vitro (Stadtfeld & Hochedlinger,
2010). They also generated teratomas in vivo and ultimately were able to contribute to
tissue development in embryos after blastocyst injection (Stadtfeld & Hochedlinger, 2010).
Following this study, laboratories around the world were able to improve the
reprogramming process and generated iPSCs that were more similar, both molecularly and
functionally, to ESCs (Maherali et al., 2007; Okita, Ichisaka, & Yamanaka, 2007; Wernig
et al., 2007). iPSCs have been established from many different species such as humans (I.
H. Park, Lerou, Zhao, Huo, & Daley, 2008; Takahash et al., 2007; J. Yu et al., 2007), rats
(W. Li et al., 2009), and rhesus monkeys (H. Liu et al., 2008) through the forced expression
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of the reprogramming factors. This suggests that the fundamental properties of the
pluripotent transcriptional web are universal and conserved throughout evolution.

Mechanisms underlying iPSC Formation
It has been widely demonstrated that the process of reprogramming follows a very strict
and systematized series of events (Figure 4). This sequence of events commences with the
downregulation of somatic cell lineage markers (Stadtfeld, Maherali, Breault, &
Hochedlinger, 2008), followed closely by morphological changes similar to those of a
mesenchymal-to-epithelial transition (MET) (R. Li et al., 2010). Next, early pluripotency
markers, such as SSEA-1 and alkaline phosphatase (AP) are activated. This occurs before
authentic pluripotency factors, including NANOG and OCT4, become expressed and
essentially give cells the ability to start relying more on endogenous gene expression rather
than exogenous genes (Brambrink et al., 2008). Due to the fact that early and late stage
iPSCs are different from one another, it seems to suggest that the reprogramming process
is still incomplete even with active endogenous pluripotency genes. Reprogramming is
believed to be complete after telomere lengthening (Marión, Strati, Li, et al., 2009), and
specific global transcriptional and DNA methylation patterns have been achieved (Chin et
al., 2009; Polo et al., 2010). Lastly, genome-wide chromatin remodelling needs to take
place for the establishment of iPSCs, although it remains unclear when exactly these
changes take place during reprogramming (Maherali, et al., 2007; Mikkelsen et al., 2008).
Due to the extensive, precise and heavily regulated nature of reprogramming, there are
numerous roadblocks that a cell needs to overcome during this process.
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Barriers to Reprogramming
Reprogramming is believed to be stochastic in nature, and in theory all cells should be able
to successfully complete the reprogramming process (Hanna et al., 2009). Practically,
however, this is not the case and current reprogramming efficiencies are quite limited.
Reprogramming attained through the use of integrating vectors demonstrate efficiencies of
0.1%-1%, while nonintegrating techniques show extremely low (~0.001%) efficiencies
(Stadtfeld & Hochedlinger, 2010). In addition, reprogramming occurs at a very slow speed
of approximately two weeks (Brambrink, et al., 2008). Somatic cells have a finite
proliferative potential and when reached, will undergo apoptosis, cell cycle arrest or
cellular senescence in vitro (Collado, Blasco, & Serrano, 2007). Up-regulation of genes
that are important in cell cycle progression and proliferation are early events that need to
occur during reprogramming (Figure 4) (Mikkelsen, et al., 2008). Although an increase in
proliferation seems to be an early event in reprogramming, immortalization is suggested to
be a late stage event (Figure 4) (Brambrink, et al., 2008; Stadtfeld, et al., 2008). The onset
of cellular senescence following ectopic expression of reprogramming factors is termed
reprogramming induced senescence (RIS) and is thought of as one of the major barriers
during reprogramming to iPSCs (Figure 4), and will be discussed in greater detail later
(Banito, Rashid, Acosta, Li, Pereira, Geti, Pinho, Silva, Azuara, Walsh, & al., 2009; Hong,
et al., 2009; Kawamura, Suzuki, Wang, Menendez, Morera, Raya, Wahl, & Belmonte,
2009; Utikal et al., 2009). Investigation of partially reprogrammed cells has revealed that
the expression of lineage-associated genes and DNA hypermethylation act as barriers that
antagonize the progression of a partially reprogrammed cell into a fully reprogrammed
iPSC (Mikkelsen, et al., 2008). Lastly, enormous reconfiguration of chromatin structure,
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such as histone modifications and nucleosome remodeling, present the epigenetic barrier
during reprogramming (Ang, Gaspar-Maia, Lemischka, & Bernstein, 2011). Evidence for
this has been captured through the use of epigenetic inhibitors during reprogramming. The
use of the DNA methyltransferase inhibitor 5-AZA increases the number of fully
reprogrammed cells (Mikkelsen, et al., 2008). Moreover, the addition of histone
deacetylase inhibitors VPA and TSA increase reprogramming efficiency (Huangfu, 2008).
Finally, a chemical inhibitor used to induce histone H3K9 hypomethylation enhanced
reprogramming of fibroblasts to iPSCs (Shi et al., 2008). Evidently, reprogramming is a
multifaceted process involving many coordinated events which present roadblocks to the
final iPSC state.
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Figure 4. Major changes occurring during reprogramming. There are some important
changes that characterize the transition of a differentiated cell to an iPSC. Key differences
between immature and mature iPSC are the full acquisition of telomere length and full
epigenetic memory erasure. Some of the major barriers of reprogramming are depicted
underneath the changes that occur during reprogramming. If a cell cannot pass any of these
roadblocks, cells either arrest at the stage that they’ve made it to or they will undergo either
senescence, apoptosis or differentiation.
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Cell Cycle Machinery in Epigenetic Regulation of Reprogramming
Apart from their role in cell cycle dependent functions, various CDKs and cyclins have
been implicated in epigenetic regulation. The enhancer of zeste homolog 2 (EZH2) is the
catalytic portion of the Polycomb repressive complex (PRC2). PRC2 is critical in
transcriptional silencing of genes that are involved in cell lineage commitment by
increasing the histone H3 repressive marker, lysine 27 through trimethylation
(H3K27me3). It has been demonstrated that CDK1 and CDK2 phosphorylate EZH2 at a
specific residue (T350), thereby activating its methyltransferase activity, in human cells (S.
Chen et al., 2010). Importantly, EZH2 dependent H3K27me3 activity aids in the
reprogramming process of human iPSCs by constricting the somatic cell lineage circuitry
during early phases of reprogramming (R. A. Rao et al., 2015). Lastly, the knockdown of
PRC2 subunits significantly decreases iPSC generation in both human and mouse
fibroblasts (Ding et al., 2014b; Onder et al., 2012a; Pereira et al., 2010). Through the
activation of enzymes that are involved in epigenetic modifications, cyclin-CDK
complexes are able to successfully couple cell cycle dependent roles with epigenetic
regulation in reprogramming.

Core Cell Cycle Regulators in Reprogramming
Characteristic of ESCs, iPSCs acquire a similar cell cycle structure such that G1 phase
becomes shortened, with most cells found in S phase (Mikkelsen, et al., 2008; Sridharan et
al., 2009). Cell cycle profile analysis during the reprogramming process determined that
the acquisition of this characteristic cell cycle profile is acquired early in reprogramming
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along with a high proliferation rate (Ruiz et al., 2011). Induction of cell proliferation aids
in the formation of iPSCs. The manipulation of cell cycle regulatory proteins showed that
the overexpression of human Cyclin D and Cyclin E increased reprogramming efficiency,
while the overexpression of CDK1, CDK2 or CDK4 had no effect on reprogramming
efficiency. Data in human iPSC formation revealed that increased proliferation rate
increases the number of cells that are responsive to being reprogrammed (Ruiz, et al.,
2011). In addition to positive modulators, such as cyclins and CDKs, playing roles in
reprogramming efficiency to induced pluripotency; negative regulators, like the CKIs, are
known to correspondingly affect reprogramming efficiencies. The best characterized CKIs
in reprogramming are p53, p21, and p16, which are further discussed below.

p53 in Reprogramming
The tumour suppressor protein p53 is often described as the “guardian of the genome” due
to the crucial role it plays in maintaining DNA stability and integrity (Vousden & Prives,
2009). The p53 pathway has been implicated in inhibiting cancer initiation and progression
by activating apoptosis or cell cycle arrest in the face of stress (Ko & Prives, 1996;
Vogelstein, Lane, & Levine, 2000). There is an emerging role for p53 in the regulation of
differentiation, self-renewal and plasticity (Spike & Wahl, 2011). Numerous research
groups have implicated p53 as a potent reprogramming inhibitor. Knockdown of p53, or
the use of p53-/- mouse embryonic fibroblast (MEFs) demonstrated the increase in
reprogramming efficiency when p53 is ablated or not present (Kawamura, Suzuki, Wang,
Menendez, Morera, Raya, Wahl, & Izpisúa Belmonte, 2009). In mouse reprogramming,
the use of p53-null MEFs abolished apoptosis in early reprogramming, allowing more cells
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to be amenable to the process (Marión, Strati, Murga, et al., 2009). Due to the fact that
permanent p53 pathway inactivation increases the chances of malignant transformation and
could generate cells with genomes that have lost their integrity, transient inhibition of p53
is a more promising route in aiding in reprogramming efficiency (Komarov et al., 1999; Y.
Zhao et al., 2008). It is clear that reprogramming of somatic cells is accompanied by the
upregulation of the p53 pathway, which is a major barrier of reprogramming.

The p53-p21 Pathway in Reprogramming
One way which p53 exerts its inhibitory role on reprogramming is through the p53-p21
pathway (Banito, Rashid, Acosta, Li, Pereira, Geti, Pinho, Silva, Azuara, Walsh, & al.,
2009; Hong, et al., 2009; Kawamura, Suzuki, Wang, Menendez, Morera, Raya, Wahl, &
Belmonte, 2009; Marión, Strati, Murga, et al., 2009; Utikal, et al., 2009). Wild-type MEFs
that are subjected to reprogramming intrinsically increase p21 protein levels. In p53-null
MEFs, there is no observed increase in p21 protein levels after the addition of the four
reprogramming factors. Furthermore, the overexpression of p21 in p53-null MEFs
significantly decrease iPSC generation. This data coincides with the fact that p21 has been
characterized as a target of p53 during iPSC derivation (Hong, et al., 2009). Further support
for the role of p21 as an inhibitor of reprogramming stems from data showing that p21
knockdown using shRNAs in human fibroblast cells results in a significant increase of
reprogrammed iPSCs (Banito, Rashid, Acosta, Li, Pereira, Geti, Pinho, Silva, Azuara,
Walsh, & al., 2009). The endogenous upregulation of p21 seems to be an early event during
reprogramming, suggesting a link between cellular senescence and reprogramming. This
is highlighted by the fact that expression of p21 has been demonstrated to be upregulated
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and remains elevated in pre-iPSCs (Banito, Rashid, Acosta, Li, Pereira, Geti, Pinho, Silva,
Azuara, Walsh, & al., 2009). Collectively, this data supports that the p53/p21 axis is a key
barrier in the reprogramming process.

INK4/Arf in Reprogramming
The Ink4/Arf locus encodes p15, p16 and p19 tumour suppressors, and well established
barriers of reprogramming in both mouse and human somatic cells. The Ink4/Arf locus is
completely silenced in both ESCs and iPSCs, which allows for a high proliferative rate and
dedifferentiation to take place (Banito, Rashid, Acosta, Li, Pereira, Geti, Pinho, Silva,
Azuara, Walsh, & al., 2009; H. Li, et al., 2009). Inhibition of the Ink4/Arf locus is one way
to increase the efficiency of reprogramming, by improving the kinetics ultimately
increasing the amount of iPSC colonies that form at the end of reprogramming (H. Li, et
al., 2009). The Ink4/Arf locus is subjected to strong epigenetic silencing through H3K27
methylation in ESCs and accordingly in iPSCs (Banito, Rashid, Acosta, Li, Pereira, Geti,
Pinho, Silva, Azuara, Walsh, & al., 2009). Silencing of the Ink4/Arf locus is a major
roadblock for reprogramming and figuring out ways to surpass this roadblock will
ultimately improve reprogramming efficiency.

c-MYC as a Source of Overriding Reprogramming Barrier
c-Myc has a plethora of downstream targets that play important roles in proliferation and
transformation (Adhikary & Eilers, 2005). The combination of OCT4, SOX2 and KLF4
without c-MYC generated significantly less iPSC colonies and the colonies that formed
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displayed a very flat and non-ESC-like morphology (K. Takahashi & Yamanaka, 2006).
Similarly, another study revealed that no fully reprogrammed iPSCs were derived without
using c-MYC as a factor (Okita, et al., 2007). Research suggests that c-MYC aids in
accelerating progression of the G1 phase of the cell cycle through its ability to regulate
cyclin-CDK activity (Amati, Alevizopoulos, & Vlach, 1998). Moreover, the role of c-MYC
has been demonstrated in inhibiting differentiation and maintaining stemness in vivo,
suggesting that it may be acting similarly during reprogramming (Satoh et al., 2004). Most
recently, it has been demonstrated that the telomerase regulatory subunit, TERT, is a cMYC target in mouse ESCs (Kim, Chu, Shen, Wang, & Orkin, 2008). One serious downfall
plaguing the reprgrogramming field is the fact that c-MYC is a potent proto-oncogene that
increases the chances of tumourigenicity in chimeric mice (K. Takahashi & Yamanaka,
2006) Further studies are needed to find different factors or different combination of factors
capable of acting similar or providing enhanced alternatives to c-MYC.

Discovery of Speedy/RINGO- Roles in Oocyte Maturation
Speedy (also known as RINGO; Rapid Inducer of G2/M progression in Oocytes) was
initially discovered in a screen for genes that could override lethality in an irradiated rad1
deficient strain of fission yeast (Lenormand, Dellinger, Knudsen, Subramani, & Donoghue,
1999). There are five confirmed mammalian Speedy family members, the originally
described is Spy1A1 (herein referred to as Spy1) (Cheng, Xiong, Ferrell, & Solomon, 2005;
Dinarina et al., 2005). The screen that initially isolated Spy1 used a Xenopus ovarian cDNA
library, and was intended to isolate genes that had the ability to confer resistance to
radiation-induced DNA damage. Spy1 was then studied in oocyte maturation and it was
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determined that it was detectable in stage IV oocytes and became undetectable at the
beginning of gastrulation (Lenormand, et al., 1999). Spy1 mRNA is tightly regulated in the
oocyte being bound by Pumilio 2 (Pum2) which represses mRNA translation of Spy1 until
progesterone treatment induces dissociation and subsequent translation of Spy1
(Arumugam et al., 2012b; Padmanabhan & Richter, 2006). These results highlight the
importance of Spy1 in the early Xenopus oocyte and implicate this protein as a potential
regulator of the DDR.
Stage IV oocytes are considered resting and remain arrested at the G2/M border
during the first meiotic division. Progesterone aids in overcoming this arrest and moving
the oocyte through the rest of meiosis. Studies have demonstrated that the addition of cell
cycle regulators, Cyclin A and Cyclin B, activated CDK1, activated Raf-1, mos, and
mitogen activated protein kinase (MAPK) can stimulate oocytes to continue the cell cycle
(Sagata, 1997; Sagata, Watanabe, Vande Woude, & Ikawa, 1989). To investigate the role
of Spy1 during the cell cycle, Spy1 mRNA was microinjected into stage IV oocytes and
oocytes were monitored for their ability to stimulate the G2/M transition (Ferby, Blazquez,
Palmer, Eritja, & Nebreda, 1999; Lenormand, et al., 1999). Injection of Spy1 mRNA
resulted in the activation of both MAPK and CDK1, and a rapid release of oocytes from
G2. Spy1 induced oocyte maturation twice as fast as rates observed with injection of either
mos mRNA or progesterone. To confirm the importance of Spy1 in oocyte maturation,
Spy1 was depleted in stage IV oocytes. This resulted in a drastic decline in oocyte
maturation, even in the face of progesterone (Ferby, et al., 1999). Progesterone induces
oocyte maturation by activating the translation of a MAP kinase kinase kinase (MAPKKK),
mos, and essentially this leads to the activation of MAPK activity through MEK (Sagata,
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1997). Oocytes treated with a MEK inhibitor to inhibit MAPK signalling demonstrated a
decline in oocyte maturation in the presence of Spy1, indicating that Spy1-induced oocyte
maturation is dependent on MAPK activation (Lenormand, et al., 1999). The ability of
Spy1 to aid in the progression of the G2/M boundary supported a role as a cell cycle
regulator. Taking this into consideration, it remained uncertain of whether Spy1 had the
capacity to interact with other cell cycle regulators. Co-immunoprecipitation experiments
revealed protein interaction between Spy1 and CDK2 leading to a significant increase in
CDK2 activity (Lenormand, et al., 1999). Spy1 also activates the cell fate determinant and
oocyte maturation factor, Musashi 1 (MSI1) which translates mos mRNA, to allow for
progression of cell cycle re-entry in Xenopus oocytes (Arumugam, et al., 2012b).
Collectively these data supported that the discovery of the Spy1 family was a unique class
of cell cycle activators that had the ability to override select cell cycle checkpoints.

Description and Function of Spy1
Mammalian Spy1 was cloned from immortalized cell lines and was found to localize
primarily to the nucleus where it can bind and activate both CDK1 and CDK2 (Cheng,
Xiong, et al., 2005; Dinarina, et al., 2005; L. A. Porter et al., 2002). When overexpressed
in mammalian somatic cells, Spy1 enhances cell proliferation and shortens G1 phase (L.
A. Porter, et al., 2002). This feature of Spy1 is dependent on CDK binding, as CDK2
inhibition ablates the capacity of Spy1 to enhance cell division (L. A. Porter, et al., 2002).
The depletion of Spy1 levels results in inhibited cell proliferation (Golipour et al., 2008;
L. A. Porter, et al., 2002). Binding of Spy1 to CDKs is mediated through the S/R box that
bears no structural similarities to cyclin proteins (Cheng, Xiong, et al., 2005; Dinarina,
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Santamaria, & Nebreda, 2009; L. A. Porter, et al., 2002). Unique to Spy1, binding and
activation of CDK2 kinase activity occurs without the presence of activating T-loop
phosphorylation on amino acid Thr160 (Cheng, Gerry, Kaldis, & Solomon, 2005; A.
Karaiskou et al., 2001). Classic cyclin-bound CDKs require inhibitory phosphorylation
(Thr14/Tyr15) on CDKs to be removed for full activation of the CDK. Spy1 is less
sensitive to these inhibitory phosphorylation events and can activate the CDK to near full
levels in the absence of dephosphorylation (A. Karaiskou, et al., 2001; D. A. McGrath et
al., 2017). Hence, Spy1 exemplifies unique activation of CDKs in a manner that is
independent of typical phosphorylation and de-phosphorylation events that are required for
classical cyclins to progress the cell cycle forward.
Early experiments demonstrated that in a yeast-two hybrid screen, Spy1 can bind
p27 through the CDK binding region of p27 (L. A. Porter, Kong-Beltran, & Donoghue,
2003). In addition, Spy1-CDK complex can phosphorylate p27 at Thr187, which causes
p27 to be targeted for degradation (C. W. McAndrew, Gastwirt, Meyer, Porter, &
Donoghue, 2007). The phosphorylation of p27 requires that Spy1 bind and activate CDK2
(Cheng, Xiong, et al., 2005; C. W. McAndrew, et al., 2007). Similarly to p27, p21 inhibits
the cell cycle by binding and inhibiting the activation of cyclin-CDK complexes (Bartek &
Lukas, 2001; G. He et al., 2005). Overexpression of p21 abrogates Cyclin A-CDK2
activity; however, this has no effect on Spy1-CDK2 activity (A. Karaiskou, et al., 2001).
This is indicative of the decreased susceptibility of Spy1 to inhibition by p21, most likely
owing to the fact that Spy1 lacks the MRAIL motif found on cyclins that is responsible for
docking p21 (A. Karaiskou, et al., 2001; D. A. McGrath, et al., 2017). Therefore, not only
is the Spy1-CDK complex less susceptible to inhibition by both p21 and p27, it can also
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target p27 protein for degradation, further confirming the role of Spy1 as an important and
unique cell cycle regulator.
Classic cyclin-CDK complexes phosphorylate substrates that contain the sequence
(S/T)PX(K/R) (Errico, Deshmukh, Tanaka, Pozniakovsky, & Hunt, 2010). These
complexes have a strong preference for basic residues at the +3 position with regards to
the phosphorylation site (Holmes & Solomon, 1996). The Spy1-CDK complex does not
have such stringent preferences and can bear a wide range of residues at the +3 position
for substrates (Cheng, Gerry, et al., 2005). Importantly, Thr160 (Thr161 in CDK1) is
responsible for making contact with the +3 residue on substrates, therefore, the ability of
Spy1 to bind and activate CDK2 in the absence of Thr160 phosphorylation may be a large
contributing factor in non-canonical substrate specificity of the Spy1-CDK complex
(Cheng, Gerry, et al., 2005). Recently, experiments using the C-terminal domain of Rb,
which contains an important sequence critical for phosphorylation by cyclin-CDK
complexes demonstrated that when this sequence was altered to a non-canonical sequence,
Cyclin A-CDK2 substrate phosphorylation drastically decreased while Spy1-CDK2
substrate phosphorylation remained similar (D. A. McGrath, et al., 2017). Altogether, these
data show the ability of Spy1-CDK complex to phosphorylate a range of substrates, both
at canonical and non-canonical phosphorylation sites, and this feature seems to contribute
to the role of Spy1 in cell cycle regulation and progression.
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Spy1 and the DNA Damage Response
Cell cycle checkpoints are found throughout different phases of the cell cycle and can
become activated in the face of stress or DNA damage. The discovery of Spy1 as a potential
mechanism to convey resistance to DNA damage (Lenormand, et al., 1999) warranted
further investigation into the role of this protein in DNA damage and the DDR. Subsequent
research revealed that increased levels of Spy1 were associated with increased cell survival
in response to DNA damage agents or UV exposure (E.A. Barnes, L.A. Porter, J.L.
Lenormand, R.W. Dellinger, & D.J. Donoghue, 2003a). The binding of Spy1 to CDK2 and
subsequent increased activation of the CDK is vital to promote cell cycle progression and
survival in the face of damage (Barnes, et al., 2003a; Gastwirt, McAndrew, & Donoghue,
2007). Moreover, this occurs in a p53-dependent manner (C. W. McAndrew, Gastwirt, &
Donoghue, 2009). In addition, overexpression of Spy1 impairs the DDR in somatic
immortalized cells, as is evidenced by the reduced phosphorylation of important mediators
of the DDR, such as H2AX and Chk1 (Barnes, et al., 2003a; C. W. McAndrew, et al.,
2009). These data suggest that Spy1 allows for continued cell cycle progression and
proliferation even though checkpoints may be activated which may promote cell
proliferation and accumulation of mutations in unwanted circumstances.

Spy1 Structure
The protein structure of Spy1 can be separated into three distinct regions (Figure 5): the
first, which has been described above is the S/R box, responsible for binding CDKs (Cheng,
Xiong, et al., 2005; Dinarina, et al., 2005; L. A. Porter, et al., 2002). The N-terminal portion
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is important in regulating Spy1 protein stability and degradation (Al Sorkhy, Craig, Market,
Ard, & Porter, 2009), and the C-terminal region is implicated in CDK activation (Cheng,
Gerry, et al., 2005; Dinarina, et al., 2005). Regardless of low sequence homology between
the S/R box and cyclins, the S/R box does in fact contain one cyclin box fold (CBF), as
recently revealed through analysis of the Spy1 crystal structure. It is in fact this cyclin fold
that is responsible for binding CDK2 and inducing the active conformation of CDK2 (D.
A. McGrath, et al., 2017). Mutations of important amino acid residues in the S/R box
completely abrogate the binding of Spy1 to CDK2 (Dinarina, et al., 2009). Further analysis
of the Spy1-CDK2 structure demonstrates that the S/R box contacts the T-loop in a manner
that completely draws it away from the kinase domain, in turn inducing an active T-loop
structure. In contrast to Spy1, cyclin binding only partially pulls the T-loop out of the active
site (D. A. McGrath, et al., 2017). The Spy1 residues that are responsible for binding the
T-loop are highly conserved among Spy1 family members, suggesting that proper binding
to the T-loop is a crucial component of Spy1-mediated activation of CDK (D. A. McGrath,
et al., 2017). This structural data validates the hypothesis that Spy1 binding CDK induces
and actives T-loop conformation, independently of T160/161 phosphorylation.
The importance of the CDK PSTAIRE helix to binding Spy1 was demonstrated in
early experiments that mutated amino acid residues Ile49 and Arg50 in the PSTAIRE helix
of CDK2, which resulted in the absence of Spy1-CDK2 binding (Dinarina, et al., 2005).
Similarly, these critical residues are involved in the binding between Cyclin A and CDK2,
suggesting that Spy1 binds CDKs in a similar manner to cyclin proteins (Dinarina, et al.,
2005; A. Karaiskou, et al., 2001). During CDK2 binding, the S/R box of Spy1 aligns in a
similar manner to that of Cyclin A at the PSTAIRE interface and a number of hydrogen
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bonds that occur between the PSTAIRE helix and Spy1 are comparable to those that have
been demonstrated in Cyclin A-CDK2 binding (Jeffrey, et al., 1995; D. A. McGrath, et al.,
2017). In contrast, the hydrophobic patch of the PSTAIRE helix is committed differently
by Cyclin A than Spy1; Spy1 uses W168, while Cyclin A uses F304 and L299 (D. A.
McGrath, et al., 2017). Not all paralogs of Spy1 have conserved PSTAIRE binding residues
and there is variety among them, suggesting that the PSTAIRE helix may be positioned
and bind in different manners depending on the Spy1 family member (D. A. McGrath, et
al., 2017).
CKIs, including p27, regulate the cell cycle through their ability to bind cyclins
(Russo, et al., 1996; Schulman, et al., 1998; Sherr & Roberts, 1995). p27 uses a sequence
motif that helps it dock into a cleft, known as the MRAIL site, in the cyclin N-terminal
region (Russo, et al., 1996). The MRAIL motif does not exist in Spy1 and the docking cleft
for CKIs in not found in the Spy1-CDK2 structure (D. A. McGrath, et al., 2017). Hence,
this data supports that certain CKIs are unable to dock into the Spy1-CDK2 complex,
rendering this complex resistant to cell cycle inhibition.

Expression of Spy1
Currently, there are no known homologs of Spy1 in yeast, worms, flies or plants (Cheng,
Xiong, et al., 2005; Dinarina, et al., 2005). Interestingly, a potential homolog has been
discovered in C. intestinalis, which is evolutionarily where modern day vertebrates initially
branched off from (Cheng, Xiong, et al., 2005). The Spy1 gene (SPDYA) is ubiquitously
expressed throughout a broad range of mammalian tissue, with high levels particularly in
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the testis, as well as fetal organs including the fetal brain (Cheng, Xiong, et al., 2005; L.
A. Porter, et al., 2002). Spy1 protein is expressed in a vast number of different immortalized
cells lines (Cheng, Xiong, et al., 2005; L. A. Porter, et al., 2002). Spy1 protein is expressed
only during the G1 and S phases of the cell cycle, with protein degradation occurring via
at least two different systems in a cell-type dependent manner (Al Sorkhy, et al., 2009;
Dinarina, et al., 2009). A number of Spy1 mutants were created to tease apart potential
important regions responsible in mediating its degradation. Upon analysis, it was revealed
that three critical amino acid residues were responsible for the degradation of Spy1.
Simultaneous mutation of these amino acids resulted in the ablation of Spy1 ubiquitination
and degradation. This mutant demonstrated superior proliferative potential as compared to
wild-type Spy1 (Al Sorkhy, et al., 2009). The E3 ubiquitin ligase, SCF-Skp2 complex is
an additional mechanism involved in the degradation of Spy1. Protein levels of Skp2 and
Spy1 are inversely correlated; a decrease in Skp2 levels results in a significant increase of
Spy1 protein levels (Dinarina, et al., 2009). Alternatively, the second mechanism of Spy1
degradation is through the Nedd4 E3 ubiquitin ligase pathway. Co-immunoprecipitation
experiments have revealed interaction between Spy1 and Nedd4, while increased Nedd4
levels result in a significant decrease of Spy1 protein (Al Sorkhy, et al., 2009). These data
provide insight into the tight regulation of Spy1 during the cell cycle through a variety of
pathways, possibly to inhibit unintended cell cycle progression in the wrong context.

Spy1 Family Members
The five identified mammalian Speedy/RINGO family members show high conservation
at the S/R box and present some differences outside of this core region (Cheng, Xiong, et
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al., 2005; Dinarina, et al., 2005). In addition to the original 5 family members, there are
isoforms of Spy1A that have been described – A1 (the isoform discussed as Spy1
throughout this document) and A2. They are different in their C-terminal region and
Spy1A1 has been identified as the longer of the two isoforms (Cheng, Xiong, et al., 2005).
The other family members are all very similar with regards to the sequence of their S/R
box, although they alter in spatial expression and their ability to bind different CDKs
(Cheng, Xiong, et al., 2005; Dinarina, et al., 2005). Spy1 contains eight exons and is found
on chromosome 2 (2p23.2). The gene has seven splice variants, four of which are protein
coding. Spy1 is found in a transcriptional hotspot. Interestingly, a tRNA methyltransferase
(TRMT61B) runs in the opposite direction. Speedy/ RINGO B is expressed exclusively in
mice testis and on its own does not have the ability to promote oocyte maturation; however
in the presence of progesterone it can accelerate oocyte maturation. Analysis of protein
interactions with other CDKs revealed Speedy/RINGO B’s preference for binding to
CDK1. Speedy/RINGO C proves very similar to Speedy/RINGO A. It’s found to be
expressed in many different tissues and binds CDK1 and CDK2 without preference for one
over the other. Little has been observed regarding Speedy/RINGO D. Finally, in stark
contrast to all other family members, Speedy/RINGO E inhibits or prolongs cell cycle
progression in Xenopus oocytes, regardless of the fact that it can bind CDK1, CDK2 as
well as CDK5 (Figure 5) (Cheng, Xiong, et al., 2005; Dinarina, et al., 2005; Dinarina et
al., 2008; Dinarina, et al., 2009) (Table 2). In summary, the Speedy/ RINGO family of
proteins denotes a new class of proteins implicated in cell cycle regulation of which we
have just begun to understand the biological roles
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Figure 5. Schematic of Spy1-RINGO structures. The importance of each region is
listed under the protein portion.

Table 2. Speedy/RINGO family members. Listed are their discovered corresponding
CDK binding partners and where the family member is expressed.
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The Role of Spy1 in Development and Cancer
Early mammalian work on the role of Spy1 revealed that the protein was tightly regulated
in some developing systems, including that of the mammary gland (Golipour, et al., 2008).
Spy1 levels are upregulated during proliferative stages (puberty and pregnancy) and
reduced during differentiation (lactation). Spy1 protein expression is downstream of cMYC and the MAPK pathway in proliferating mammary cells. Spy1 protein levels were
also demonstrated to be one of the most highly upregulated genes in ductal breast
carcinoma (Zucchi et al., 2004).
The role of Spy1 in normal development of the brain is still under investigation,
more is known about the role of Spy1 in cancers of the CNS. Injury of the sciatic nerve
demonstrated that Spy1 was rapidly upregulated after nerve injury and this was correlated
to increased levels of cell proliferation (Cao et al., 2013). Furthermore, the overexpression
of Spy1 has been implicated in high stage gliomas (Zhang et al., 2012). Spy1 also plays a
significant role in driving the symmetric division of the aggressive tumour initiating
CD133+ cell population of high grade gliomas. Depletion of Spy1 in the CD133+
population of cells decreased proliferation and stemness properties and encouraged
functional differentiation (Lubanska et al., 2014).
Elevated Spy1 levels have been found in a host of cancers in addition to breast and
brain including, Non-Hodgkin’s lymphoma, hepatocellular carcinoma and ovarian cancer
(Hang et al., 2012; Ke, Ji, Cheng, Zhang, Lu, Wang, et al., 2009; Lu et al., 2016). In
lymphoma, the levels of Spy1 protein correlate with a poor patient prognosis and reduction
of Spy1 protein levels results in an increase in p27 levels corresponding to a cell cycle
arrest (Hang, et al., 2012). Spy1 levels correlate with increasing histological grade,
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potentially through increased cell proliferation due to p27 degradation (Ke, Ji, Cheng,
Zhang, Lu, Wang, et al., 2009) and in ovarian cancer reduction of Spy1 levels promoted
cell cycle arrest and apoptosis (Lu, et al., 2016). Hence, Spy1 may be a mechanism hijacked
by many different forms of cancer to promote uncontrolled cell proliferation and disease
progression.
The generation of Spy1 knockout (KO) mice has provided insight into the
physiological role of Spy1 (Tu et al., 2017). Spy1A is endogenously expressed in meiotic
germ cells and KO leads to a loss of both male and female germ cells and organism sterility.
The testes of Spy1 KO mice were atrophic (Mikolcevic et al., 2016). Both studies show
that endogenous Spy1 co-localizes with CDK2 at the telomeres (Mikolcevic, et al., 2016;
Tu, et al., 2017). In Spy1 KO mice, telomere-nuclear envelope (NE) attachment was
impaired which led to a meiotic arrest of the cells (Tu, et al., 2017).Spermatogonia of Spy1
KO mice had decreased telomere length as compared to their controls (Mikolcevic, et al.,
2016). Notably, the observations made in Spy1 KO mice with regards to the phenotype of
the spermatocytes is very similar to what has been described for CDK2 KO spermatocytes
(Ortega et al., 2003; Viera et al., 2009), supporting the hypothesis that Spy1 could be a
critical regulator of CDK2 during meiosis.

The Mouse as a Model Organism
The house mouse, Mus musculus, is one of the most extensively used model
organisms to study development and disease. It has been a reliable system to elucidate
molecular features of normal and abnormal tissue development that is most closely related
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to humans. Correspondingly, the mouse can be used to visualize multifaceted processes
including both embryonic and post-natal development. Mouse and human genomes share
significant homology, with close to 99% of their genes considered homologous. Moreover,
they both contain a comparable number of protein coding genes (Guenet, 2005). In
addition, model generation is straightforward, with a moderately rapid generation time.
Both the genetics and physiology have been well established, providing researchers with a
detailed understanding of phenotypes that correspond to differences in gene expression.
Transgenic mice can be created through genetic manipulation of the mouse genome.
Genetically modified mice are an invaluable tool to evaluate phenotypic changes that result
from the manipulation of genes.

Transgenic Mice Models
The first transgenic mouse was generated in the 1980’s through pronuclear injection
(Brinster et al., 1981; Gordon, Scangos, Plotkin, Barbosa, & Ruddle, 1980; Palmiter et al.,
1982). Ever since their initial discovery, transgenic mouse models have become a staple
tool for many discoveries. The vast practice of transgenic mouse models as a research tool
to study a variety of developmental phenomena and diseases truly highlights the value of
this system and immense contribution it has made to biology. Most often, transgenic mice
are created by injecting a double-stranded transgenic DNA plasmid construct into an
oocyte. The design of the transgenic construct includes important elements to ensure that
gene expression occurs, such as a promoter, introns, the DNA protein-coding sequence,
and finally, a poly adenylation site (Haruyama, Cho, & Kulkarni, 2009). The transgene
construct can be tested and validated in vitro prior to pronuclear injection. The construct is
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then digested to isolate the transgene fragment prior to injection into a fertilized oocyte.
Random transgene integration means that each founder mouse will likely have unique
transgene insertion sites with variable copy numbers (Haruyama, et al., 2009). It is
important to note that transgene expression does not necessarily correlate with the number
of transgenes that were integrated, expression is dependent on the promoter selected
(Woychik, Stewart, Davis, D'Eustachio, & Leder, 1985).
Transgene expression can be constitutive by exploiting a promoter that will be
continually driven in select tissues, or expression can be inducibly controlled through the
use of a transactivator. There are two transactivator systems routinely used: 1) tetracycline
transactivator (tTA), and 2) reverse tetracycline transactivator (rtTA). To properly work,
both systems function through the application of a tetracycline responsive element (TRE)
and an induction agent. The TRE promoter element is a repeat of the tetracycline operator
sequence (TetO), which will bind the fusion proteins tTA or rtTA. Doxycycline, or its
synthetic analogue, tetracycline, are used to either turn on or turn off these systems (Furth
et al., 1994; Gossen & Bujard, 1992; Gossen et al., 1995; Hennighausen, Wall, Tillmann,
Li, & Furth, 1995; Y. Sun, Chen, & Xiao, 2007). The tTA system is known as the tet-off
system. The presence of doxycycline results in a dissociation of the tTA from the TRE and
ultimately causes a repression of the transgene (Furth, et al., 1994) (Figure 6). In contrast,
the rtTA system is referred to as a tet-on system. The presence of doxycycline here results
in the binding of the rtTA to the TRE and turns on transgene expression (Gossen, et al.,
1995) (Figure 6). One of the biggest advantages of these systems is their tight, temporal
control of transgene expression complimented by the fact that expression can be promptly
turned on or off (Furth, et al., 1994; Y. Sun, et al., 2007). These inducible systems can
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easily be combined with tissue or cell specific promoters that will drive the expression of
the tTA or rtTA. In this manner, transgene expression can be controlled temporally and
spatially (E. J. Gunther et al., 2002). Transgenic mouse models represent a strong tool that
can be used to study the effect of genetic manipulations. Designing these models to control
the timing and/or tissue location of expression permits very select questions to be addressed
in vivo.
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Figure 6. Tet-on and Tet-off mechanisms in mouse models. The tet-off system (left)
requires the absence of doxycycline, allowing the tetracycline transactivator (rTA) to bind
the tetracycline response element (TRE) and express the transgene. The tet-on system
requires the presence of doxycycline for the reverse tetracycline transactivator (rtTA) to
bind the TRE and express the transgene.
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HYPOTHESIS AND OBJECTIVES
This work aims to elucidate the role of the atypical cell cycle regulator Spy1 in stem cell
regulation, focusing on induced pluripotent stem cells and neural stem cells. We will
address the implications of Spy1-mediated effects in reprogramming and central nervous
system development.
We hypothesize that Spy1 is an important reprogramming factor to induced
pluripotency that acts by overriding senescent barriers. Moreover, we also hypothesize
that Spy1-mediated mechanisms drive abnormal growth and division in neural stem cells
which may have potential effects on learning and memory.
Our hypothesis was addressed through the following objectives:
o To elucidate the role of Spy1 in overriding senescent and epigenetic barriers as a
reprogramming factor
o To generate and characterize a transgenic mouse model system that overexpresses
Spy1 specifically within the neural stem cell population of the brain
o To elucidate the role of Spy1 in neural stem cell DNA damage
The work of this project and results obtained during the course of this study will
enhance our understanding of the role that Spy1 plays in cell cycle regulation during
reprogramming and the development of the adult central nervous system. This work will
contribute to the understanding of creating more and safer induced pluripotent stem cells.
This work will also offer insight into physiological changes associated with manipulation
of critical population of the brain and potential impacts this may have on diseases of the
aging brain, including neural cancers.
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CHAPTER 2
NEURAL STEM CELL EXPANSION BY CYCLIN-LIKE PROTEINS SUPPRESSES
NEURAL DIFFERENTIATION AND RECOGNITION MEMORY
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INTRODUCTION
The development of the central nervous system (CNS) during embryogenesis requires a
fine balance between apoptosis, survival, cellular proliferation, self-renewal and
differentiation. All these processes are constantly regulated so that there is homeostasis to
maintain a properly structured and fully functioning mature brain tissue. Neurogenesis was
thought, until recently, to occur only during embryonic development in mammals.
However, much has been discovered regarding the process of neurogenesis throughout the
lifespan of mammals. The presence of newly generated cells in the postnatal brain was first
shown in rats (J. Altman, Das, G.D., 1965). More recently, multipotent adult NSCs have
been excised from mammalian brains (B. A. Reynolds, Weiss, S. , 1992; L. J. Richards,
Kilpatrick, T.J., Bartlett, P.F., 1992). Although lineage tracing has revealed life-long
ongoing neurogenesis in many mammals (H. G. Kuhn, Dickinson-Anson, H., Gage, F.H.,
1996), including humans (P. S. Eriksson, Perfilieva, E., Björk-Eriksson, T., Alborn, A.M.,
Nordborg, C., Peterson, D.A., Gage, F.H., 1998); recent evidence has come to light
indicating that hippocampal neurogenesis in adult humans is in fact extremely rare (Sorrells
et al., 2018). Evidently, the extent to which neurogenesis occurs in mature mammals is a
mounting area of inquiry.
Adult NSCs are found in one of two areas in the mammalian brain – the lateral
ventricles of the subventricular zone (SVZ), and dentate gyrus of the subgranular zone
(SGZ) (Alvarez-Buylla, 2004; Lie, 2004). In the SVZ, neurons are continuously produced
and migrate through the rostral migratory stream (RMS) to the olfactory bulbs. In the SGZ,
new neurons are generated and remain local (G. Ming, Song, H. , 2005). The identity of
the NSC in the adult mammalian brain that continuously give rise to new neurons has been
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a topic of controversial debate (F. Doetsch, Caille, I., Lim, D.A., Garcia-Verdugo, J.M.,
Alvarez-Buylla, A., 1999; Johansson, 1999; A. Kriegstein & Alvarez-Buylla, 2009;
Morshead, 1994). Many molecular biomarkers have been used in attempts to
unambiguously categorize the NSC and their progeny in the adult SVZ. Glial fibrillary
acidic protein (GFAP) marks NSCs as well as some transit amplifying cells (TACs) and
differentiated astrocytes (Pennartz, 2004; Sibbe, 2009). SRY (sex determining region Y)box 2, or otherwise known as Sox2 identifies both NSCs and TACs in the SVZ (F. Doetsch,
Garcia-Verdugo, J.M., Alvarez-Buylla, A. , 1997; Ferri, 2004). Nestin is another known
marker of the NSC and TAC populations of the SVZ (C. Lois, Alvarez-Buylla, A. , 1994).
Data suggest that Nestin is necessary for NSC self-renewal and survival (D. Park, Xiang,
A.P., Mao, F.F., Zhang, L., Di, C.G., Liu X.M., Shao, Y., Ma, B.F., Lee, J.H., Ha, K.S.,
Walton, N., Lahn, B.T. , 2010). Nestin-positive cells are exclusively found in regions of
the brain that harbors a niche tailored to the maintenance of stem and progenitor
populations (Namik, 2012).
During neurogenesis, cell cycle regulators and transcription factors play critical
roles in regulating both extracellular and intracellular signals to make decisions regarding
the fate of a NSC (Becker, 2004; Galderisi, 2003; Hughes, 1999; Ohnuma, 2003). NSCs
use quiescent mechanisms to maintain infrequent divisions to preserve DNA integrity and
lifespan (L. Li, Clevers, H. , 2010). Decisions to divide symmetrically or asymmetrically
to produce either more NSCs or progenitor cells, respectively, requires the cells to exit
quiescence and re-enter the cell cycle (Neumuller, 2009). Among many regulators, the
tumor suppressor p53 plays a crucial role in these cell cycle events that determine the selfrenewal and differentiation of NSCs in the CNS (A. Armesilla-Diaz, Bragado, P., Del
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Valle, I., Cuevas, E., Lazaro, I., Martin, C., Cigudosa, J.C., Silva, A. , 2009; Helton, 2007;
W. B. Jacobs, Kaplan, D.R., Muller, F.D. , 2006). As a result of p53’s association with
other cell cycle regulators, including the cyclin dependent kinase (CDK) inhibitor p21, it
can be inferred that many p53-dependent pathways could be playing similar roles in
controlling NSC fate decisions. Interestingly, the control of cell cycle pathways in adult
NSCs has also been observed to be regulated by p21 independently of p53. NSCs that lack
p21 are consequently exhausted readily throughout the murine lifespan (T. E. Kippin,
Martens, D.J., van der Kooy, D. , 2005; K. Meletis, Wirta, V., Hede, S.M., Nister, M.,
Lundeberg, J., Frisen, J. , 2006). Yet, many mechanisms that are involved in the regulation
of self-renewal and differentiation of adult NSCs remain unresolved.
Through the utilization of techniques responsible for observing and characterizing
NSCs, many groups have reported that cancers of the brain contain self-renewing
tumourigenic stem cells (Galli, et al., 2004; Hemmati et al., 2003a; Ignatova et al., 2002;
Singh, et al., 2003). A family of cyclin-like proteins, termed Speedy/RINGO (Spy1), was
recently found to be involved in the suppression of differentiation in neuroblastoma stem
cell populations. Spy1 overexpression promoted clonal growth and abrogated neuronal
differentiation (D. Lubanska, and Porter, L.A. , 2014). Mechanistically, the impacts of
Spy1 on stem cell populations may be due to effects on cell division properties. In human
glioma, Spy1 drives the expansion of the CD133-positive population by promoting
symmetric division. Results indicate that Spy1 levels are critical for the fate of glioma stem
and progenitor populations (D. Lubanska, Market-Velker, B.A., deCarvalho, A.C.,
Mikkelsen, T., Fidalgo da Silva, E., Porter, L.A., 2014).
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Spy1 protein is developmentally regulated in a tissue-specific manner (A. Cheng,
Xiong, W., Ferrell, J.E., Jr., and Solomon, M.J., 2005). Spy1 directly binds to both CDK1
and CDK2 independently of activating phosphorylation events and deactivating
dephosphorylation events (A. Cheng, Gerry, S., Kaldis, P., and Solomon, M.J., 2005) (D.
A. McGrath, Fifield, B.A., Marceau, A.H., Tripathi, S., Porter, L.A., Rubin, S.M. , 2017).
This unique way in which Spy1 activates CDKs suggests that Spy1 overrides the
established cell cycle checkpoints by bypassing the routes of DNA damage, cellular
senescence and cell cycle arrest (J. L. Lenormand, Dellinger, R.W., Knudsen, K.E.,
Subramani, S., and Donoghue, D.J., 1999; C. W. McAndrew, Gastwirt, R.F., Meyer, A.N.,
Porter, L.A., and Donoghue, D.J, 2007). Spy1 binds and promotes the degradation of CDK
inhibitor protein p27 (L. A. Porter, Kong-Beltran, M., and Donoghue, D.J., 2003). The
Spy1-CDK complex shows less susceptibility to inhibition by p21 because Spy1 lacks the
MRAIL motif (A. P. Karaiskou, L.H., Ferby, I., Ozon, R., Jessus, C., & Nebreda, A.R.,
2001). Cyclins contain the MRAIL motif which aids in docking cyclin kinase dependent
inhibitors (CKIs), such as p21 and p27 (Russo, et al., 1996). CKIs, therefore, have little to
no effect on the Spy1/CDK complex due to the fact that Spy1 can’t dock these proteins (A.
P. Karaiskou, L.H., Ferby, I., Ozon, R., Jessus, C., & Nebreda, A.R., 2001; D. A. McGrath,
Fifield, B.A., Marceau, A.H., Tripathi, S., Porter, L.A., Rubin, S.M. , 2017). Cell cycle
regulation plays an essential role in the maintenance of the stem cell population. It’s been
suggested that cell cycle regulation, particularly during the G1 phase, is important to NSC
characteristics (Calegari & Huttner, 2003). The implications of these results are important
in the processes involved in adult NSC maintenance.
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In addition, Spy1 levels accumulate following acute sciatic injury, implicating its
role in CNS regeneration (Y. Huang, Liu, Y., Chen, X., Yu, J., Yang, M., Lu, Q., Ke, Q.,
Shen, A., Yan, M. , 2009). The objective of this work was to create a mouse model to
determine the effects of elevated Spy1 protein levels on NSC division in vivo at different
developmental stages. Furthermore, we wanted to elucidate the implications of Spy1
mediated effects in sustaining the NSC pool throughout adulthood.
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MATERIALS AND METHODS
Generation of Spy1-pTRE Transgene
Site directed mutagenesis was performed to create an Xbal site in Flag-Spy1A-pLXSN (L.
A. Porter, Kong-Beltran, M., and Donoghue, D.J., 2003). The pTRE-Tight caspase 3
(p12)::n2[TU#817] plasmid (Addgene 16084) was digested with EcoRI and Xbal to
remove the caspase 3. Flag-Spy1 from the Flag-Spy1A-pLXSN vector was ligated into the
pTRE-Tight backbone.
Generation and Maintenance of Spy1-pTRE Mice and Maintenance of Nestin-rtTA
XhoI enzyme was used to remove the Spy1-pTRE transgene fragment from the Spy1-pTRE
vector. The transgenic fragment was sent to London Regional Transgenic and Gene
Targeting Facility to use for pronuclear injections into B6CBAF1/J hybrid embryos. PCR
analysis was used to identify founders, and to maintain the colony. A 25ul PCR reaction
was prepared comprising of 100-150ng of genomic DNA, 0.4uM forward primer, 0.4uM
reverse primers (Supplemental Table 1), and 12.5ul of New England Biolabs Master Mix.
The PCR cycling conditions used are as follows: 95°C for 2 minutes and 30 seconds; 95°C
for 45 seconds, 60°C for 45 seconds and 72°C for 1 minute and 30 seconds (40 cycles);
this was followed by a final extension at 72°C for 10 minutes. B6CBAF1/J Spy1-pTRE
mice were backcrossed with FVB wildtype mice to produce mixed B6CBAF1/J FVB Spy1pTRE mice.
Nestin-rtTA mice were purchased from the Jackson Laboratory [FVB/N-Tg (NesrtTA) 306Rsv/J] or from in house breeding at the University of Windsor. Nestin-rtTA mice
harbor a reverse tetracycline transactivator (rtTA) protein under the control of the rat Nestin
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promoter. PCR was used to genotype and maintain the Nestin-rtTA colony. A 25ul PCR
reaction was Nestin-rtTA mice were crossed with TRE-Spy1 mice to produce the NestinSpy1 (NTA) mice which were on a mixed genetic background (B6CBAF1/J FVB). This
tet-ON system allows doxycycline to activate gene expression of Spy1 specifically in the
Nestin+ cell populations. Expression of Spy1 was induced orally through food containing
2g/kg of doxycycline (Harlan Laboratories) at the time of breeding and was maintained
until animal was used for in vitro or in vivo studies. Animal care and use procedures follow
the Canadian Council on Animal Care Guidelines under the animal utilization protocol
procedure (AUPP; 10-16) approved by the University of Windsor.
Primary Neural Stem Cell Isolations and Cell Culture
Mice were humanely euthanized, according to the University standards (AUPP 10-16).
Midline incision was made to the skin along the full length of mouse. The skull was cut at
the sides and peeled off with forceps. Cranial nerves and blood vessels were cut, forceps
were used to slide the brain out. Brain was transferred to 60mm dish containing media with
3% penicillin/streptomycin (P/S) solution. Brain was sliced coronally and the area around
the lateral ventricles was dissected under a microscope. The tissue was transferred to a
separate dish with 3% P/S solution and using a scalpel blade, tissue was minced and
collected by centrifugation. The supernatant was removed and 1 ml of Trypsin- 0.05%
EDTA (Thermo) was added. The cells were incubated for 1 minute in 37°C. 1 ml of media
containing 10% fetal bovine serum (FBS) was added and incubated for 5 minutes and cells
were collected.
Primary cells were cultured in serum-free Neurobasal medium (Corning)
containing B27 supplement (Gibco) , hEGF (20ng/ml; Gibco) and bFGF (10ng/ml; Sigma),
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2 mM L-glutamine at 37 °C in 5% CO2 in ultra-low cluster plates (ULCP; Corning).
Neurospheres were subcultured every 5-10 days. Neurosphere formation assays were
conducted in 6-well ULCP plates at the density of 50,000 cells per well. Neurospheres were
scored only when larger than 50 microns in diameter at 20X magnification in order to
delineate boundaries between spheres. Clonal assays were performed in neurosphere media
in 96-well ULCP plates. Cells were plated through serial dilution and wells containing 1-5
cells were included for experimental analysis.
For differentiation experiments, single cells were dissociated from primary
neurospheres and seeded in media supplemented with 2% FBS (Gibco), as previously
described (Kerosuo, 2008). For all lineage specific differentiation protocols, single cells
were seeded in polyornithine (Sigma) coated plates and supplemented with different
growth mediums. For neural specific differentiation, cells were given Neurobasal medium
(Corning) supplemented with 2% B27 (Gibco) and 2 mM GlutaMAX-I (Gibco) for 7 days
in which dibutyryl cAMP (Sigma) was added to a final concentration of 0.5mM for 3 days.
For astrocyte differentiation, single cells were seeded in DMEM (Thermo) supplemented
with 1% N2 (Thermo), 2mM GlutaMAX-I (Gibco), and 1% FBS for 7 days with media
changes every other day. For oligodendrocyte specific differentiation, single cells were
seeded in Neurobasal medium (Corning) supplemented with 2% B27 (Gibco), 2mM
GlutaMAX-I (Gibco) and 30 ng/mL T3 (Sigma) for 7 days with media changes every other
day.
Quantitative Real Time (qRT) PCR Analysis
Total RNA was isolated using Qiagen RNeasy Plus Mini Kit as per manufacturer’s
instructions. cDNA was synthesized using qSCRIPT (Quanta) as per manufacturer’s
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instructions. SYBR Green detection (Applied Biosystems) was used for real time PCR and
was performed and analyzed using Viia7 Real Time PCR System (Life Technologies) and
software. Primers for qRT-PCR reactions can be found in supplementary material Table 1.
All qRT data is represented as log10 relative quantification (RQ) relative to a control.
Bromodeoxyuridine (BrdU) Proliferation Assay
Cells were seeded on coverslips and allowed to adhere overnight. BrdU (BD Pharmingen)
was added at a final concentration of 10µM. Cells were incubated in media containing
BrdU overnight at 37°C, 5% CO2. Media containing BrdU was removed and cells were
washed 3 times with 1X PBS. Cells were fixed in 4% PFA. Cells were incubated with 2M
HCl for 20 minutes at 37°C and subsequently incubated with Anti-BrdU (BD Biosciences
in 0.1% Tween/PBS for 45 minutes at room temperature. Cells were incubated with Alexafluor anti-mouse (1:1000) for 1 hour at room temperature. This was followed by Hoechst
(Thermo) counterstain for 10 minutes at room temperature. Three coverslips were used for
each independent experiment and 5 pictures were taken at different fields of view on one
coverslip. Cells were imaged using the Leica CTR 6500 microscope (Leica Microsystems,
Heidelberg, Germany).
Beta-galactosidase (β-gal) Stain
Cells were seeded on coverslips and allowed to attach overnight. Cells were fixed in 4%
PFA for 10 minutes at room temperature. Staining solution (5mM K4[Fe(CN)6]·3 H2O, 5
mM K3[Fe(CN)6] and 2 mM MgCl2) was prepared in 1X PBS. Complete staining solution
was prepared right before staining and contained 25 µL of 40mg/mL X-gal per mL of
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staining solution. Cells were stained overnight at 37°C. Cells were imaged using the Leica
CTR 6500 microscope (Leica Microsystems, Heidelberg, Germany).
Immunofluorescence
Single cells were seeded on coverslips and allowed to adhere overnight. Cells were washed
with PBS and fixed in 4% PFA for 10 minutes at room temperature. Cells were
permeabilized using 0.2% triton-X in 1X PBS for 10 minutes at room temperature. Cells
were blocked with blocker (0.1% triton-X, 0.2M glycine, 2.5% FBS). Cells were incubated
with primary antibody (γH2A.X; Millipore, 1:200) for 1 hour at room temperature.
Subsequently, cells were incubated with secondary Alexa-fluor anti-mouse (Thermo,
1:1000) for 45 minutes at room temperature. Finally cells were counterstained with
Hoechst (Thermo) for 10 minutes at room temperature. Coverslips were mounted on slides
and imaged using the Leica CTR 6500 microscope (Leica Microsystems, Heidelberg,
Germany).
Protein Isolation and Immunoblotting
Cells were lysed with TNE buffer (50mM Tris, 150mM NaCl, 5mM EDTA) supplemented
with protease inhibitors (2µg/mL leupeptin, 5µg/mL aprotinin, and 100µg/mL PMSF).
Cells were lysed for 20 minutes on ice and vortexed every 5 minutes for 30 seconds. Cells
were centrifuged at 4°C at 13,000rpm for 15 minutes. Supernatant was collected and stored
at -20°C until use.
Protein concentrations were determined through the Bradford assay as per
manufacturer’s instructions. Equal amounts of protein were calculated to be used for
loading. 100µg of protein were loaded on a 10%- SDS polyacrylamide gel and ran for 3
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hours at 120V. The gels were transferred to a PVDF membrane at 30V for 2 hours using a
wet transfer method. Membranes were blocked for 1 hour at room temperature in either
2% BSA or 2% milk, depending on antibodies used. Primary antibodies were incubated
overnight at 4°C. Following incubation with primary antibody, membranes were washed
with tris-buffered-saline-tween 20 (TBST) 3 times for 8 minutes each. This was followed
with secondary antibody incubation at room temperature for 1 hour. Following secondary
antibody incubation, membranes were washed 3 times in TBST for 5 minute intervals.
Protein signal was detected using chemiluminescent peroxidase substrate (Pierce) as per
manufacturer’s instructions, and images were taken on Alpha Innotech HD2, densitometry
analysis was performed on AlphaEase FC software.
Antibodies
For immunoblot analysis, antibodies used include: Actin (Millipore, 1:1000), Spy1
(Abcam, 1:700), Sox2 (Cell Signaling, 1:1000), Klf4 (EMD Millipore), p27 (Abcam,
1:800), Musashi 1 (Abcam, 1:1000), Numb (Abcam, 1:800). All secondary antibodies,
mouse IgG (Sigma Aldrich) and rabbit IgG (Sigma Aldrich), were used at a concentration
of 1:10,000.
Cell Pair Assay and Immunofluorescence
Single cells were isolated with 0.05% Trypsin-EDTA and plated in a drop of media onto
MaxGelTM ECM (Sigma) coated cover-slips. Cell division was monitored over 20 hours
and then fixed in 4% PFA for 15 min at room temperature. Cells were washed,
permeabilized and incubated with 1:200 Numb antibody (Cell signaling). Alexafluorophore conjugated secondary antibody (1:1000 dilution) (Invitrogen) was applied for
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1/2 hr. Nuclei were stained with Hoechst. Five random fields of view were scored for Numb
protein distribution in mitotic cell pairs/treatment/replicate. Analysis was performed using
Leica CTR 6500 microscope (Leica Microsystems, Heidelberg, Germany) and AF
software.
Immunostaining
Brain tissue was collected and fixed in 10% neutral buffered formalin. Brain tissue was
dehydrated through a series of increasing EtOH concentrations and cleared in xylene.
Tissues were embedded in paraffin wax and sectioned into 5 µM sections using Leica
RM2125RT. Sections were rehydrated through a series of decreasing EtOH concentrations
and heat mediated antigen retrieval was performed with 10 mM sodium citrate buffer.
Sections were blocked at room temperature for 1 hour with 3% BSA- 0.1% Tween-20 in
1x PBS for rabbut secondary antibodies. Sections were incubated with primary PCNA
(1:200) antibody in blocking solution overnight at 4°C. Sections were incubated in
secondary antibody (1:750) for 1 hour at room temperature in a humidified chamber.
Sections were coverslipped using Permount toluene solution (Thermo) and imaged with
Leica CTR 6500 microscope (Leica Microsystems, Heidelberg, Germany).
Novel Object Recognition Test
Novel object recognition test was performed as described (T. Huang & Hsueh, 2014).
Plexiglas boxes were built with the dimensions of 40cm x 40cm x 40cm and covered with
frosted white paper to impair outside views from the box. The objects used were
approximately 4cm x 4cm x 4cm and were shaped simple either square or rectangular and
made of plastic. The objects were either blue or yellow in colour. Computer cameras were
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used to record the videos. On days 1 and 2, mice were transported to area near the boxes
for 10 minutes. Then the mice were individually put in the boxes for 10 minutes each on
day 1 and day 2 to acclimate to the environment to decrease stress. The plexiglas boxes
and the objects are cleaned with 70% EtOH after every mouse and dried for 10 minutes
before the next mouse is placed inside. Similarly to day 1 and 2, mice were transported to
area near boxes and allowed to sit in holding cages for 10 minutes. Mice were placed in
the boxes to explore for 10 minutes and were recorded. Day 4 was testing day where one
of the old objects was replaced with a novel object. Similarly, mice are taken to area near
boxes, allowed to sit for 10 minutes and then placed inside the boxes and recorded for 10
minutes. The exploration time was counted by the period that the mice stay within a 5 cm
radius of the object and are facing the object. Exploration times of under 20 seconds or
over 5 minutes at an object were excluded. Preference rate was measured by dividing the
total time spent exploring both objects by the time spent exploring one object.
Statistical Analysis
Student’s t-test was used and a p-value of less than 0.05 was considered significant. All
data are reported as a means of standard deviation. For qRT-PCR analysis, Ct values of
internal control gene (GAPDH) was subtracted from the corresponding Ct value of a target
gene which generated a dCt value which was subjected to the Student’s t-test analysis.
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RESULTS
Construction and generation of pTRE-Spy1 transgenic mouse
In order to study the role of Spy1 in NSC populations of the mammalian brain we generated
a transgenic mouse termed NTA-Spy1 which permits inducible, spatially homogenous
expression of Spy1 throughout the course of development as originally described by the
Chodosh group (E. J. Gunther, et al. , 2002). This mouse model inducibly drives Spy1
under the Nestin promoter. Nestin is an intermediate filament protein that begins to
accumulate in the neural precursor cells of the brain at embryonic day 12 (E12) and is
retained in NSC populations throughout adult life (Hendrickson, 2011). To generate the
NTA-Spy1 mouse, pTRE-Spy1 transgenic mice were crossed with Nestin-rtTA mice
(Figure 1A). This ensured that Spy1 would be expressed under the Nestin promoter only
in the presence of doxycycline.
To create the pTRE-Spy1 transgenic mouse, the Flag-Spy1 sequence was removed
from a previously described vector – Flag-Spy1A-pLXSN. This was cloned into a pTRETight capsase3 vector backbone (Figure S1A). A Restriction digest using XhoI and AlwNI
was performed to remove the 536bp portion of the plasmid that was used for microinjection
(Figure S1B). PCR analysis depicted pTRE-Spy1 positive founder mice through the
presence of a 536bp band (Figure S1C). The pTRE-Spy1 mice express the open reading
frame of Spy1 downstream of a promoter containing a series of tetracycline operator
sequences. Lastly, the positive founder mice of a B6CBAF1/J background were all able to
transmit the pTRE-Spy1 transgene to their progeny (Figure S1D).
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Supplement Figure 1. Generation of pTRE-Spy1 transgenic mouse model. (A)
Complete plasmid map illustrating pTRE-Spy1 vector. (B) Agarose gel depicting RT-PCR
analysis of 536bp portion cut from vector in (A) using XhoI and AlwNI. (C) Agarose gel
depicting RT-PCR of the 536bp band of founder pTRE-Spy1 mice. Yellow boxes indicate
positive founders. (D) Agarose gel depicting RT-PCR corresponding to successful
germline transmission of the pTRE-Spy1 transgene (red arrow). Numbers in (C) and (D)
are indicative of the mouse tag number belonging to each tail sample that was screened.
Vectors represents the pTRE-Spy1 plasmid used as a positive control.
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Characterization of the NTA-Spy1 transgenic mouse model system
The SVZ is a unique brain region which contains NSCs. In order to establish a primary
culture, post-natal (PN) day 2 murine brains were micro-dissected to remove the SVZ.
Extracted cells from the SVZ were cultured in the presence or absence of doxycycline, in
order to test the rtTA system. qRT-PCR was performed for Flag and Spdya mRNA
expression in the NTA-Spy1 and all other littermate controls. NTA-Spy1 mice show
significant increase in Flag and Spdya expression in the presence of doxycycline as
compared to littermate controls (Figure 1B; top and bottom, respectively). Primary cells
harvested from SVZ were also used for western blot analysis. NTA-Spy1 doxycycline
treated NSCs show an increase in SPY1 protein levels when compared to NTA-Spy1 cells
not treated with doxycycline as well as pTRE-Spy1 littermate controls with or without
doxycycline. A representative western blot (left) is shown (Figure 1C; left) and protein
levels were measured in relative units for densitometry values (Figure 1C; right). The rtTA
gene of the Nestin-rtTA transgenic mouse is cotranscribed with the lacZ reporter gene,
βgeo, for detection (Canzoniere, 2004; T. S. Yu, et al. , 2005). Beta-galactosidase staining
was performed in primary NSCs to indicate when Nestin promoter was on and
consequently when rtTA was being expressed. Blue staining was seen in both Nestin-rtTA
and NTA-Spy1 cells that both contain the Nestin promoter upstream of the βgeo gene. As
expected we did not detect blue stain in the pTRE-Spy1 cells indicating the absence of the
Nestin-rtTA transactivator (Figure 1D). To determine that Spy1 levels were being
upregulated specifically in the Nestin positive population, mouse SVZ were dissected and
subjected to fluorescence activated cell sorting for NESTIN. The positive and negative
NESTIN cell populations from both the NTA-Spy1 and littermate controls pTRE-Spy1
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were analyzed through qRT-PCR for Spdya levels (Figure 1E). Not only were there
significant increases in Spdya levels within each genotype when comparing the NESTIN
positive and negative populations, there was also a significant increase in Spdya expression
between the pTRE-Spy1 Nestin-positive population and the NTA-Spy1 NESTIN-positive
population (Figure 1E). This is the first mouse model directing Spy1 expression to the brain
and has been designed to control cell types, timing and the relative expression levels of
Spy1.
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Figure 1. Characterization of NTA-Spy1 transgenic mouse. (A) Schematic
representation of the Nestin-rtTA transactivator crossed with pTRE-Spy1 target transgenic
mouse. Doxycycline addition turns on Spy1 under Nestin promoter. (B) qRT-PCR gene
expression analysis for Flag (top) and Spdya (bottom) in wildtype (WT), Nestin-rtTA,
pTRE-Spy1, and NTA-Spy1 littermate primary NSCs without (dark grey) and with (light
grey) the addition of doxycycline. (n=6). (C) Western blot (left) for SPY1 protein using
primary NSCs in pTRE-Spy1 and NTA-Spy1 littermates without and with doxycycline
addition. Densitometry (right) analysis left expressed as the Integrated Density Value
(IDV) of Spy1/ Actin in pTRE-Spy1 and NTA-Spy1 littermates without (dark grey) and
with (light grey) doxycycline addition. (n=3). (D) β-gal staining (light blue) in primary
cells of Nestin-rtTA, pTRE-Spy1 and NTA-Spy1 littermates. (E) qRT-PCR gene
expression levels of Spdya in pTRE-Spy1 and NTA-Spy1 littermates by FACS sorted cell
populations for NESTIN- (dark grey) and NESTIN+ (light grey) cells. (n=5). qRT-PCR
values are normalized to Gapdh. Results presented as the mean ±s.d.; *p < 0.05, **p <
0.01, ***p < 0.005. Scale bar = 50 µm.
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Enhanced proliferation and NSC expansion in NTA-Spy1 mice
Data obtained in the lab using wildtype extracted NSCs of the SVZ showed that the
lentivirus mediated overexpression of Spy1 caused a significant increase of key stem cell
markers, Msi1, Cd133, Bmi1, Vimentin and Nestin, when compared to control (Figure S2).
To assess the role of Spy1 in the proliferation of NSC populations of the NTA-Spy1
mice, we performed BrdU incorporation assay in cells extracted from the SVZ of NTASpy1 mice and their littermate controls. Adherent monolayer NSC cultures have proven as
a great in vitro comparison to mimic in vivo proliferation (T. Walker, Kempermann, G.,
2014). NTA-Spy1 derived NSCs cultured as adherent monolayer of cells were stained with
anti-BrdU antibody (Figure 2A; left). The percent of BrdU positive cells was established
by calculating BrdU+ cells over the total cell number (Figure 2A; right). NTA-Spy1 cells
had a significantly higher percentage of cells positive for BrdU incorporation compared to
all other control cells suggesting that Spy1 increases cell division in populations of NSCs.
Stemness characteristics in neural systems can be studied through the careful
assessment of numbers of spheres generated in conditions supporting self-renewal (B. A.
Reynolds, Weiss, S., 1996; B. A. Reynolds, Weiss, S. , 1992). Using the neurosphere
formation assay we found that NTA-Spy1 cells form significantly more spheres at serial
passaging (Figure 2B; right, top) and the neurospheres are generally larger in size (Figure
2B; bottom) as compared to controls, suggesting enhanced stemness and proliferation of
NTA-Spy1 derived NSCs. To address the limitation of the neurosphere formation assay in
determining single cell-derived spheres, we employed clonality self-renewal assay. The
cells were single-cell seeded in 96-well low attachment plates and monitored for
neurosphere generation over time. The data obtained showed that NTA-Spy1 cells have a
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higher proportion of self-renewing NSC (Figure 2C). NTA-Spy1 also had a significant
increase in gene expression for stemness markers Cd133, Sox2 and Nestin throughout serial
passaging (Figure 2D). In addition, protein expression (Figure 2E; top) revealed that SOX2
protein levels, unlike those of another stemness marker KLF4, were significantly elevated
in the NTA-Spy1 NSC population as compared to pTRE-Spy1 cells as quantified through
densitometry analysis (Figure 2E; bottom). In summary our results show that elevated
levels of Spy1 in NSC populations increase their self-renewal and stemness characteristics.
Interestingly, upon further investigation of transcription factor genes Oct4, Sox2, cMyc, Klf4 and Nanog, known to be involved in cellular reprogramming (K. Takahashi,
Yamanaka, S. , 2006; J. Yu, et al. , 2007), qRT-PCR analysis revealed that NTA-Spy1 cells
have upregulated levels of reprogramming gene expression as compared to pTRE-Spy1
littermate controls (Figure S3A). Due to an intrinsic increase in reprogramming genes, we
wanted to determine whether NTA-Spy1 cells had the potential to sustain self-renewal
regardless of being cultured in differentiation-promoting media. We employed a resphering assay, as previously described (Kerosuo, 2008). Briefly, dissociated neurospheres
were plated at low cell numbers per well in media promoting differentiation (Figure S3B).
Although initially there was no visible sphere formation and cells had differentiated, new
neurospheres started appearing in the differentiation conditions 2 weeks after
differentiation conditions were applied. The percentage of cells that were able to re-sphere
was higher in the NTA-Spy1 cells as compared to pTRE-Spy1 controls (Figure S3C; left).
The re-sphered cells remained attached in 2D during the span of the differentiation
experiment (Figure S3C; right). qRT-PCR analysis of differentiation markers S-100b,
Foxo4 (O4), and Mapt show an increase during differentiation compared to initial
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neurospheres, and decreased in the newly formed spheres compared to differentiated cells
(Figure S3D). Interestingly, NTA-Spy1 cells had significantly lower expression of all
differentiation markers throughout all stages, ranging from parental sphere cultures to
populations which had undergone re-sphering. This seems to suggest that the cells that
were capable of re-sphering were primed for this prior to being subjected to differentiation.
We were able to remove and dissociate individual spheres and plate them back into
neurosphere culture where they were able to continue expanding as 3D floating
neurospheres.
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Supplement Figure 2. Lentiviral overexpression of Spy1 increases stemness markers.
qRT-PCR analysis for gene expression of genes Msi1, Vimentin, Bmi1, Nestin and Cd133
represented at relative quantity of mRNA levels on Spy1 overexpressing primary mouse
NSC and control.
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Figure 2. NTA- Spy1 mice have enhanced stemness characteristics. (A) BrdU
incorporation representative images (left) in wildtype (WT), Nestin-rtTA, pTRE-Spy1, and
NTA-Spy1 littermate primary NSCs. BrdU+ cells scored and quantified as percentage of
total population tested (right). (n=3). (B) Neurosphere formation assay over serial passages
(primary, secondary, tertiary) in wildtype (WT), Nestin-rtTA, pTRE-Spy1, and NTA-Spy1
littermate primary NSCs. Representative images (upper left), quantified number of
neurospheres as a fold change (upper right), and neurosphere size through serial passaging
(bottom). (n=5). (C) Clonal assay quantified as percentage of single cells that formed
spheres in pTRE-Spy1 and NTA-Spy1 cells. (n=5) (D) qRT-PCR analysis for gene
expression of Cd133 (darkest grey), Nestin (medium grey) and Sox2 (light grey) in the
primary, secondary and tertiary neurospheres of NTA-Spy1 cells controlled to pTRE-Spy1
cells. (n=3) (E) Western blot for KLF4 and SOX2 protein levels (top) in pTRE-Spy1 and
NTA-Spy1 cells. Actin used as a loading control. Densitometry (bottom) of SOX2/ACTIN
IDV in pTRE-Spy1 and NTA-Spy1 cells. (n=3). qRT-PCR values are normalized to
Gapdh. Results presented as the mean ±s.d.; *p < 0.05, **p < 0.01, ***p < 0.005. Scale
bar = 50 µm.
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Supplement Figure 3. NTA-Spy1 cells maintain self-renewal ability of differentiating
NSCs. (A) qRT-PCR gene expression analysis for Oct3/4, Sox2, Klf4, c-Myc and Nanog
in NTA-Spy1 primary NSCs corrected for pTRE-Spy1 control expression levels. Gapdh
was used as loading control. (B) Schematic showing experiment set-up for the re-sphering
assay. (C) Percent of cells that had the capacity to re-form a sphere quantified as spheres
formed over the total number of cells seeded in pTRE-Spy1 and NTA-Spy1 primary cells
(left). Representative light microscope images of pTRE-Spy1 and NTA-Spy1 primary cells
depicting the “re-sphere” in the NTA-Spy1 culture (right). (D) qRT-PCR analysis of
differentiation markers S100b, O4, and Mapt from primary neurospheres (NS) to
differentiated cells to “re-sphering cells” in pTRE-Spy1 (dark grey) and NTA-Spy1 (light
grey) primary cells. Scale bar = 50 µm. Results presented as the mean ±s.d.; *p < 0.05, **p
< 0.01, ***p < 0.005.
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NTA-Spy1 mouse derived NSCs exhibit decreased neural differentiation capacity
Deprivation of essential growth factors such as EGF and FGF supporting neurosphere
growth and introduction of FBS promote differentiation of NSC cultures. To determine the
effect of increased levels of Spy1 on NSC lineage differentiation, we cultured NSCs in
adherent conditions in the presence of 2% FBS and absence of EGF and FGF. Morphology
was used to score differentiated cells at the indicated time points. Cells that contained
outgrowth processes of at least two cell-body diameters were scored as differentiated
(Figure 3A; left). We found that NTA-Spy1 cells had a significant decrease in the number
of differentiated cells when compared to control littermates and scored as a percentage
(Figure 3A; right). To distinguish potential differences between affected lineages, we
analysed specific marker gene expression at the indicated time points in NTA-Spy1 and
control cells subjected to differentiation separately into three main neural lineages (Figure
3B). Gene expression was analyzed through qRT-PCR for S100b (astrocyte marker), O4
(oligodendrocyte marker), Beta III tubulin (neuronal marker) as well as Mapt (neuronal
marker) at the specified time period up until 8 days post differentiation (Figure 3B).
Although NTA-Spy1 cells show a decrease in the gene expression of both astrocytic and
oligodendrocytic specific markers, S100b and O4, respectively (Figure 3B; top left and
right), the most pronounced effect was observed in the levels of the markers of neuronal
lineage, Beta III tubulin and Mapt (Figure 3B; bottom left and right) Our results suggest
that increased levels of Spy1 in NTA-Spy1 cells cause an early chronic and significant
decrease in neuronal differentiation capacity compared to control pTRE-Spy1 cells. The
CKI, p27, has been implicated in enhancing neuronal differentiation (Bahrami, Matin, &
Andrews, 2005; Zheng et al., 2010). Notably, prior to the commencement of
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differentiation, protein expression of p27 was analyzed in pTRE-Spy1 and NTA-Spy1 cells
through western blotting. We found that there was significantly less p27 protein in NTASpy1 compared to pTRE-Spy1 controls (Figure 3C). This suggests that Spy1 inhibits
differentiation, specifically neuronal differentiation potentially due to its ability to regulate
cell cycle progression and aid in targeting p27 for degradation in NSCs.
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Figure 3. NTA-Spy1 mice have decreased differentiation capacity. (A) Representative
brightfield images (left) of pTRE-Spy1 (dark grey) and NTA- Spy1 (light grey) cells
subjected to differentiation using 2% FBS. Number of differentiated cells scored and
quantified as percentage of population tested at each indicated time point (right). (B) qRTPCR analysis for astrocyte specific (S100b), oligodendrocyte specific (O4) and neural
specific (Beta III Tubulin, Mapt) genes in pTRE-Spy1 (dark grey) and NTA- Spy1 (light
grey) cells at indicated time points of differentiation. qRT-PCR values are normalized to
Gapdh. (C) Western blot (left) for CKI and differentiation associated protein p27 in pTRESpy1 and NTA- Spy1 cells. Actin used as a loading control. Densitometry (right) of
p27/ACTIN IDV in pTRE-Spy1 and NTA-Spy1 cells. qRT-PCR values are normalized to
GAPDH. Results presented as the mean ±s.d.; *p < 0.05, **p < 0.01, ***p < 0.005. (n=3).
Scale bar = 50 µm.
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NTA-Spy1 NSC shift towards Musashi-1 mediated symmetric mode of division
The maintenance of NSCs is dependent on mechanisms such as self-renewal (Neumuller,
2009). To elucidate the role of Spy1 in cell fate decisions and self-renewal regulation,
pTRE-Spy1 and NTA-Spy1 cells were cultured at low densities in Matrigel. This system
provides an adherent substrate in which multipotent cells of neurospheres can develop in a
way that allows all the relevant brain cells to propagate. We found that Spy1 upregulation
resulted in over 3- fold increase in number of 3D colonies that were being formed and
drastically decreased the percent of differentiated cells (Figure 4A). It is well recognized
that lengthening of the cell cycle, specifically G1 phase is correlated with a decrease in
stemness ability. In addition, the differentiation program in an epithelial cell line has been
shown to depend on asymmetric cellular division (Gomez-Flores, 2010). Moreover,
asymmetric cell division has also been described to be linked to terminal differentiation
identity of neurons in C. elegans (Bertrand, 2009). As described previously, we have
demonstrated that Spy1 drives expansion of glioma stem cells through regulating their
mode of division (D. Lubanska, and Porter, L.A. , 2014). We wanted to determine if the
expansion of the NSC pool and resistance to differentiation in NTA-Spy1 mice was due to
the mode of cell division. In Drosophila, the basic molecular mechanism to asymmetric
cell division was found to involve the cell fate determining protein Numb (J. A. Knoblich,
Jan, L.Y., & Jan Y.N. , 1995; Rhyu, 1994). Asymmetric localization of Numb controls cell
fate in the CNS of Drosophila (Spana, 1995) and asymmetric segregation of Numb was
found in asymmetrically dividing murine cerebral cortical stem cells and neuroblasts
(Shen, 2002). To study cell division decisions in NTA-Spy1 mice, we performed a cell pair
assay using MaxGel ECM and monitored the distribution of the established cell fate
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regulator protein, NUMB, between mitotic cell pairs (Figure 4B; left). We found that NTASpy1 populations had significantly more cell pairs presenting equal distribution of NUMB
protein as quantified over the total cell pair number in comparison to control littermate
pTRE-Spy1 (Figure 4B; right).
The expression of Notch, one of the main regulators of neural stemness (Chojnacki,
Shimazaki, Gregg, Weinmaster, & Weiss, 2003; Hitoshi et al., 2002; Nyfeler et al., 2005)
is regulated by NUMB and MSI1 (Okano, Imai, & Okabe, 2002). Western blot analysis
(Figure 4C; left) revealed that MSI1 protein levels are dramatically increased in NTA-Spy1
cells as compared to pTRE-Spy1, inversely correlating with the protein levels of NUMB
(Figure 4C; right).
Musashi activation and function can be induced through Spy1-CDK-mediated
phosphorylation (Arumugam et al., 2012a). To test if Spy1 was mediating symmetric
division through Msi1, we analyzed the mode of division in NTA-Spy1 and control cells
treated with short interference RNA (siRNA) against Msi1. qRT-PCR analysis reveals a
significant decrease in Msi1 mRNA levels (Figure 4D; left) followed by a decrease in Msi1
downstream targets, Hes1 and Hes5 (Figure 4D; right). Under siMsi1 conditions, we find
that there is a decrease in symmetric cell division in NTA-Spy1 cells compares to pTRESpy1 control cells (Figure 4E). This suggests that Spy1 mediated effects on the mode of
division in NSCs depend on the presence of Msi1.
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Figure 4. NTA-Spy1 mice show increased symmetric division through Msi1 mediated
mechanism. (A) pTRE-Spy1 (left) and NTA-Spy1 (right) cultured in MatrigelTM. Cells
scored for differentiation and colony formation and quantified as percentage of the cell
population seeded. (n=6). (B) Cell pair assay in MaxGel ECM. Representative images of
NUMB protein distribution in mitotic pairs (left) of pTRE-Spy1 (top) and NTA-Spy1
(bottom). Mitotic cell pairs were quantified (right) as asymmetric (light grey) or symmetric
(dark grey) as a percent of total mitotic pairs counted in pTRE-Spy1 and NTA-Spy1 cells.
(n=6) (C) Western blot for NUMB, MSI1 (left). ACTIN used as a loading control.
Densitometry analysis (right) of NUMB/ACTIN IDV and MSI1/ACTIN IDV in pTRESpy1 and NTA-Spy1 cells. (n=3). (D) qRT-PCR analysis for gene expression of Msi1 in
pTRE-Spy1 and NTA-Spy1 siMsi1 cells (left), qRT-PCR analysis for Hes1 and Hes5 in
pTRE-Spy1 and NTA-Spy1 siMsi1 cells (right). LogRQ values controlled for siControl
pTRE-Spy1 or NTA-Spy1. (n=3). (E) Clonal assay quantified as percentage of single cells
that formed spheres in pTRE-Spy1 and NTA-Spy1 cells treated with si Control (dark grey)
or siMsi1 (light grey). (n=3). qRT-PCR values are normalized to Gapdh. Results presented
as the mean ±s.d.; *p < 0.05, **p < 0.01, ***p < 0.005. Scale bar = 10 µm.
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Aging NTA- Spy1 mice retain pools of actively proliferating NSCs
To address the role of Spy1 in the maintenance of NSC pools over the lifespan of an
organism and its implications in sustaining the stemness in aging brains we tested cells
derived from 20 month-old NTA-Spy1 and control littermate mice. Cells derived from
NTA-Spy1 mice showed not only significantly increased proliferation in comparison to
controls as assessed by BrdU incorporation assay (Figure 5A),

but continued to

demonstrate a decrease in the number of differentiated cells at each time point in aging
primary NTA-Spy1 cells in comparison to control (Figure 5B). In vivo testing of the
expression of proliferation marker PCNA in brain sections obtained from mice of the same
age revealed upregulation of the number of PCNA+ cells in NTA-Spy1 mice in comparison
to control mice (Figure 5C). Furthermore, NTA-Spy1 cells presented increased levels of
mRNA expression of proliferation marker Ki67 (Figure 5D), as well as significantly
decreased levels of CKI gene expression of Cdkn1a, Cdkn2a, and Trp53 (Figure 5E) as
compared to pTRE-Spy1 cells. Histone γH2A.X is the most common marker for DNA
double strand breaks and telomere shortening (Hovest, Brüggenolte, Hosseini, Krieg, &
Herrmann, 2006b; Sedelnikova et al., 2004b), and at times can also be used as a cellular
senescence marker (Narita et al., 2003). Notably, when we performed immunofluorescence
for γH2A.X foci we found that NTA-Spy1 cells had a significant decreased in the number
of γH2A.X foci compared to control littermates (Figure 5F). Moreover, Caspase 3/7
activity tested in the NTA-Spy1 cells compared to pTRE-Spy1 controls was significantly
downregulated (Figure 5G). This data suggests that elevated levels of Spy1 in the
population of NSCs of an aging brain contribute to sustained proliferation and decrease in
cell death.
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Aging NTA-Spy1 mice present impaired cognitive functions
To determine how the observed delay in differentiation processes and increased
proliferation affects neuronal layering of the brain cortex, we stained sections with a neuron
specific stain, Nissl, and scored Nissl+ cells. NTA- Spy1 mice showed a shift in neuronal
positioning of the cortical plate (Figure 5H) with obvious accumulation of neuronal bodies
in closer proximity to ventricular zone as compared to Nestin-rtTA control mice,
suggesting the role of Spy1 in control over neuronal in these mice during development.
Finally, we sought to establish if observed changes to neuronal positioning could
contribute to changes in cognitive functions in the mice. We performed the novel object
recognition task, as demonstrated by a schematic (Figure 5I; left). Interestingly, NTA-Spy1
mice had significantly decreased preference for novel object brought to the task set up as
compared to control littermates (Figure 5I; right), suggesting that the inhibition of
differentiation in NTA-Spy1 mice may be a cause of decreased memory retention. In
summary, upregulation of Spy1 levels in Nestin+ cells causes abnormal positioning of
neurons and seems to impair cognitive function in NTA-Spy1 mice.
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Figure 5. Aging NTA- Spy1 mice retain NSC pool and present with impaired cognitive
functions. (A) BrdU incorporation representative images (top) in aged (20 month) NestinrtTA, pTRE-Spy1, and NTA-Spy1 littermate primary NSCs. BrdU+ cells scored and
quantified as percentage of total population tested (bottom). Scale bar = 50 µm. (n=3). (B)
Number of differentiated cells scored and quantified as percentage of population tested at
each indicated time point in aged Nestin-rtTA (dark grey), pTRE-Spy1 (light grey) and
NTA- Spy1 (medium grey). (n=3). (C) Nestin-rtTA and NTA-Spy1 derived brain sections
stained for PCNA representative images (top) and PCNA+ cells scored (bottom). Scale bar
= 50 µm. (n=6). (D) qRT-PCR analysis for Ki67 in aged pTRE-Spy1 and NTA- Spy1
derived NSCs. (n=3). (E) qRT-PCR analysis for CKI genes Cdkn1a, Cdkn2a and Trp53 in
aged NTA-Spy1 NSCs controlled to pTRE-Spy1. (n=3). (F) γH2A.X immunofluorescence
representative imaged (top) in aged pTRE-Spy1 and NTA- Spy1 derived NSCs. Scale bar
= 20 µm. The average number of γH2A.X foci per cell were quantified (bottom). (n=3).
(G) Caspase 3/7 activity quantified as CPS x103 units in aged pTRE-Spy1 and NTA-Spy1
derived NSCs. (n=3). (H) Analysis and quantification of the distribution of Nissl+ neuronal
cells in the cortical plate for Nestin-rtTA and NTA-Spy1 of aged brain sections. (n=5). (I)
Schematic of novel object recognition memory test (left). Preference for novel object at
day 4 measured as a percentage of time spent at novel object versus the overall time spent
at objects in aged control (Nestin-rtTA, pTRE-Spy1) and NTA-Spy1 mice (right). (n=12).
qRT-PCR values are normalized to GAPDH. Results presented as the mean ±s.d.; *p <
0.05, **p < 0.01, ***p < 0.005.
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DISCUSSION
At the heart of adult neurogenesis lies the ability of the brain to sustain a healthy NSC pool
while being sensitive to differentiation stimuli and cues in the face of insult, or injury, to
permit regeneration. The G1 phase of the cell cycle is a well-established and critical piece
in determining cell fate decisions in which a stem cell population will undertake. During
neural development, changes in G1 have been correlated to changes in differentiation
potential, stemness capacity, and proliferative capability (S. Lim & Kaldis, 2012a). CKI
genes prevent the activation of cyclin-CDK complexes, most notably those of the G1/S
phases, in part to allow neurogenesis to occur (Durand, et al., 1998; Hindley & Philpott,
2012). Similarly, genes that aid in the activation of cell cycle cyclin-CDK complexes, and
ultimately proliferation, aid in supporting an expanding stem cell pool while limiting
successful neurogenesis (Lange & Calegari, 2010). The roles of different positive
regulators of the cell cycle in neurogenic events remain unclear. The number and families
of proteins that are involved in cell cycle progression have evolved in multicellular
organisms. The Spy1/RINGO family are a unique class of atypical cyclin-like proteins (A.
Cheng, Gerry, S., Kaldis, P., and Solomon, M.J., 2005). Spy1 appears to facilitate a distinct
cellular response in the NSC population of neurogenic regions in the brain. In human
CD133+ brain tumour initiating cells (BTICs), symmetric division regulated by Spy1
appears to be critical in self-renewal, as well as continued proliferation and expansion of
this pool (D. Lubanska, Market-Velker, B.A., deCarvalho, A.C., Mikkelsen, T., Fidalgo da
Silva, E., Porter, L.A., 2014). The molecular mechanisms by which Spy1 regulates the
NSC pool in the normal adult brain remain fundamentally unknown. Whether changes in
the endogenous program of the NSC population, through Spy1 manipulation, can cause
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abnormalities in adult mammalian brain was previously untested. Our data provides an in
vivo demonstration that Spy1 maintains NSC self-renewal during adulthood, at least in part,
through Msi1. Increased levels of Spy1 in NSCs prevent functional differentiation down
all lineages and enhances stemness capacity. Although the link between NSCs and
neurogenesis has been extensively determined, the links between NSCs and their
implications in learning and memory have only recently begun to unravel. We provide
evidence which suggest that molecular regulation of NSCs could have implications in
memory retention.
The pTRE-Spy1 mouse model permits a more detailed study on cell cycle
regulation in NSCs throughout development. Crossing this mouse with the Nestin-rtTA
generated the NTA-Spy1 mouse. Using the NTA-Spy1 mouse, we were able to control
spatial and temporal expression of Spy1 under the Nestin promoter upon the administration
of doxycycline, either in mice diet or cell culture media supplement. The work presented
here demonstrates that Spy1 significantly increased proliferation while maintaining stem
cell attributes of the Nestin+ population, both in young and old mice. We also found that
increased levels of Spy1 in NSCs of these mice inhibits functional differentiation induced
by removal of growth factors EGF and FGF, especially down the neuronal lineage. This
suggests that Spy1 overexpression inhibits endogenous neuronal regeneration and
maintains stemness.
Our data indicate that Spy1 promotes cell fate decisions that favour symmetric
division rather than asymmetric division. A shift towards a proliferative symmetric division
mode occurs from the reduction of G1 phase length, which ultimately inhibits neurogenesis
(Pilaz et al., 2009a) and increased length of G1 is attributed to the progression of
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neurogenesis and asymmetric cell divisions (T. Takahashi, Nowakowski, & Caviness,
1995c). A well-established regulatory mechanism in mode of division is the segregation of
the cell fate determinant protein Numb. Numb inhibits the Notch signaling pathway, which
is critical to stem cell self-renewal and symmetric division (Y. Song & Lu, 2012). Our
work establishes a role for the cyclin-like protein Spy1 in favouring a symmetric mode of
division in NSCs and thereby maintaining self-renewal. Interestingly, Spy1/CDK
activation and signalling has been implicated as a conserved mechanism for activation of
MSI1 in oocyte maturation (Arumugam, et al., 2012a). MSI1 stimulates the Notch
signalling pathway through inhibition of Numb (Okano, et al., 2002). Hence, Spy1/CDK
mediated activation of MSI1 might be responsible for increased symmetric division and
self-renewal of the NSC population. Our data demonstrates that NTA-Spy1 primary cells
had an increase in MSI1 and decrease in NUMB levels. The decrease in Msi1 levels in the
NTA-Spy1 cells through siRNA demonstrates a shift to asymmetric division at levels
similar to control, revealing that indeed Spy1 is acting through Msi1 in regulating NSC
mode of division in vertebrates. Notch has been associated as a transcriptional repressor of
p21 (Noseda et al., 2004). Finally, we also present that p21 levels are decreased in NTASpy1 mice.
Memory is an essential hallmark of neurogenic plasticity; however, there is little
work to show how memory is regulated at the molecular level (Berry, Cervantes-Sandoval,
Nicholas, & Davis, 2012; A. Inoue et al., 2013; Shuai et al., 2010). Recently, Msi1 in C.
elegans has been demonstrated to be involved in forgetting and decreased memory
acquisition (Hadziselimovic et al., 2014). Our mouse model upregulates levels of Spy1
under Nestin+ NSC populations which are found both in the SVZ and in the SGZ. Memory
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and learning in mammals occurs in the hippocampus where the dentate gyrus is located. It
seems that the inability of NSCs to differentiate and increased symmetric division, in the
face of upregulated levels of Spy1 is inhibiting neurogenesis and ultimately causing an
effect on recognition memory (Figure 6). Our aged NTA-Spy1 mice show a decreased
preference for a novel object in a behavioural memory recognition test as compared to their
control littermates. Hence, this could be a mechanism upstream of Msi1 that molecularly
may be involved in memory. Although further work would help reveal the importance of
Spy1 in this behavioural trait.
Spy1 can activate both CDK1 and CDK2 independently of critical phosphorylation
and dephosphorylation events compared to their cyclin-binding partners (A. Cheng, Gerry,
S., Kaldis, P., and Solomon, M.J., 2005). Spy1 can also promote the degradation of the
CKI, p27 (L. A. Porter, Kong-Beltran, M., and Donoghue, D.J., 2003). In addition, Spy1
stimulates the maintenance of the CD133+ stem cell population in human brain tumours
(D. Lubanska, Market-Velker, B.A., deCarvalho, A.C., Mikkelsen, T., Fidalgo da Silva,
E., Porter, L.A., 2014). This demonstrates that Spy1 can drive proliferation and
maintenance of a stem cell population. Our results suggest that the inhibition of
neurogenesis in NTA-Spy1 mice is two-fold: 1) a decrease in the differentiation
programme, and 2) an increase in symmetric division of NSCs; both of which hold NSCs
in a stem cell state regardless of cues. As a result of elevated levels of Spy1 in the brain,
we see an impairment in recognition memory. This work provides support that elevated
levels of Spy1 may be an early step in driving NSCs towards uncontrolled and aberrant
growth, potentially increasing the susceptibility of these cells towards becoming brain
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tumour initiating cells (BTICs). It also provides evidence that Spy1 may play a role in CNS
aging defects which are associated with memory.
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Figure 6. Graphical conclusion of NTA-Spy1 mice properties in NSCs and CNS
function. NTA-Spy1 mice NSCs present with increased symmetric cell division, decreased
differentiation capacity resulting in impaired recognition memory as compared to control.
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SUPPLEMENTAL MATERIAL
Supplemental Materials and Methods
Transfection of Primary NSCs
pTRE-Spy1 and NTA-Spy1 neurospheres were single cell dissociated and plated on 0.1%
gelatin coated 6cm plates and allowed to adhere overnight. The Lipofectamine 2000
(Thermo)/siRNA (mouse si Msi1; Thermo) complex was prepared in 400 µL media and
allowed to incubate at room temperature for 15 minutes. Final Lipofectamine 2000 reagent
per plate used was 12 µL and the final amount of siRNA added to each plate was 1.5 µg.
The Lipofectamine/siRNA transfection media was added dropwise to plates. Cells were
incubated in transfection media for 5 hours. This was followed by a media change and cell
were used for experiments 48 hours post transfection.
Caspase 3/7 Cell Death Assay
The Capase-Glo 3/7 Assay (Promega) was done as per manufacturer’s instructions.
Luminescence was measured on Wallac Victor 1420 plate reader (Perkin Elmer, software
work out 2.0).
Nestin Fluorescence Activated Cell Sorting (FACS)
NSCs were harvested, and neurospheres dissociated. Cells were washed through a 70 µm
cell strainer and collected at a concentration of 1 x 106 cells/mL of ice cold PBS. To aid in
intracellular staining for Nestin, cells were fixed with fixation buffer (BD Pharmingen) and
permeabilized with permeabilization/ wash buffer. Cells were stained using BD
Pharmingen Stain Buffer containing FBS. 1 x 106 cells/mL of buffer. Anti-mouse/rat
Nestin PE conjugated antibody (R&D Systems) was used at a concentration of 10 µL/mL
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of stain buffer. Cells were stained in the dark on ice for 1 hour, with vortexing every 10
minutes. Cells were spun down, and staining solution was removed. Cells were washed
twice in wash buffer and resuspended in ice cold PBS for FACS. All flow cytometry
experiments were performed using BD LSRFortessa X-20 with FACSDiva software. Cell
debris was excluded from analysis.
TABLES/FIGURES

Supplemental Table 1. Primers used for RT-PCR and qRT-PCR analysis. The primers
are listed with their name, their purpose (RT or qRT), the sequence of forward (5’3’)
primer and the sequence of reverse (5’3’) primer.
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CHAPTER 3
SPY1 DOWNREGULATES THE DNA DAMAGE RESPONSE AND INHIBITS
ASTROCYTIC DIFFERENTIATION FOLLOWING UV IRRADIATION IN NSC
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INTRODUCTION
The manner in which adult stem cells (ASCs) respond to DNA damage throughout the
lifetime of an organism plays a major role in determining overall tissue maintenance.
Sensitivity or resistance to DNA damage may also reveal mechanisms that underlie tissue
degeneration or carcinogenesis. Therefore, the response of ASCs to DNA damage may
provide critical insight into how tissue homeostasis is maintained.
Existing data documenting how different stem cells respond to DNA damage, such
as that contributed by ionizing radiation (IR), is incomplete and fragmented. Growing
evidence in this field shows that ASCs exhibit distinct responses to DNA damage as
compared to their differentiated progeny (Insinga, Cicalese, & Pelicci, 2014; Mandal,
Blanpain, & Rossi, 2011). Among ASC populations studied, the DNA damage response
(DDR) has been best characterized in haematopoietic stem cells (HSCs). Following IR,
quiescent HSCs sustain DNA damage and re-enter the cycle in order to replenish their
depleted progeny (Meijne et al., 1991; Mohrin et al., 2010; Walter et al., 2015). Repeated
cell cycle re-entry following DNA damage in HSCs during aging causes depletion of this
population (Walter, et al., 2015). Cell cycle re-entry following DNA damage is p21dependent and p53-independent (Insinga et al., 2013). Lastly, HSCs have been shown to
differentiate in times of excessive DNA damage to maintain genomic integrity (Wingert &
Rieger, 2016; Wingert et al., 2016).
In this study, we focus on neural stem cells (NSCs), located specifically in the
largest stem cell niche of the brain –the subventricular zone (SVZ). NSCs are responsible
for brain tissue homeostasis and are regarded as the population which are accountable for
neurogenesis throughout adulthood (F. Doetsch, Caille, Lim, Garcia-Verdugo, & Alvarez143

Buylla, 1999). Within the neurogenic niche there are different populations of stem and
progenitor cells including the most stem-like type B cells which are relatively quiescent
and capable of symmetric division to give rise to more NSCs, as well as asymmetric
division to give rise to type C transit amplifying cells (TAPs). TAPs generate more
differentiated type A cells (Ponti et al., 2013). Several studies have provided insight into
the DDR of the stem and progenitor cells of the SVZ (Bellinzona, Gobbel, Shinohara, &
Fike, 1996b; F. Doetsch, Garcia-Verdugo, & Alvarez-Buylla, 1999). The canonical DDR
signalling pathway is functional in NSCs of the mammalian brain (Daynac, et al., 2013;
Schneider, Fumagalli, & d'Adda di Fagagna, 2012; Schneider, et al., 2013). Following IR
exposure type C progenitor populations of the SVZ are depleted which force NSCs to reenter the cell cycle (Daynac, et al., 2013). It has been demonstrated that the induction of
DNA damage through IR leads to cellular senescence in NSC populations despite a
downregulation of DDR genes such as Atm, Chk2, Trp53 and H2ax. In addition, the
damage sustained forces downregulation of stem cell markers and induces terminal
astrocyte differentiation of the NSC population of the SVZ (Schneider, et al., 2013).
Coordination between all components of the DDR following IR is responsible for
activating quiescent NSCs and increasing differentiation (Barazzuol, et al., 2017).
Cell cycle checkpoints are critical and complex signalling networks that direct
cellular response to genotoxic stress, including DNA damage. The integrity of these
checkpoints are important in maintaining genomic integrity and DNA damage repair
(O’Connell, Walworth, & Carr, 2000). In mammals, ultraviolet (UV) radiation results in
photochemical reactions that create pyrimidine dimer lesions (Setlow, 1966; Unrau,
Wheatcroft, & Cox, 1971; You et al., 2001). These photoproducts hinder the progression
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of the replication fork and inhibit DNA and RNA polymerases. Stalled replication forks
that persist may breakdown and create DNA double strand breaks (DSBs) (Garinis et al.,
2005). DSBs following UV irradiation upregulate ataxia telangiectasia mutated (ATM)
kinase (Garinis, Mitchell, Moorhouse, Hanada, & de Waard, 2005). This is succeeded by
upregulation of downstream targets of the DDR signaling pathway including the transducer
kinase, CHK2 (Hirao et al., 2000). The increase in CHK2 activation is followed by an
increase in the transducer kinase CHK1 (Q. Liu et al., 2000; Takai et al., 2000), which are
key events that initiate the DDR following UV irradiation. Downstream effectors of these
proteins include the tumor suppressor p53 (Hirao, et al., 2000). Notably, CHK1/2
phosphorylate p53 at Ser15 (p53-pS15) to ease the inhibition or degradation of p53 by
MDM2, which permits p53 activation and stabilization (Shieh, Ahn, Tamai, Taya, &
Prives, 2000; Shieh, Ikeda, Taya, & Prives, 1997). This allows p53 to modulate genes that
are critical for cell cycle arrest, DNA repair or apoptosis.
A cyclin-like cell cycle mediator, termed Speedy/RINGO (Spy1), was initially
discovered in a screen for genes that could override lethality in an ultraviolet (UV)
irradiated rad1-deficient strain of S. Pombe (Lenormand, et al., 1999). Spy1 was also
shown to override the G2/M maturation checkpoint in Xenopus laevis oocytes (Lenormand,
et al., 1999). Later studies demonstrated that Spy1 binds and activates both cyclin
dependent kinase (CDK) 1 and 2, independent of post-translational modification of the
CDK required for classic cyclin activation (Cheng, Gerry, et al., 2005; D. A. McGrath, et
al., 2017). Studies that followed demonstrated that Spy1 overexpression increased cell
survival in response to a number of DNA damaging agents including UV radiation (Barnes,
et al., 2003a; Gastwirt, et al., 2007; C. W. McAndrew, et al., 2009). Mechanistically
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elevated levels of Spy1 reduced the immediate activation of critical DDR mediators
following damage, including H2AX and CHK1 in a p53-dependent manner (Barnes, et al.,
2003a; Gastwirt, et al., 2007; C. W. McAndrew, et al., 2009). Hence, this suggests that
Spy1 contributes to continual cell cycle progression and proliferation in the presence of
activated checkpoints. These data support the hypothesis that Spy1 may ultimately promote
aberrant cell proliferation and permit the accumulation of mutations in unwarranted
circumstances, which may lead to carcinogenesis.
Interestingly, elevated levels of Spy1 are found in cell populations with stem-like
properties of human glioma (Lubanska, et al., 2014). This work found that Spy1 is essential
for the continued symmetric cell division of CD133 positive brain tumour initiating cell
populations and permits the expansion of this aggressive pool of cells. In this work we use
an inducible transgenic mouse model to increase the expression of Spy1 in NSCs to study
the role of Spy1 in the DDR of aging NSCs. This work demonstrates the role of Spy1 in
the DDR of NSCs as well as fate decisions following DNA damage. Understanding how
Spy1 regulates the DDR in NSCs will provide insight into growth/development
mechanisms as well as tumourigenesis.
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MATERIALS AND METHODS
Primary NSC Isolations and Cell Culture
Aged (24 months) NTA-Spy1 transgenic and control mice were humanely euthanized.
Animal care and use procedures follow the Canadian Council on Animal Care Guidelines
under the animal utilization protocol procedure (AUPP #10-16) approved by the University
of Windsor. NTA-Spy1 animals express Spy1 under the transcriptional control of Nestin
promoter in the presence of doxycycline. A midline incision was made to the skin along
the full length of mouse. The skull was cut at the sides and peeled off with forceps. Cranial
nerves and blood vessels were cut, forceps were used to slide the brain out. Brain was
transferred to a 60mm dish containing media with 3% penicillin/streptomycin (P/S)
solution. The brain was sliced coronally and the area around the lateral ventricles was
dissected under a microscope. The tissue was transferred to a separate dish with 3% P/S
solution and using a scalpel blade, tissue was minced and collected by centrifugation. The
supernatant was removed and 1 ml of Trypsin- 0.05% EDTA (Thermo) was added. The
cells were incubated for 1 minute in 37°C. 1 ml of media containing 10% fetal bovine
serum (FBS) was added and incubated for 5 minutes and cells were collected.
Primary cells were cultured in serum-free Neurobasal medium (Corning)
containing B27 supplement (Gibco) , hEGF (20ng/ml; Gibco) and bFGF (10ng/ml; Sigma),
2 mM L-glutamine at 37 °C in 5% CO2 in ultra-low cluster plates (ULCP; Corning).
Neurospheres were subcultured every 5-10 days.
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UV Irradiation
Cells were seeded on 0.1% gelatin (Stem Cell Techonologies) and allowed to adhere.
Media was removed and cells were washed once with 1X PBS and subsequently subjected
to 100J/m2 UV radiation using the GS Gene Linker (Bio Rad). Fresh media was added to
the cells following irradiation.
Quantitative Real Time (qRT) PCR Analysis
Total RNA was isolated using Qiagen RNeasy Plus Mini Kit as per manufacturer’s
instructions. cDNA was synthesized using qSCRIPT (Quanta) as per manufacturer’s
instructions. SYBR Green detection (Applied Biosystems) was used for real time PCR and
was performed and analyzed using Viia7 Real Time PCR System (Life Technologies) and
software. Primers for qRT-PCR reactions can be found in supplementary material Table 1.
All qRT data is represented as log10 relative quantification (RQ) relative to a control.
Bromodeoxyuridine (BrdU) Proliferation Assay
Cells were seeded on coverslips and allowed to adhere overnight. BrdU (BD Pharmingen)
was added at a final concentration of 10µM. Cells were incubated in media containing
BrdU overnight at 37°C, 5% CO2. Media containing BrdU was removed and cells were
washed 3 times with 1X PBS. Cells were fixed in 4% PFA. Cells were incubated with 2M
HCl for 20 minutes at 37°C and subsequently incubated with Anti-BrdU (BD Biosciences
in 0.1% Tween/PBS for 45 minutes at room temperature. Cells were incubated with Alexa567 anti-mouse (1:1000) for 1 hour at room temperature. This was followed by Hoechst
(Thermo) counterstain for 10 minutes at room temperature. Cells were imaged using the
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Leica CTR 6500 microscope (Leica Microsystems, Heidelberg, Germany) and AF
software.
Immunofluorescence
Single cells were seeded on 0.1% gelatin (Stem Cell Technologies) coated coverslips and
allowed to adhere. Cells were washed with PBS and fixed in 4% PFA for 10 minutes at
room temperature. Cells were permeabilized using 0.2% triton-X in 1X PBS for 10 minutes
at room temperature. Cells were blocked with LAP blocker (0.1% triton-X, 0.2M glycine,
2.5% FBS). Cells were incubated with primary antibody (Actin, 1:250, EMD Millipore;
GFPAP, 1:200, Sigma; Sox2, 1:200, Abcam) for 1 hour at room temperature. Cells were
incubated with secondary Alexa-fluor anti-mouse (Thermo, 1:1000) for 45 minutes at room
temperature. Finally cells were counterstained with Hoechst (Thermo) for 10 minutes at
room temperature. Coverslips were mounted on slides and imaged using the Leica CTR
6500 microscope (Leica Microsystems, Heidelberg, Germany) and AF software.
Protein Isolation and Immunoblotting
Cells were lysed with TNE buffer (50mM Tris, 150mM NaCl, 5mM EDTA) supplemented
with protease inhibitors (2µg/mL leupeptin, 5µg/mL aprotinin, and 100µg/mL PMSF).
Cells were lysed for 20 minutes on ice and vortexed every 5 minutes for 30 seconds. Cells
were centrifuged at 4°C at 13,000rpm for 15 minutes. Supernatant was collected and stored
at -20°C until use.
Protein concentrations were determined through the Bradford assay as per
manufacturer’s instructions. Membranes were blocked for 1 hour at room temperature in
either 2% BSA or 2% milk, depending on antibodies used. Primary antibodies (p53-pS15,
149

1:800 Abcam; Chk2, 1:600, Epitomics; ATM, 1:600; Epitomics; Actin, 1:1000, EMD
Millipore) were incubated overnight at 4°C. This was followed with secondary antibody
incubation at room temperature for 1 hour. Protein signal was detected using
chemiluminescent peroxidase substrate (Pierce) as per manufacturer’s instructions, and
images were taken on Alpha Innotech HD2, densitometry analysis was performed on
AlphaEase FC software.
Lentivirus Production and Primary Cell Infection
Transfection of HEK293 LentiX cells with vector plasmid targeting shp53 (pLenLox_U6
p53; Addgene #59360) or a control pLB plasmid along with packaging plasmids pMDG,
pMDL2, and pRSV using branched polyethylenimine (PEI). Primary cells were seeded on
6cm plates coated in 0.1% gelatin containing 6 µg/mL of polybrene. Viral particles of both
the shp53 and pLB control were added to cells at an MOI of 5 overnight at 37°C, 5% CO2.
Infection media was removed and replenished with fresh media. Cells were confirmed for
knockdown of p53 72 hours following infection.
Statistical Analysis
Student’s t-test was used and a p-value of less than 0.05 was considered significant. All
data are reported as a means of standard deviation. For qRT-PCR analysis, Ct values of
internal control gene (GAPDH) was subtracted from the corresponding Ct value of a target
gene which generated a dCt value which was subjected to the Student’s t-test analysis.
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RESULTS
NTA-Spy1 NSCs override senescence induced by DNA damage
Using primary NSCs extracted from ageing NTA-Spy1 mice and control littermates
(pTRE-Spy1), we initiated DSBs through administering 100J/m2 of UV radiation to
determine the role of Spy1 in NSC DDR. We collected NTA-Spy1 and pTRE-Spy1 cells
at 3 hours, 1 day and 3 days following UV radiation, as well as non-irradiated controls and
preformed a BrdU incorporation assay. Both NTA-Spy1 and pTRE-Spy1 cells only show
a significant decrease in BrdU incorporation at 3 hours post-UV; NTA-Spy1 are
significantly more proliferative than pTRE-Spy1 (Figure 1A). This was further validated
through qRT-PCR analysis for gene expression of proliferation marker Ki67 (Figure 1B).
Cell morphology analysis through Actin immunofluorescence showed that 3 days post UV
radiation, most, if not all of the pTRE-Spy1 cells had obtained a senescence-like
morphology, including an enlarged and flattened cytoplasm as compared to pTRE-Spy1
non-irradiated control (Figure 1C; top). Contrastingly, NTA-Spy1 cells demonstrated a less
severe change in cell morphology, at 3 days post UV radiation (Figure 1C; bottom). The
second most widely used marker of senescence is histone γH2AX. Most commonly,
however, γH2AX is used as a marker for DSBs and telomere shortening (Hovest,
Brüggenolte, Hosseini, Krieg, & Herrmann, 2006a; Sedelnikova et al., 2004a). Staining for
γH2AX demonstrated that although the percent of cells positive for γH2AX was promptly
increased at 3 hours post UV radiation in both NTA-Spy1 cells and in pTRE-Spy1 controls,
the percentage of NTA-Spy1 cells positive for γH2AX decreased significantly over the
time course which was not seen in pTRE-Spy1 control cells (Figure 1D). Thus, our results

151

reveal that NSCs with elevated Spy1 remain more proliferative following DNA damage
and have reduced markers of senescence.
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Figure 1. NTA-Spy1 NSCs override senescence induced by DNA damage following
UV radiation. (A) Time course study of proliferation through BrdU incorporation assay.
BrdU+ cells scored and quantified as a percentage of total population tested for pTRESpy1 (dark grey) and NTA-Spy1 (light grey) at 3 hours, 1 day, and 3 days post UV radiation
as well as non-irradiated (non-irr) control. (B) qRT-PCR analysis for expression of Ki67
in pTRE-Spy1 (dark grey) and NTA-Spy1 (light grey) at 3 hours, 1 day, and 3 days post
UV radiation as well as non-irradiated control. Gapdh was used as a loading control. (C)
Representative immunofluorescence images of Actin showing changes in cell morphology
in non-irradiated and 3 days post UV radiated pTRE-Spy1 and NTA-Spy1 primary NSCs.
(D) Quantification of the percentage of cells positive for γH2AX in pTRE-Spy1 (dark grey)
and NTA-Spy1 (light grey) at 3 hours, 1 day, and 3 days post UV radiation as well as nonirr control. Results presented as the mean ±s.d.; (n=3) *p < 0.05, **p < 0.01, ***p < 0.005.
Scale bar = 10 µm.

154

UV irradiated NTA-Spy1 NSCs demonstrate downregulation of DDR signaling
Since we observed that NTA-Spy1 NSCs had a significant decrease in γH2AX (Figure 1D)
post UV irradiation compared to pTRE-Spy1 control cells, we wanted to determine if other
DDR signaling proteins were downregulated in a similar pattern. Serine 15
phosphorylation of p53 is the primary target for the DDR following ATM and ATR protein
kinase activation. This phosphorylation event triggers consequent phosphorylation events
in p53 which contribute to p53 activation (Meek, 2009; Meek & Anderson, 2009).
Immunoblotting was performed to analyze levels of DDR signaling proteins - ATM, Chk2
and p53-pS15 – at 3 hours and 1 day post UV irradiation as well as non-irradiated controls
in both pTRE-Spy1 and NTA-Spy1 cells (Figure 2A; top). The most significant change
that was observed through immunoblotting occurred at 3 hours post UV radiation.
Densitometry quantifications of ATM, CHK2 and p53-pS15 over ACTIN loading control
revealed that NTA-Spy1 cells have a significant decrease in all three proteins as compared
to pTRE-Spy1 controls at 3 hours post UV irradiation (Figure 2A; bottom). Further
characterization of DDR genes through qRT-PCR analysis demonstrated that NTA-Spy1
cells had significant transcriptional downregulation of Atm, Atr, Chk1, Chk2, Trp53, Mdc1,
and H2ax at 3 hours post UV irradiation compared to pTRE-Spy1 control cells (Figure 2B).
Hence, our results support the conclusion that Spy1 overexpression downregulates the
DDR following UV irradiation in NSCs.

155

156

Figure 2. NTA-Spy1 NSCs demonstrate downregulation of DDR signaling following
UV radiation. (A) Western blot analysis of DDR signaling proteins p53 phospho-serine15,
CHK2, ATM and ACTIN loading control of pTRE (pTRE-Spy1) and NTA (NTA-Spy1)
NSCs at 3 hours and 1 day following UV radiation as well as non-irr controls (top).
Densitometry quantification for p53-pS15, CHK2 and ATM for pTRE-Spy1 and NTASpy1 cells at 3 hours post UV radiation (bottom). (B) qRT-PCR gene expression analysis
of DDR and DNA repair genes (Atm, Atr, Chk1, Chk2, Trp53, Mdc1, and H2ax) in NTASpy1 NSCs controlled for pTRE-Spy1 expression at 3 hours post UV radiation. Gapdh was
used as a loading control. Results presented as the mean ±s.d.;(n=3) *p < 0.05, **p < 0.01,
***p < 0.005.
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UV irradiated NTA-Spy1 NSCs resist differentiation and maintain stem cell markers
According to previous studies, it has been demonstrated that normal NSCs activate the
DDR following radiation, lose NSC associated features such as marker expression and
become constrained to a differentiation fate, most specifically, astrocytic fate (Schneider,
Fumagalli, & d'Adda di Fagagna, 2012; Schneider, et al., 2013).
To determine the role of Spy1 in NSC identity and fate decisions following UV
radiation we investigated the expression of the astrocytic intermediate filament protein glial
fibrillary acidic protein (GFAP) at 5 days post UV irradiation through IF in pTRE-Spy1
and NTA-Spy1 NSCs (Figure 3A; left). We find a significant decrease in the percent of
cells positive for GFAP in the NTA-Spy1 cells compared to pTRE-Spy1 (Figure 3A; right).
The phenomena of DNA damage induced astrocyte differentiation in NSCs has been shown
through the increased expression of astrocyte-associated marker S100b (Raponi et al.,
2007). Our results corroborate these findings as qRT-PCR analysis for S100b revealed that
pTRE-Spy1 cells have a significant upregulation in S100b transcript levels at 5 days post
UV irradiation when compared to NTA-Spy1 cells (Figure 3B). This indicated an inhibition
of differentiation towards the astrocytic lineage in NTA-Spy1 cells.
We examined the expression of the stem cell marker SOX2 at 5 days post UV
irradiation through IF in pTRE-Spy1 and NTA-Spy1 NSCs (Figure 3C; left). The number
of SOX2 positive cells were quantified and there is a significant increase in SOX2 positive
cells in the NTA-Spy1 cell population as compared to pTRE-Spy1 at 5 days post UV
irradiation (Figure 3C; right). Furthermore, through qRT-PCR analysis we consistently
detected significant upregulation in transcript levels of typical NSC markers including
Sox2, Nestin, Msi1 and Cd133 in the NTA-Spy1 cells as compared to pTRE-Spy1 controls
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at 5 days post UV irradiation (Figure 3D). This suggests that Spy1 is aiding in the
maintenance of a NSC population following DNA damage succumbed through UV
irradiation.
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Figure 3. NTA-Spy1 cells maintain stem cell markers and prevent spontaneous
differentiation following UV radiation. (A) Representative microscope images of GFAP
astrocyte differentiation protein detected by IF in pTRE-Spy1 and NTA-Spy1 5 days post
UV radiation (left). The percent of GFAP positive cells were quantified (right). (B) qRTPCR gene expression analysis for astrocyte marker S100b in pTRE-Spy1 and NTA-Spy1
5 days post UV radiation. (C) Representative microscope images of stem cell marker SOX2
detected by IF in pTRE-Spy1 and NTA-Spy1 5 days post UV radiation (left).
Quantification of the percent of Sox2 positive cells (right). (D) qRT-PCR gene expression
analysis for stem cell markers Sox2, Nestin, Msi1 and Cd133 5 days post UV radiation in
NTA-Spy1 NSCs controlled for pTRE-Spy1. Gapdh was used as a loading control. Results
presented as the mean ±s.d.;(n=3) *p < 0.05, **p < 0.01, ***p < 0.005. Scale bar = 10 µm.

161

NTA-Spy1 NSC maintenance following DNA damage is dependent on the presence of p53
Work in the lab has shown that Spy1 protein levels decrease in response to upregulated
levels of CHK2 and p53 through a proteasome-dependent mechanism, most likely to allow
the cell to undertake DNA damage checkpoints in order to protect genome integrity. Since
we do demonstrate a slight DDR signalling response in NTA-Spy1 cells 3 hours following
UV irradiation (Figure 2), we wanted to elucidate what the role of p53 is in NTA-Spy1 UV
irradiated cells.
To determine the role of p53 in the NTA-Spy1 cells following UV irradiation, we
used a lentiviral shp53 construct to infect NTA-Spy1 NSCs prior to UV irradiation (Figure
4). We confirmed knockdown through qRT-PCR analysis for Trp53 transcript levels and
we demonstrated that there was significant p53 knockdown in the shp53 infected cells
compared to sh-Control infected cells (Figure 4A). A BrdU incorporation assay reveals
that 3 days post UV irradiation there is no significant change in the percent of cells
incorporating BrdU between NTA-Spy1 sh-Control and NTA-Spy1 shp53 (Figure 4B). We
also observed no difference between control or p53 knockdown cells when we analyzed
gene expression of the proliferation marker Ki67 3 days post-UV (Figure 4C). This
suggests that Spy1 can initiate and maintain a proliferative potential both in the presence
and in the absence of p53 in NSCs following UV irradiation.
Next, we investigated the expression of pivotal NSC genes. Interestingly, qRT-PCR
analysis of gene expression for Sox2, Nestin, Msi1 and Cd133 revealed that the knockdown
of p53 in NTA-Spy1 cells at 3 days post UV irradiation significantly decreases the
transcript levels of all genes as compared to NTA-Spy1 sh-Control cells (Figure 4D). This
suggests that p53 levels are important for Spy1 mediated effects on stemness.
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Figure 4. NTA-Spy1 NSC maintenance following DNA damage is dependent on p53
presence. (A) NTA-Spy1 NSCs infected with shp53 lentivirus were collected to validate
knockdown efficiency. qRT-PCR analysis for Trp53 gene expression in sh-Control
infected NTA-Spy1 cells and shp53 infected NTA-Spy1 cells. (B) BrdU incorporation
assay for NTA-Spy1 shp53 and control NSCs 3 days following UV radiation. Percent of
cells positive for BrdU were quantified measuring 10 fields of view per experiment. (C)
qRT-PCR analysis for Ki67 gene expression sh-Control infected NTA-Spy1 cells and
shp53 infected NTA-Spy1 cells 3 days post UV radiation. (D) qRT-PCR analysis for stem
cell markers Sox2, Nestin, Msi1, and Cd133 in sh-Control (dark grey) and shp53 (light
grey) infected NTA-Spy1 NSCs at 3 days post UV radiation. Gapdh was used as a loading
control. Results presented as the mean ±s.d.; (n=3)*p < 0.05, **p < 0.01, ***p < 0.005.
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DISCUSSION
Cells encounter a number of different stressors throughout their lifetime which can
ultimately lead to DNA damage. The DDR is a critical signaling pathway that aids in the
maintenance of genomic stability to ensure that the population of cells remains healthy.
Studies have shown that the knockdown of Spy1 can lead to the activation of the DDR
through the increase of activated γH2AX as well as increased CHK1 phosphorylation and
decreased proliferation ability (C. W. McAndrew, et al., 2009). Here we demonstrate that
upregulated levels of Spy1 in NSCs protects cells from damage-induced senescence and
differentiation. Primary NSCs from mice overexpressing Spy1 show a decrease in the
levels of mediators of the DDR and DDR associated genes.
Previous studies in NSCs demonstrated that DNA damage induced by IR causes
cellular senescence and completely ablates proliferative potential (Schneider, Fumagalli,
& d'Adda di Fagagna, 2012; Schneider, et al., 2013). Our results confirm this finding in
control pTRE-Spy1 mice following UV irradiation. Unlike pTRE-Spy1 NSCs however,
NTA-Spy1 NSCs maintain a high proliferative potential and do not succumb to cellular
senescence.
Spy1-CDK complexes are more resistant to CDK inhibitors, including those found
downstream of p53 (A. Karaiskou, et al., 2001; C. W. McAndrew, et al., 2007; D. A.
McGrath, et al., 2017; L. A. Porter, et al., 2003). This means that in systems that have
upregulated Spy1, proliferation is permitted even in the face of DNA damage which leads
to aberrant cell growth and division. This collectively supports a hypothesis where Spy1
levels should be kept in check to support DNA integrity by supporting the presence of
functional checkpoints throughout the cell cycle. This is critical because many studies have
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implicated Spy1 in a number of human cancers (Al Sorkhy et al., 2012; Gastwirt, et al.,
2007; Golipour, et al., 2008; Ke, Ji, Cheng, Zhang, Lu, & al., 2009; L. A. Porter, et al.,
2002; Zucchi, et al., 2004). A requirement for maintained cellular senescence in terminally
differentiated cells is the presence of a persistent DDR. However, in NSCs, studies have
established that senescence occurs even in the absence of continued and persistent DDR
signaling (d'Adda di Fagagna, 2008; Jackson & Bartek, 2009). Hence, this suggests that
epigenetic mechanisms could be involved in the maintenance or absence of senescence in
NSCs. We show that in some instances, Spy1 overexpression can override cellular
senescence in part through epigenetic regulation (Qemo; Chapter 4 PhD Dissertation), and
this may hold true in NSCs, although further knowledge is required.
The differentiation of stem and progenitor populations includes the decline of
expression of stem cell markers and an increase in differentiation associated genes.
Previous studies in NSCs have observed terminal differentiation towards astrocytic lineage
after DNA damage by a host of sources (Schneider, Fumagalli, & d'Adda di Fagagna, 2012;
Schneider, et al., 2013). The tendency of irradiated NSCs to differentiate intro astrocytes
might reflect their glial nature (F. Doetsch, 2003). A number of other studies carried out in
rodent brains observed that irradiated NSCs upregulate cell-cycle checkpoints and start to
lose their stem cell capacity (Acharya et al., 2010; Monje, Mizumatsu, Fike, & Palmer,
2002). In our model, similar to available literature, we report that UV irradiated pTRESpy1 cells also demonstrate an increase in differentiation towards the astrocyte lineage.
However, irradiated NTA-Spy1 cells barely differentiate towards astrocytes, and in fact,
they maintain their stem cell characteristics and properties. It is hypothesized that tumour
initiation, progression and/or relapse could be a result of NSCs that have escaped this
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differentiation program in the face of DNA damage, allowing the expansion of this
dangerous stem cell population. Spy1 has been shown to be a critical regulator of
symmetric cell division in the CD133-positive stem cell compartment of high grade
gliomas (Lubanska, et al., 2014). Taken together, this indicates that Spy1 inhibits the
differentiation of a dangerous stem cell population in gliomas following radiation therapy.
The differentiation of DNA damaged NSCs shows that mechanisms are established in a
way to stop the tumourigenic potential of these stem cells without completely killing off
their population.
Our data shows that Spy1 maintains the stem cell population following DNA
damage in a p53-dependent manner; however, Spy1-mediated effects on proliferation are
p53-independent. NTA-Spy1 NSCs infected with a lentiviral construct to knockdown p53
show a decrease in NSC markers following UV irradiation as compared to NTA-Spy1 cells
that were infected with a control vector. In immortalized somatic cells Spy1 impedes
checkpoint activation and apoptosis following UV irradiation in a p53-dependent manner
(C. W. McAndrew, et al., 2009). With regard to the NTA-Spy1 shp53 cells, we can
hypothesize that Spy1 activation of the cell cycle to promote proliferation is independent
of p53 however it is known that in stem cell populations the responses with regard to
stemness and differentiation are altered (Levine & Berger, 2017). Further investigation into
the DDR following UV irradiation in NTA-Spy1 shp53 cells will reveal how DDR
signalling pathways change and what that would mean to the NSC population. The
continued proliferation of these cells could be due the unique way in which Spy1 binds and
actives CDKs without the need for activating phosphorylation and dephosphorylation
events (Cheng, Gerry, et al., 2005; D. A. McGrath, et al., 2017). The p53 tumour suppressor
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is known to be mutated or downregulated in many human cancers (Vogelstein, et al., 2000).
The collection of data presented in this chapter, along with data in the literature may
suggest that increasing levels of Spy1 in cancers which p53 mutations arise due to DNA
damage through different stressors, including UV irradiation, may in fact hinder tumour
promotion.
The objective of this work was to use a mouse model which overexpresses Spy1
specifically in the NSC populations of the brain to study the DDR as well as fate decision
following UV radiation in vitro. We also studied the effects of the presence or absence of
p53 on Spy1-mediated effects. Collectively, this work indicates that elevated levels of Spy1
abrogates the ability of NSCs to respond appropriately to damaged DNA, this may have
crucial implications on growth/ development and tumourigenesis.
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SUPPLEMENTAL MATERIAL

Supplemental Table 1. Primers used for qRT-PCR analysis. The primers are listed with
their name, their purpose (qRT), the sequence of forward (5’3’) primer and the sequence
of reverse (5’3’) primer.
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CHAPTER 4
THE CYCLIN-LIKE PROTEIN SPY1 OVERRIDES REPROGRAMMING INDUCED
SENESCENCE THROUGH EZH2 MEDIATED H3K27ME3
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INTRODUCTION
A landmark publication by Yamanaka et al. revealed that fully differentiated somatic cells
can be reprogrammed to induced pluripotent stem cells (iPSCs) through the expression of
a set of fundamental transcription factors – Oct4, Sox2, Klf4, and c-Myc (T. K. Takahashi
K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al., 2007; Y. S. Takahashi K, 2006 ; J.
Yu, Vodyanik, M.A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, JL., Tian, S., et al,
2007). These cells offer tremendous potential as sources for drug discovery, disease
modeling, and in regenerative medicine. However, one limitation for the use of
reprogramming is characteristic low efficiency (T. K. Takahashi K, Ohnuki M, Narita M,
Ichisaka T, Tomoda K, et al., 2007; Y. S. Takahashi K, 2006 ; Wernig M, 2007; J. Yu,
Vodyanik, M.A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, JL., Tian, S., et al,
2007). The generation of iPSCs from somatic cells is a gradual process involving the
remodelling of both genetic and epigenetic programs which take 16-21 days, where
lineage-specific genes are turned off and pluripotency genes turn on (Jaenisch R., 2008; S.
Yamanaka, 2009; S. Yamanaka, Blau, HM., 2010). This all occurs at a frequency of less
than 0.1% (Brambrink T, 2008; Maherali N, 2007; T. K. Takahashi K, Ohnuki M, Narita
M, Ichisaka T, Tomoda K, et al., 2007; Y. S. Takahashi K, 2006 ; J. Yu, Vodyanik, M.A.,
Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, JL., Tian, S., et al, 2007).
Transcriptional profiling during reprogramming revealed that there is an immediate
and marked upregulation of many antiproliferative genes, including the tumor suppressor
p53, and cyclin dependent kinase (CDK) inhibitors p21Cip1 and p16Ink4 (Banito, Rashid,
Acosta, Li, Pereira, Geti, Pinho, Silva, Azuara, Walsh, Vallier, et al., 2009; Mikkelsen TS,
2008; Sridharan R, 2009). These genes are involved in many different responses during
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reprogramming, including apoptosis and senescence. Early on during reprogramming,
somatic cells encounter a cell-cycle arrest that is characteristic to that of cellular senescence
(Collado M, 2007), which has been termed reprogramming induced senescence (RIS)
(Banito, Rashid, Acosta, Li, Pereira, Geti, Pinho, Silva, Azuara, Walsh, Vallier, et al.,
2009). Many groups have analyzed whether the expression of a specific factor, or
combination of factors directly triggers the onset of RIS. It was shown that, not only is the
combination of three or more Yamanaka factors enough to trigger this response, the
expression of individual factors Oct4 and Sox2 is sufficient to upregulate antiproliferative
genes (Banito, Rashid, Acosta, Li, Pereira, Geti, Pinho, Silva, Azuara, Walsh, Vallier, et
al., 2009; Hong H, 2009; Kawamura T, 2009).
The inclusion of c-Myc as a reprogramming factor is attributed to increasing
reprogramming efficiency. The combination of Oct4, Sox2 and Klf4 without c-Myc
generated significantly less iPSC colonies and the colonies that formed displayed a very
flat and non-ESC-like morphology. However, due to the fact that it’s a well-established
proto-oncogene, c-Myc increases the likelihood that resultant iPSCs will become
tumourigenic (Y. S. Takahashi K, 2006 ).
The cell cycle lies at the core of early reprogramming events that will determine
the fate of a differentiated somatic cell that has been induced to pluripotency. The unique
cell-cycle structure of embryonic stem cells (ESCs), which is composed of a short G1 phase
and long S phase (Neganova, 2008; J. White, Dalton, S., 2005), is also established in iPSCs
(Ruiz S, 2011). It was demonstrated that the acquisition of ESC cell cycle characteristics
is an early event in reprogramming and coincides with a high proliferation rate for the cells
that do not succumb to barriers (Ruiz S, 2011). The induction of a high proliferation rate
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ultimately sets the stage for an increase in reprogramming efficiency. Cell cycle
progression involves the binding between CDKs and their cyclin partners to phosphorylate
targets that will drive the cell cycle forward (Harbour, 2000; R. A. Weinberg, 1995).
Apart from their role in cell cycle regulation, CDKs and cyclins have also been
linked to epigenetic regulation. The enhancer of zeste homolog 2 (EZH2) is the catalytic
member of the Polycomb repressive complex 2 (PRC2) and plays a critical role in gene
silencing through the trimethlyation of histone 3 lysine 27 (H3K27me3). In human cells,
CDK1 and 2 phosphorylate EZH2 at threonine 350 (T350), which activates its
methyltransferase activity (S. Chen, Bohrer, L. R., Rai, A. N., Pan, Y., Gan, L., Zhou, X.,
Bagchi, A., Simon, J. A., Huang, H., 2010). One key change in reprogramming marked by
trimethylation of histone 3 (H3) at lysine 27 (H3K27me3) is the repression of p21Cip1 and
p16Ink4 promoters to overcome RIS (Kouzarides, 2007 ).
More recently, a highly conserved family of cyclin-like proteins was discovered –
termed the Speedy/RINGO family. The originally characterized member, Spy1A1 (herin
referred to as Spy1), has been implicated in driving the symmetric division of glioma stem
cells (D. Lubanska, Market-Velker, BA., deCarvalho, AC., Mikkelsen, T., Fidalgo da
Silva, E., Porter, LA., 2014). Spy1 binds to and activates CDK1 and CDK2 (J. L.
Lenormand, Dellinger, R.W., Knudsen, K.E., Subramani, S. & Donoghue, D.J., 1999), in
an atypical manner that does not depend on classical activating and deactivating
phosphorylation events of the CDKs (A. P. Karaiskou, L.H., Ferby, I., Ozon, R., Jessus,
C., & Nebreda, A.R., 2001). This exclusive manner of activating CDKs has been attributed
as the mechanism by which Spy1 can bypass cell cycle barriers, including cellular
senescence and the DNA damage response (C. W. McAndrew, Gastwirt, R.F., Meyer,
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A.N., Porter, L.A., and Donoghue, D.J, 2007; L. A. Porter, Kong-Beltran, M., and
Donoghue, D.J., 2003). The implication of this in overriding reprogramming barriers is
exciting and may offer great potential to improve reprogramming efficiency. The ability of
Spy1 to bind CDKs and increase phosphorylation to target substrates more readily and
easily than cyclins may mechanistically implicate Spy1 in the epigenetic regulation during
reprogramming. The objective of this study was to determine whether Spy1 plays a role in
the reprogramming process, adding to our knowledge of the mechanism of action of this
process and offering unique opportunities to improve this process.
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MATERIALS AND METHODS
Animals
Balb/c mice (Jackson Lab) were subjected to regulatory standards identified by the
Canadian Council for Animal Care. Approval of protocols and procedures was provided
by the University of Windsor Animal Care Committee (AUPP #16-05).
Cell culture and lentiviral infection
IMR90 human fibroblasts were from American Type Culture Collection (ATCC CCL186). Human fibroblasts were cultured in EMEM (ATCC 30-2003) supplemented with
10% fetal bovine serum (FBS; Thermo 10437-028). Primary mouse embryonic fibroblasts
(MEFs) were isolated between embryonic day 13 and embryonic day 14. Mouse fibroblasts
were cultured in DMEM (Hyclone SH30081.01) supplemented with 10% FBS. Mouse
induced pluripotent stem cells (mIPSCs) were cultured on 0.1% gelatin in GMEM (Thermo
11710-035) with 5% ES FBS (Thermo 16141-061), 5% Knockout serum replacement
(KSR; Thermo 10828-010), 0.1mM β-mercaptoethanol (Sigma 516732), 1X Non-essential
amino acid solution (NEAA; Thermo 11140-050) and 1000 U/mL leukemia inhibitory
factor (LIF; Sigma L5158). Detailed description for methods used in isolating MEFs,
lentiviral production and infection is given in the Supplemental Material.
Plasmids
OKSiM was a gift from Jose Cibelli (Addgene plasmid # 24603). The plasmid pSin-EF2Oct4-Pur was a gift from James Thomson (Addgene plasmid #16579) and was used as the
control vector for OKSiM once Oct4 was excised from the vector. pEIZ, pEIZ-Spy1,
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pLKO-shscrambled, pLKO-shSpy #1, #2 and pLKO-shCyclinE #1, #2 were cloned and
designed in our lab (L. A. Porter, et al., 2002).
Quantitative Real Time (qRT) PCR Analysis
Total RNA was isolated using Qiagen RNeasy Plus Mini Kit as per manufacturer’s
instructions. cDNA was synthesized using qSCRIPT (Quanta) as per manufacturer’s
instructions. SYBR Green detection (Applied Biosystems) was used for real time PCR and
was performed and analyzed using Viia7 Real Time PCR System (Life Technologies) and
software. Primers for qRT-PCR reactions can be found in supplementary material Table 1.
All qRT data is represented as log10 relative quantification (RQ) relative to a control.
Bromodeoxyuridine (BrdU) Staining
Cells were seeded on coverslips and allowed to adhere overnight. BrdU (BD Pharmingen)
was added at a final concentration of 10µM. Cells were incubated in media containing
BrdU overnight for 16 hours at 37°C, 5% CO2. Media containing BrdU was removed and
cells were washed 3 times with 1X PBS. Cells were fixed in 4% PFA. Cells were incubated
with 2M HCl for 20 minutes at 37°C to denature DNA and subsequently incubated with
Anti-BrdU (BD Biosciences in 0.1% Tween/PBS for 45 minutes at room temperature. Cells
were incubated with Alexa-567 anti-mouse (1:1000) for 1 hour at room temperature. This
was followed by Hoechst (Thermo) counterstain for 10 minutes at room temperature. Cells
were imaged using the Leica CTR 6500 microscope (Leica Microsystems, Heidelberg,
Germany) and AF software.
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Senescence-associated beta-galactosidase (β-gal) staining
Cells were seeded on coverslips and allowed to attach overnight. Cells were fixed in 4%
PFA for 10 minutes at room temperature. Staining solution (5mM K4[Fe(CN)6]·3 H2O, 5
mM K3[Fe(CN)6] and 2 mM MgCl2) was prepared in 1X PBS. Complete staining solution
(pH 6) was prepared right before staining and contained 25 µL of 40mg/mL X-gal per mL
of staining solution. Cells were stained overnight at 37°C. Cells were imaged using the
Leica CTR 6500 microscope (Leica Microsystems, Heidelberg, Germany).
Immunofluorescence
Cells were washed with PBS and fixed in 4% PFA for 10 minutes at room temperature.
Cells were permeabilized using 0.2% triton-X in 1X PBS for 10 minutes at room
temperature. Cells were blocked with blocker (0.1% triton-X, 0.2M glycine, 2.5% FBS).
Cells were incubated with primary antibody (Oct4; Sigma, 1:100 and Sox2; Abcam, 1:200)
for 1 hour at room temperature. Subsequently, cells were incubated with secondary Alexafluor anti-mouse or anti-rabbit (Thermo, 1:1000) for 45 minutes at room temperature.
Finally cells were counterstained with Hoechst (Thermo) for 10 minutes at room
temperature. Coverslips were mounted on slides and imaged using the Leica CTR 6500
microscope (Leica Microsystems, Heidelberg, Germany) and AF software.
Protein Isolation and Western Blotting
Cells were lysed with TNE buffer (50mM Tris, 150mM NaCl, 5mM EDTA) supplemented
with protease inhibitors (2µg/mL leupeptin, 5µg/mL aprotinin, and 100µg/mL PMSF).
Cells were lysed for 20 minutes on ice and vortexed every 5 minutes for 30 seconds. Cells
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were centrifuged at 4°C at 13,000rpm for 15 minutes. Supernatant was collected and stored
at -20°C until use.
Protein concentrations were determined through the Bradford assay as per
manufacturer’s instructions. Equal amounts of protein were calculated to be used for
loading. 100µg of protein were loaded on a 10%- SDS polyacrylamide gel and ran for 3
hours at 120V. The gels were transferred to a PVDF membrane at 30V for 2 hours using a
wet transfer method. Membranes were blocked for 1 hour at room temperature in either
2% BSA or 2% milk, depending on antibodies used. Primary antibodies were incubated
overnight at 4°C. Following incubation with primary antibody, membranes were washed
with tris-buffered-saline-tween 20 (TBST) 3 times for 8 minutes each. This was followed
with secondary antibody incubation at room temperature for 1 hour. Following secondary
antibody incubation, membranes were washed 3 times in TBST for 5 minute intervals.
Protein signal was detected using chemiluminescent peroxidase substrate (Pierce) as per
manufacturer’s instructions, and images were taken on Alpha Innotech HD2, densitometry
analysis was performed on AlphaEase FC software.
Antibodies
For immunoblot analysis, antibodies used include: Actin (Millipore, 1:1000), pEZH2
(Active Motif, 1:500), H3K27me3 (Abcam, 1:1000), and Histone 3 (H3) (Abcam, 1:1000).
All secondary antibodies, mouse IgG (Sigma Aldrich) and rabbit IgG (Sigma Aldrich),
were used at a concentration of 1:10,000.
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Reprogramming of mouse embryonic fibroblasts (MEFs)
Reprogramming of MEFs was carried out following previously described protocol (Y. S.
Takahashi K, 2006 ). Three days post infection, or post induction with doxycycline
(Sigma) cells were plated on 0.1% gelatin (Sigma G1890) coated 6 well plates at a density
of 5X104 per well with mESC medium described above. Medium was changed every day
for a period of 3-4 weeks. At this time, individual colonies were manually picked,
dissociated and passaged directly to freshly coated 0.1% gelatin wells.
Statistical Analysis
Student t-test was used and a p-value of less than 0.05 was considered significant. All data
are reported as a means of standard deviation. For qRT-PCR analysis, Ct values of internal
control gene (GAPDH) was subtracted from the corresponding Ct value of a target gene
which generated a dCt value which was subjected to the Student t-test analysis.
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RESULTS
Endogenous levels of Spy1 are necessary for overriding RIS
RIS is recognized as one of the major barriers during reprogramming to iPSCs (Banito,
Rashid, Acosta, Li, Pereira, Geti, Pinho, Silva, Azuara, Walsh, Vallier, et al., 2009; Hong
H, 2009; Kawamura T, 2009) and seems to be characteristically similar to cellular
senescence (Banito, Rashid, Acosta, Li, Pereira, Geti, Pinho, Silva, Azuara, Walsh, Vallier,
et al., 2009). Given the ability of Spy1 to override cellular senescence (C. W. McAndrew,
Gastwirt, R.F., Meyer, A.N., Porter, L.A., and Donoghue, D.J, 2007; L. A. Porter, KongBeltran, M., and Donoghue, D.J., 2003), we speculated Spy1 plays a similar role in
overriding RIS during reprogramming. IMR90 human fibroblasts were reprogrammed
using lentivirus with the reprogramming vector OKSiM (containing Oct4, Klf4, Sox2 and
c-Myc)(Ross, 2010) alone, or in combination with two different small hairpin RNA
(shRNA) constructs against Spy1 (shSpy1) or a scrambled control (pLKO). Due to the fact
that Spy1 binds to and activates CDK2 in a unique way as compared to that of cyclins and
Spy1-CDK2 complex has a different substrate specificity than that of Cyclin E-CDK2 (A.
Cheng, Xiong, W., Ferrell, J.E., Jr., and Solomon, M.J., 2005), we also used shRNA
constructs targeted towards Cyclin E to determine whether the roles of Spy1 during
reprogramming were unique. Both of the shSpy1 and shCycE constructs significantly
decreased the targeted genes as indicated through mRNA transcript levels (Figure 1A).
Early events following infection with the OKSiM construct alone or combination with the
knockdown vectors were analyzed. Cell division kinetics revealed that the knockdown of
Spy1 during early reprogramming significantly hindered cell growth as compared to
OKSiM alone. This decrease in growth was unique to Spy1, as there was no significant
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difference between OKSiM and OKSiM in combination with shCyclinE (Figure 1B).
Proliferation assay through BrdU incorporation revealed that the knockdown of Spy1
during reprogramming significantly decreases proliferation as compared to Cyclin E
(Figure 1C). Furthermore, senescence associated β-galactosidase staining (Dimri, 1995)
indicated that knocking down Spy1 during early stages of reprogramming increased RIS
as compared to knockdown of Cyclin E (Figure 1D). It has been demonstrated that upregulation of genes that are important in cell cycle progression and proliferation are early
events that need to occur during reprogramming (Mikkelsen TS, 2008). We demonstrate
that Spy1 is critical in proliferation events that occur early on in reprogramming. Together,
this suggests that Spy1 is an important regulator of the cell cycle during reprogramming
and is essential in overriding early barriers of reprogramming, including RIS.
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Figure 1. Endogenous Spy1 required for reprogramming to iPSCs. (A) qRT-PCR gene
expression levels of SPDYA (top) and CCNE1 (bottom) in their respective short hairpin
constructs. (B) Cell counts (104) of each indicated treatment. 60,000 cells of each treatment
were seeded at day 0 which marks 4 days post infection. (C) Representative
Bromodeoxyuridine (BrdU) staining cells (left) for indicated treatment of cells. Scale bar=
50µm. The percent of BrdU positive cells (right), calculated as a ratio of BrdU positive
cells to total cells, for each treatment at day 4 post infection. (D) Representative
senescence-associated β-gal staining in blue for indicated treatments (left). Scale bar =
50µm. The percent of β-gal positive cells, calculated as a ratio of cells staining for β-gal to
total cells counted, for each treatment at 4 days post infection (right). qRT-PCR values are
normalized to GAPDH. Results presented as the mean ±s.d.; *p < 0.05, **p < 0.01, ***p
< 0.005. (n=3, 15 fields of view for each replicate).
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Spy1 enhances reprogramming efficiency and upregulates pluripotency factors
RIS diminishes successful reprogramming to iPSCs (Banito, Rashid, Acosta, Li, Pereira,
Geti, Pinho, Silva, Azuara, Walsh, Vallier, et al., 2009). One interpretation of our
observations is that the role that Spy1 is playing in overriding RIS could potentially be
enhancing reprogramming efficiency. To explore this, we infected primary MEFs with
lentivirus containing the OKSiM construct alone or in combination with the overexpression
of Spy1. Spy1 overexpression significantly increased Spdya mRNA transcript levels as
expected (Figure 2A), and OKSiM overexpression was assessed using OKSiM vector
specific oligonucleotides in qRT-PCR analysis (Figure 2B). Cells were cultured in mouse
embryonic stem cell (mESC) conditions (Yamasaki, 2013) to promote the appearance of
mouse iPSC colonies. After 21 days (Kou, 2010 ), colonies were imaged (Figure 2C) and
colonies resembling mESC colony morphology, including a round shape, and an increased
nucleus: cytoplasm ratio were counted (M. Evans, Kaufman, M. , 1981). Due to the fact
that the overexpression Spy1 plasmid contains a GFP reporter, we were able to distinguish
colonies that had arisen under the simultaneous overexpression of both OKSiM and Spy1;
only these were scored as colonies for OKSiM+ Spy1 conditions. Overexpressing Spy1 in
MEFs during reprogramming almost doubled the number of miPSC colonies that were
formed (Figure 2C; right). The resultant colonies were validated and characterized for some
in vitro features of iPSCs. Colonies showed positive staining for OCT4 and SOX2 protein
(Figure S1A). A more stringent test to assess pluripotency is embryoid body (EB)
formation. EB are 3D cell aggregates that contain differentiated cells from all 3 germ layers
(Burkert, von Rüden, & Wagner, 1991; Doetschman, Eistetter, Katz, Schmidt, & Kemler,
1985). Mouse iPSC colonies were picked and introduced to static suspension cultures and
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allowed to grow. EBs formed in the OKSiM, OKSiM+ Spy1 reprogrammed iPS cells
(Figure S1B). The MEFs that had been infected with a control vector did not form EBs.
Interestingly, EBs produced from OKSiM+ Spy1 infected cells were significantly larger in
size (Figure S1B; right). Recent studies have implicated pluripotent stem cell
differentiation as a function EB size (Bauwens et al., 2008; Bauwens et al., 2011). This
may suggest that proportion of ectoderm, endoderm and mesoderm differentiation may
vary between OKSiM and OKSiM+ Spy1. The resultant colonies were also positive for
alkaline phosphatase (AP) (Štefková, Procházková, & Pacherník, 2015) (Figure S1C).
Hence, Spy1 results in increased reprogramming efficiency with resultant iPSCs that
resemble ESCs.
The overexpression of Spy1 during reprogramming also resulted in a marked
increase in pluripotency transcription factors Oct4, Sox2, Klf4, c-Myc and Nanog (Figure
2D). Interestingly, the expression of OKSiM construct in MEFs resulted in a significant
increase in Spy1 expression (Figure 2E). Collectively, these results support the conclusion
that the role that Spy1 plays in overriding RIS is correlated to an increase in reprogramming
efficiency.
It has been demonstrated that the use of the combination of 3 out of 4 of the
reprogramming factors- Oct4, Sox2, and Klf4, without c-Myc generates a significantly
reduced amount of iPSC colonies (Y. S. Takahashi K, 2006 ). Moreover, the colonies that
are produced display a very flat-like and non ESC-like morphology, indicating that these
cells are succumbing to reprogramming barriers including RIS (Y. S. Takahashi K, 2006
). Another study was unable to derive fully reprogrammed cells without using c-Myc as a
reprogramming factor (Okita, et al., 2007). The idea of using c-Myc as a reprogramming
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factor for clinical application, is hampered by the fact that c-Myc is a potent protooncogene. Hence, we tested if Spy1 could act as an alternative factor to c-Myc during
reprogramming. We created a novel Tet-inducible vector in which we replaced c-Myc with
a Spy1 insert (OSKS; Figure S2A). Overexpression of OSKS had a significant increase in
the reprogramming efficiency as compared to both OSK and OSKM (Figure S2B). This
suggests that other reprogramming factors such as Spy1 may act as alternatives for c-Myc
during reprogramming.
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Figure 2. Overexpression of Spy1 improves reprogramming efficiency. (A) qRT-PCR
gene expression levels of Spdya in control and overexpression vector. (B) qRT-PCR gene
expression levels of primers targeted against the OKSiM vector to check overexpression.
(C) Representative images of mouse iPSCs colonies (left) at day 21 formed in OKSiM and
OKSiM+Spy1 at 1X, 2,5X and 20X magnification. Lack of colony formation in the control
vector is visible under the control panel. Representative colony of OKSiM+Spy1 (right;
top) in bright field and fluorescence indicating GFP of colony forming with Spy1.
Reprogramming efficiency (right; bottom) was scored as a percent of colonies that had
been formed by day 21 with respect to the number of cells initially seeded for each one of
the treatments. (D) qRT-PCR gene expression levels of pluripotency genes of
OKSiM+Spy1 infected cells compared to OKSiM control. (E) qRT-PCR gene expression
levels of Spdya in OKSiM infected cells compared to control vector infected cells. qRTPCR values are normalized to Gapdh. Results presented as the mean ±s.d.; *p < 0.05, **p
< 0.01, ***p < 0.005. (n=3).
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Supplement Figure 1. Validation and characterization of mouse iPSCs. (A)
Immunofluorescence for endogenous OCT4 (left), and SOX2 (right) in OKSiM and
OKSiM+Spy1 mouse iPSCs. Hoechst used as a nuclear control. Scale bar = 200 µm. (B)
Representative brightfield images of embryoid body (EB) formation (left) in OKSiM and
OKSiM+Spy1 reprogrammed mouse iPSCs at day 3, day 5 and day 7 differentiation. Lack
of EB formation in control vector is visible. Scale bar = 50 µm. EB diameters were
quantified and average between OKSiM and OKSiM+Spy1 was graphed (right). (C)
Alkaline phosphatase (AP) staining of formed mouse iPSCs in OKSiM and OKSiM+Spy1.
Scale bar = 100 µm.
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Supplemental Figure 2. OSKS improves reprgrogramming efficiency. (A) Schematic
of the construction of the TetO inducible OSKS vector from ligating a piece of the MycSpy1A-pCS3 vector into the Teto-FUW-OSK vector from which c-Myc was removed. (B)
Representative images of colony formation (left) of mouse iPSCs in OSK, OSKM, and
OSKS cells at 2.5X (Scale bar = 200µm) and 10X (Scale bar= 50 µm) magnification at day
21 reprogramming. The number of colonies were scored and quantified at 21 days for OSK,
OSKM, and OSKS and presented as a fold change in colony formation (right). Results
presented as the mean ±s.d.; *p < 0.05, **p < 0.01, ***p < 0.005. (n=3).
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Spy1 overrides RIS through the downregulation of tumour suppressors
It is known that important senescent factors are upregulated in response to the addition of
reprogramming factors, including the tumour suppressors p16, p53 and p21 (Banito,
Rashid, Acosta, Li, Pereira, Geti, Pinho, Silva, Azuara, Walsh, Vallier, et al., 2009).
Analysis of tumour suppressor expression at early stages of reprogramming showed that
the overexpression of Spy1 with the OKSiM vector significantly decreases the mRNA
transcript levels of Cdkn1a and Cdkn2a (Figure 3A). Although the levels of Trp53 gene
expression decrease with Spy1 overexpression during reprogramming, this was not
statistically significant. In addition, the levels of Cdkn2a transcript were significantly
increased if Spy1 was knockdown during reprogramming (Figure 3A). Quantification of
immunofluorescence for p16, p21 and p53 protein levels (Figure 3B; left) indicate that the
overexpression of Spy1 during reprogramming significantly decreases the number of cells
positive for each one of the mentioned CKIs (Figure 3B; right). Although the knockdown
of Spy1 resulted in an increase of p16, p21 and p53 protein, the trend was not statistically
significant (Figure 3B; right).
We speculated that if Spy1 was playing an important role in downregulating
senescence effectors early on during reprogramming, then it might be keeping the levels of
senescence effectors down throughout the reprogramming process. We looked at Cdkn1a,
Cdkn2a, and Trp53 gene expression levels throughout the reprogramming process at days
4, 7, 14 and 21 with Spy1 overexpression and knockdown (Figure 3C). Although the levels
of all 3 effectors decreased throughout the reprogramming process, cells that were
reprogrammed in combination with Spy1 overexpression had significantly lower levels of
Cdkn1a, Cdkn2a, and Trp53 transcripts, while cells that were reprogrammed in
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combination with knockdown of Spy1 had significantly higher levels of all 3 senescence
effectors as compared to the control OKSiM alone (Figure 3C). Therefore, it seems that
Spy1 is overriding RIS by decreasing levels of senescence effectors throughout
reprogramming.
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Figure 3. Spy1 overrides reprogramming induced senescence. (A) qRT-PCR gene
expression levels of Cdkn1a, Cdkn2a, and Trp53 in OKSiM, OKSiM+Spy1 and OKSiM +
shSpy1 at day 4 reprogramming. (B) Representative immunofluorescence images (left) for
p16, p21 and p53 in OKSiM, OKSiM + shSpy1 and OKSiM + Spy1 at day 4
reprogramming. Scale bar = 20µm. Fluorescence staining was quantified as a percentage
(right) of p16 positive cells (top), p21 positive cells (middle), and p53 positive cells
(bottom). (C) qRT-PCR gene expression levels for Trp53 (top; left), Cdkn1a (top; right)
and Cdkn2a (bottom; left) during the reprogramming time course at indicated days for
OKSiM+ shSpy1 and OKSiM+ Spy1 (controlled for OKSiM +control). qRT-PCR values
are normalized to Gapdh. Results presented as the mean ±s.d.; *p < 0.05, **p < 0.01, ***p
< 0.005. (n=3)
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Spy1 represses tumour suppressors through Ezh2 mediated H3K27me3 activity
Many epigenetic changes occur during reprogramming to establish a pluripotent state and
perturb the somatic programme. A number of studies to date have shown that the
knockdown of demethylases enhance iPSC generation, as does the overexpression of
methyltransferases (Mansour et al., 2012; Onder et al., 2012b; T. Wang et al., 2011).
Polycomb repressive complex 2 (PRC2) is composed of EZH2, SUZ12 and EED, which
help modulate repressive chromatin marks (L. Ringrose & Paro, 2004). The knockdown of
PRC2 components in mESC induce differentiation (Boyer et al., 2006). We studied the
response of PRC2 components during MEF reprogramming in response to Spy1
manipulation. The major PRC2 component, Ezh2, had significant increase in transcript
expression when Spy1 was overexpressed during reprogramming in comparison to OKSiM
alone (Figure 4A). Although the same trend was observed for the transcript levels of the
other PRC2 components, Suz12 and Eed, they were not significant (Figure 4A). The
knockdown of Spy1 during reprogramming resulted in a decrease of all PCR2 components,
this trend was not significant. The levels of EZH2 are inversely correlated with TGF-β
signalling (R. A. Rao, Dhele, N., Cheemadan, S., Ketkar, A., Jayandharan, G. R.,
Palakodeti, D., & Rampalli, S., 2015). Increased EZH2 represses downstream TGF-β
signalling and decreases downstream transcription of mesenchymal transcription factors
SNAIL and TWIST (R. A. Rao, Dhele, N., Cheemadan, S., Ketkar, A., Jayandharan, G. R.,
Palakodeti, D., & Rampalli, S., 2015). We observed that gene expression levels of both
Twist and Snail were significantly downregulated in OKSiM+ Spy1 cells as compared to
OKSiM alone (Figure 4B). Expression of all PRC2 members change throughout the
process of reprogramming and continue to increase until iPSC have been formed (R. A.
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Rao, Dhele, N., Cheemadan, S., Ketkar, A., Jayandharan, G. R., Palakodeti, D., &
Rampalli, S., 2015). We tested the effects of manipulating Spy1 on the reprogramming
process, using expression levels of Ezh2, Suz12, and Eed at days 4, 7, 14 and 21. Cells that
were reprogrammed in combination with overexpressed Spy1 show a significant increase
in both Ezh2 and Eed at days 7 and 14 (Figure 4C) as compared to OKSiM alone.
Moreover, all PRC2 components continued to increase all the way up to 21 days, and those
reprogrammed with OKSiM+ Spy1 show a trend in high transcript levels of all PRC2
components as compared to OKSiM alone. Spy1 knockdown showed a decrease in overall
accumulation of PRC2 components over time, although differences in levels were not
statistically significant (Figure 4C). EZH2 is the enzymatic subunit of the PRC2 and it
catalyzes the trimethlyation of histone H3 on lysine 27 residue (L. P. Ringrose, R., 2004).
It has been demonstrated that CDK1 and CDK2 phosphorylate EZH2, which is important
in recruiting PRC2 component to target loci (S. Chen, Bohrer, L. R., Rai, A. N., Pan, Y.,
Gan, L., Zhou, X., Bagchi, A., Simon, J. A., Huang, H., 2010). Spy1 can bind and activate
both CDK1 and CDK2 in a distinct manner compared to cyclins (A. P. Karaiskou, L.H.,
Ferby, I., Ozon, R., Jessus, C., & Nebreda, A.R., 2001; J. L. Lenormand, Dellinger, R.W.,
Knudsen, K.E., Subramani, S. & Donoghue, D.J., 1999). To determine whether Spy1 was
activating EZH2, and ultimately H3K27me3, through a CDK mediated mechanism,
western blot analysis was conducted (Figure 4D). There was a significant increase in the
activating phosphorylation (T345) on EZH2 when Spy1 is overexpressed in
reprogramming to iPSCs as compared to OKSiM alone (Figure 4D; left). The knockdown
of Spy1 had no measurable difference in the protein levels of phosphorylated EZH2. Next
we analyzed whether this activating phosphorylation on EZH2 caused an increase in the
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trimethlyation of histone H3 at the lysine 27 residue (Figure 4D). MEFs reprogrammed
with Spy1 overexpression in combination with OKSiM also had a significant increase in
H3K27me3 as compared to MEFs reprogrammed only with OKSiM (Figure 4D). This
suggests a mechanism where Spy1 is overriding RIS by repressing the expression of CKIs
through EZH2 mediated H3K27me3.
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Figure 4. Spy1 overrides reprogramming induced senescence through Ezh2-mediated
trimethylation of H3K27. (A) qRT-PCR gene expression levels for Ezh2, Suz12, and Eed
in OKSiM, OKSiM + shSpy1 and OKSiM + Spy1 at day 4 reprogramming. (B) qRT-PCR
gene expression levels for Twist and Snail in OKSiM, OKSiM + shSpy1 and OKSiM +
Spy1 at day 4 reprogramming. (C) qRT-PCR gene expression levels for Ezh2 (top; left),
Suz12 (top; right), and Eed (bottom; left) during the reprogramming time course at
indicated days for OKSiM, OKSiM + shSpy1 and OKSiM + Spy1. (D) Western blot
representative images (left) for phosphor EZH2 (T345), H3K27me3, Histone 3 (H3) and
loading control ACTIN in OKSiM, OKSiM + shSpy1 and OKSiM + Spy1. Densitometry
quantifications for p-EZH2 (top; right) and H3K27me3 (bottom; right). spy1-PCR values
are normalized to Gapdh. Results presented as the mean ±s.d.; *p < 0.05, **p < 0.01, ***p
< 0.005. (n=3).
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DISCUSSION
Many studies have reported a failure to produce fully reprogrammed cells that correlate
with barriers of late stage reprogramming (Mikkelsen TS, 2008). Cells that become trapped
in late stage reprogramming can be pushed forward through the inhibition of DNA
methylation as well as ablation of lineage-commitment genes to increase reprogramming
efficiency (Silva et al., 2008). The senescence barrier, or RIS, is known to occur early on
during reprogramming and bypassing this barrier is required to promote reprogramming.
Mechanisms to overcome RIS ultimately results in a higher number of both fully and
partially reprogrammed iPSCs (Banito, Rashid, Acosta, Li, Pereira, Geti, Pinho, Silva,
Azuara, Walsh, Vallier, et al., 2009).
Mechanistically RIS is associated with the activation of senescence regulators,
including those of the p53 pathway (Kawamura T, 2009). The upregulation of various CKIs
including p16 and p21 are early events that occur during reprogramming, and at least in
part, depend upon the epigenetic remodeling of their loci (Banito, Rashid, Acosta, Li,
Pereira, Geti, Pinho, Silva, Azuara, Walsh, Vallier, et al., 2009; H. e. a. Li, 2009). In this
study, we report the importance of a novel cell cycle regulator, Spy1, on overriding RIS
and improving reprogramming efficiency to induced pluripotency. We show that
overexpressing Spy1 during the reprogramming process doubles the number of colonies
that arise compared to using the classic reprogramming factors alone. Cells reprogrammed
with Spy1 have decreased CKI gene expression (Cdkn1aand Cdkn2a). In contrast, when
Spy1 was knocked down during reprogramming, the levels of CKIs were higher and there
was a significant increase in RIS. We studied temporal changes during reprogramming
with Spy1 overexpression and knockdown. A significant decrease in the levels of p16, p21
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and p53 were observed in the face of Spy1 overexpression, seen as early as day 4
reprogramming. Moreover, this effect lasted through until near almost the end of
reprogramming. This could indicate that Spy1 aids in repressing these genes until latter
portions of reprogramming, where partially and fully reprogrammed cells have completely
suppressed the indicated CKIs and are concerned with other barriers. Interestingly, the
overexpression of Spy1 demonstrates an increase in all pluripotency factors when
compared to OKSiM alone. This could suggest that Spy1 is supporting another early event
in reprogramming, which is the activation of the pluripotent gene network (Stadtfeld, et
al., 2008).
Spy1 overcomes cell cycle checkpoints and drives proliferation in the face of stress
and damaged DNA (E.A. Barnes, L.A. Porter, J.L. Lenormand, R.W. Dellinger, & D.J.
Donoghue, 2003b; Gastwirt, Slavin, McAndrew, & Donoghue, 2006), and hence, it is
plausible that Spy1-induced movement through the cell cycle makes cells more amenable
to becoming iPSCs. Increased cell proliferation is reported as an early event in
reprogramming and it is hypothesized that any factor which has the ability to increase
proliferation should correlate with increased reprogramming efficiency (Stadtfeld, et al.,
2008). What was interesting was the observed exclusivity of Spy1 to have these effects on
reprogramming when compared to another G1 phase cyclin – Cyclin E. CKIs are
upregulated early on in reprogramming and initiate RIS. The ability of CKIs such as p27
to inhibit cyclin-CDK depends on a direct cyclin-CKI interaction through a MRAIL motif
on the cyclin (Russo, et al., 1996). Spy1 does not contain this MRAIL motif (A. P.
Karaiskou, L.H., Ferby, I., Ozon, R., Jessus, C., & Nebreda, A.R., 2001; D. A. McGrath,
Fifield, B.A., Marceau, A.H., Tripathi, S., Porter, L.A., Rubin, S.M. , 2017) and CKIs such
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as p27 bind very weakly to a Spy1-CDK complex as compared to a cyclin-CDK complex.
Studies have shown that p21 is able to abrogate cyclin A-CDK2 activity, but has no effect
on Spy1-CDK2 activity (A. P. Karaiskou, L.H., Ferby, I., Ozon, R., Jessus, C., & Nebreda,
A.R., 2001). Hence, one way in which Spy1 can override RIS is through a unique canonical
activation of the cell cycle in the face of CKI accumulation.
c-Myc is included as a reprogramming factor due to its ability to enhance
reprogramming efficiency (Y. S. Takahashi K, 2006 ). We created a novel plasmid referred
to as the OSKS (Oct4, Sox, Klf4, and Spy1) vector, designed to replace c-Myc with Spy1.
We found that OSKS nearly doubled the amount of colonies as compared to OSK or
OSKM. Spy1 alone is not known to be tumourigenic unless the protein is stabilized.
Replacing Spy1 with c-Myc in the engineered vectors to drive pluripotency may decrease
the potential for spontaneous tumourigenic properties for cells during the reprogramming
process, hence making this a possible safer alternative for application.
Chen and colleagues previously reported that the functions of cyclins and CDKs
are not just limited to the cell cycle and downstream substrates but have a host of noncanonical functions including epigenetic regulation (S. Chen, Bohrer, L. R., Rai, A. N.,
Pan, Y., Gan, L., Zhou, X., Bagchi, A., Simon, J. A., Huang, H., 2010). Cyclin-CDK
binding and activation results in an activating phosphorylation of the methyltransferase
EZH2 (S. Chen, Bohrer, L. R., Rai, A. N., Pan, Y., Gan, L., Zhou, X., Bagchi, A., Simon,
J. A., Huang, H., 2010). EZH2 dependent H3K27me3 increases reprogramming efficiency
by repressing transcription of some CKIs early on during reprogramming (R. A. Rao,
Dhele, N., Cheemadan, S., Ketkar, A., Jayandharan, G. R., Palakodeti, D., & Rampalli, S.,
2015). Spy1 is able to bind and activate CDK partners and hence we studied whether the
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Spy1-CDK complex can also play a role in epigenetic regulation. We report that the
overexpression of Spy1 had an effect on the PRC2 component, EZH2 early in
reprogramming. This supports that this particular epigenetic regulation plays a role at a
distinct phase of reprogramming. Known downstream repressive targets of EZH2 are the
pro-EMT transcription factors Twist and Snail (R. A. Rao, Dhele, N., Cheemadan, S.,
Ketkar, A., Jayandharan, G. R., Palakodeti, D., & Rampalli, S., 2015). We show that the
overexpression of Spy1 decreases the levels of these fibroblast specific targets and
increases EZH2 activating phosphorylation. Spy1 promotes an increase in trimethylation
of H3 at K27 supporting that EZH2 is functionally activated. This methylating mark is
known to, in part, function by repressing the loci of CKIs including p16 (Ding et al., 2014a
). Hence, the ability of Spy1-CDK to enhance phosphorylation of EZH2, resulting in
increased H3K27me3, acts as a mechanism to circumvent barriers during reprogramming.
In summary, the present study demonstrates that the atypical cyclin-like protein
Spy1 increases reprogramming efficiency through both cell cycle dependent, and cell cycle
independent mechanisms. Spy1 causes a significant decrease in the expression CKIs
throughout reprogramming, having the greatest effects at time points that correlate with the
RIS barrier. Understanding how to safely override senescence during reprogramming is an
important area of study to improve reprogramming efficiency to make iPSCs a technology
that may be used for clinical applications.
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SUPPLEMENTAL MATERIAL
Supplemental Materials and Methods
Isolation of MEFs
Uteri isolated from 13-14-day-pregnant mice were washed in PBS. The head and internal
organs were removed from embryos before MEF isolation. The remainder of the embryo
was washed and minced using scalpel blade. Cell were incubated in 0.05% (wt/vol)
trypsin/1mM EDTA for 20 minutes at 37oC. After trypsinization, equal parts of medium
(DMEM + 10% FBS) was added. Tissue was dissociated by trituration. The
trypsin/medium mixture was incubated at 37oC for 5 minutes. The supernatant was
transferred to a new conical tube and cells were centrifuged at 500g for 5 minutes at 4 oC.
Cells were resuspended in fresh medium (passage 1). Cells were cultured on 100mm dishes
at 37oC 5%CO2. MEFs were used within 5 passages to avoid replicative senescence.
Lentiviral production and infection
Lenti-X 293T (Clontech) were seeded at a density of 4X106 cells per 100mm plate 24 hours
prior to transfection in DMEM supplemented with 10%FBS. For transfection, cells should
be 70% confluent. Transfection complex was prepared with the following: 800 µL DMEM,
4 µg transfer plasmid, 2 µg of envelope plasmid (pMD2.G Addgene Plasmid: 12259), 2 µg
of gag-pol plasmid vector (pMDLg/pRRE Addgene Plasmid: 12251), 2 µg of Rev plasmid
vector (pRSV-Rev Addgene Plasmid: 12253), and 30 µg of branched polyethylenimine
(PEI; Sigma). Transfection complex was added to Lenti-X 293T and incubated for 6 hours
at 37oC, 5% CO2. Transfection medium was removed and fresh medium was added to
transfected cells. Lentivirus containing medium was collected from Lenti-X 293T 48 post
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transfections and fresh medium was added to the cells. Lentivirus containing medium was
stored at 4oC overnight. Lentivirus containing medium was collected again 72 hours post
transfection and pooled with lentivirus containing medium collected the previous day.
Lentivirus containing medium was filtered through a 0.45 µm filter and put into an
ultrasound centrifuge tube. Virus was pelleted by centrifugation at 22,000 rpm for 3 hours
at 4oC. Virus pellet was resuspended with DMEM and aliquoted before storage in -80oC.
Human and mouse fibroblasts were infected using the same method. Fibroblasts
were seeded at 15,000 cells per well of a 96 well plate. Cells were incubated at 37 oC, 5%
CO2 overnight. Full medium was replaced with serum-free DMEM or EMEM
supplemented with 4 µg/mL polybrene (Santa Cruz). 5 µL of virus was added to each well.
Cells were incubated overnight at 37oC, 5% CO2. Infection medium was removed and
replaced with fresh medium. For cells containing a selectable marker – zeocin or
puromycin – this was added 3 days post infection. Puromycin (Thermo) was added at a
final concentration of 1µg/mL. Zeocin (Thermo) was added at a final concentration of 250
µg/mL.
Plasmid cloning
The plasmid that served as the parent plasmid in the generation of the new Oct4, Sox2,
Klf4, and Spy1 (OSKS) construct was the TetO-FUW-OSKM plasmid which is 13, 457
base pairs (Addgene 20321). Spy1 that was used for the OSKS vector was removed from
a plasmid that is the current property of the Porter lab- Myc-SpyA-pCS3. The generation
of the OSK vector without c-Myc was carried out by restriction enzyme digestion. The
digestion was prepared by adding DNA to restriction enzyme buffer, restriction enzyme
SgsI (AscI; Thermo). Digestion reactions were inactivated by heating at temperature
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recommended by Thermo. DNA samples were subjected to gel electrophoresis in an
agarose gel for 1 hour at 100V. Fragments were visualized and band of interest was excised.
Gel extraction was conducted using reagents and protocol from EZ-10 Spin Column DNA
Gel Extraction Kit (Biobasics). Polymerase chain reaction (PCR) was used to remove Spy1
component from the Myc-SpyA-pCS3 plasmid, and to amplify the target fragment. PCR
reaction was conducted using established protocols. The following forward
(5’AATTGGCGCGCCATACAAGCTACCGGTTCTTTTT GCAGG 3’) and reverse
(5’AATTGGCGCGCCATTAATTTAACTCATATTGTTGG 3’) primers (Operon) were
used for Spy1. DNA ligation of the TetO-FUW-OSK vector and Spy1 was performed using
T4-DNA ligase (Thermo). Transformation of the ligation reaction was performed using
established protocol. Colonies were picked and assessed for size to determine which ones
had incorporated the Spy1 insert.
Alkaline phosphatase staining
Induced pluripotent stem cell colonies were fixed with 4% PFA and stained using the
Alkaline Phosphatase Staining Kit II as per manufacturer’s instructions (Stemgent).
Embryoid body (EB) formation
Induced pluripotent stem cell colonies were picked and dissociated into single cells with
0.25% (wt/vol) trypsin/1mM EDTA. Cells were plated on 6 well ultra-low-attachment
plates at a cell density of 1X105 cells/mL containing 2mL of mESC medium without LIF.
EBs were cultured for 7 days and medium was changed every other day.
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TABLES

Supplemental Table 1. Primers used for qRT-PCR analysis. The primers are listed with
their name, their purpose (qRT), the sequence of forward (5’3’) primer and the sequence
of reverse (5’3’) primer.
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CHAPTER 5
GENERAL DISCUSSION AND FUTURE DIRECTIONS
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DISCUSSION
Role of Spy1 in NSC Maintenance
This work has validated Spy1 (also known as SPDYA; Speedy; Spy1A1; RINGO A) as an
important protein in the in decisions involved in the acquisition of stemness through
dedifferentiation as well as an important regulator of neural stem cells (NSCs) of the
mammalian brain. This work uses a novel mouse model (NTA-Spy1) which upregulates
Spy1 levels under the Nestin promoter in the presence of doxycycline. Nestin is a widely
accepted marker of NSC populations which begins to accumulate in neural precursors of
the brain at day 12 of embryonic development and is maintained in the NSC populations
throughout adulthood. Nestin expressing NSCs are found in the two neurogenic regions of
the brain in the subventricular zone (SVZ) of the lateral ventricles and the subgranular zone
(SGZ) of the dentate gyrus (Hendrickson et al., 2011). We show that upregulation of Spy1
in NSCs hinders differentiation capacity, especially towards the neuronal lineage, as well
as increases self-renewal ability of the stem cell population. This is seen at both early time
points such as post-natal day2 and is maintained well into later time points, 24 months in
the adult mammalian brain. In addition, neuron specific Nissl staining revealed that NTASpy1 mice brains show phenotypic changes in a decline of neuronal cells numbers and a
shift of the cortical plate. Collectively, this data suggests that Spy1 plays a role in the
maintenance and fate determination decision of the NSC population in the mammalian
brain.
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Role of Spy1 in Inhibition of Differentiation
At the cellular level, neurogenesis relies on homeostasis in the brain, allowing NSC
populations to transiently re-enter the cell cycle only when there is a demand for cells to
be repopulated. Differentiation of progenitor populations require cyclin dependent kinase
inhibitors (CKIs). One G1/S CKI, p27 is required and important in the initiation and
maintenance of differentiated neurons in the central nervous system (CNS) (Durand et al.,
1997; Li et al., 2009). Spy1 can bind and activate CDK1/2 using a unique mechanism that
is less sensitive to inhibition by CKIs such as p21 and p27 (Cheng et al., 2005; Dinarina et
al., 2005; McGrath et al., 2017). Spy1 can also bind to p27 directly and promote
degradation of this CKI (McAndrew et al., 2007; Porter et al., 2003). In NTA-Spy1 mice
we see a decrease in p27 protein levels (Chapter 2, Figure 3C), suggesting that this
mechanism may be participating in the inhibition of differentiation of the NSCs in these
mice. Due to the fact that Spy1 lacks a critical motif, known as the MRAIL motif, which
is found on cyclins and aids the binding of CKIs; the Spy1-CDK complex prevents the
docking of CKIs which is required for the physical blocking of the activation site of the
CDK (Karaiskou et al., 2001; McGrath et al., 2017). Our lab has created a number of Spy1
binding mutants that are unable to bind CDK2 as well as p27 (Al Sorkhy et al., 2012). It
will be important to make mouse models of these Spy1 mutants observe whether they
would have alterations in neural fate decisions in the CNS. We would predict that the p27
binding mutant would result in higher p27 levels, due to the fact that it is not being targeted
for degradation by Spy1, and an increased propensity towards neuronal lineage
differentiation. CDK2 binding mutants would completely ablate the function Spy1 during
G1 phase and we would expect to see drastic increases in differentiation.
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In addition, the use of other mouse models to drive Spy1 in progenitor populations,
such as and differentiated cells would provide important mechanistic insight into the Spy1
mediated effects on different cell populations of the brain. These other mouse models
would be generated by crossing the pTRE-Spy1 mice that were created in the lab with
available transgenic mice that utilize the tet-on or tet-off systems under different promoters
and ultimately under different brain cell populations; to drive Spy under the progenitor cell
population, a mouse model with a Sox1 promoter may be used (Venere et al., 2012), and
there are a number of markers that can be used to drive Spy1 under the three different cell
lineages of the brain. Another important future direction would be to demonstrate whether
Spy1 is essential in different populations of the brain. This could be elucidated through
CRISPR knockout of Spy1 in mouse primary derived NSCs. Collectively, this will resolve
as to which cell type (type B, type C or type A) that the functions of Spy1 are critical, and
what occurs when these functions are completely impaired in NSC populations.
Lastly, the generation of transgenic mouse models harboring Spy1 binding mutants
against CDKs will provide great insight into Spy1 mediated functions – as to whether they
are dependent solely on binding and activation of CDKs. If phenotypes are observed with
Spy1 binding mutants, it will be necessary to determine the alternative function(s) of Spy1
and the mechanism by which Spy1 may be facilitating them.

Role of Spy1 in Neurogenesis; Implications in Memory
According to a number of different studies, there are correlations between NSCs,
neurogenesis and their importance in brain functions including learning and memory (Saxe
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et al., 2006; Shors et al., 2002; Snyder et al., 2005; Winocur et al., 2006; Zhao et al., 2008).
Disruption or abnormalities in neurogenesis results in a decline of memory and learning
capacity. We demonstrate that Spy1 hinders differentiation down all three lineages of the
brain and increases symmetric division of NSCs. The generation of new differentiated cells
in NTA-Spy1 mice brains drop which causes impairments in memory retention as
demonstrated through the novel object recognition test. The molecular regulation of
memory has recently started to attract investigation (Berry et al., 2012; Inoue et al., 2013;
Shuai et al., 2010). Musashi 1 (Msi1) in C. elegans is involved in forgetting and in a decline
in memory acquisition (Hadziselimovic et al., 2014). Interestingly, we demonstrate
increased transcript and protein levels of Msi1 in the NTA-Spy1 mice (Chapter 2, Figure
4C). Spy1-CDK2 complex activates Msi1 activity through phosphorylation, allowing for
promotion of the cell cycle (Arumugam et al., 2012). The knockdown of Msi1 through
siRNA in the NTA-Spy1 cells demonstrated that there was a decrease in symmetric cell
division and a shift towards asymmetric cell division (Chapter 2, Figure 4E). This suggests
that Spy1-mediated effects on the expansion of the NSC population could be due to the
activation of Msi1 through Spy1-CDK2 activation. Further examination of these cells and
the phosphorylation status of Msi1 as compared to their control littermates, as will
abrogation of this phosphorylation site through site-directed mutagenesis in Msi1, will be
necessary to conclusively state that Spy1 mediated effects of Msi1 could be playing a role
in memory functions.
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Role of Spy1 in Neural Tumourigenesis
There are many theories of how cancers may arise. The cancer stem cell hypothesis
suggests that in heterogeneous tumours, a subset of cells, known as cancer stem cells
(CSCs) have the ability to self-renew and give rise to the cells that comprise a tumour bulk
(Wicha et al., 2006). Most recently, it’s been suggested that CSCs don’t necessarily
originate because of oncogenic transformation in normal adult stem cells (Visvader, 2011).
In fact, the most aggressive type of malignant gliomas, glioblastoma (GBM) shows great
tumour cell plasticity and CSC have been shown to arise through the dedifferentiation of
neurons and astrocytes (Friedmann-Morvinski et al., 2012). Data also indicates that
aberrant genetic pathways are responsible for the emergence of GBM, rather than the cell
of origin (Bachoo et al., 2002).
The similarities between cellular reprogramming of differentiated somatic cells to
generate induced pluripotent stem cells (iPSCs) and the generation of CSC in
tumourigenesis are prominent. Both processes need the overexpression of known
oncogenes, the downregulation of tumour suppressor genes, overcoming senescence
barriers, and overriding epigenetic barriers (Hong H, 2009; Kawamura T, 2009; Li, 2009;
Riggs et al., 2013; Tapia N, 2010). We demonstrate that the overexpression of Spy1 during
reprogramming aids in overcoming senescence barrier through the activation of Ezh2
methyltransferase, which is responsible for the repression of a number of tumour
suppressor genes, including p21 and p16. Reprogramming requires the expression of a
cocktail of oncogenes – Oct4, Sox2, Klf4 and c-Myc (OSKM). We show that Spy1
increases reprogramming efficiency when added to this cocktail. This suggests that,
similarly to reprogramming, in the face of oncogenic factors, Spy1 may increase tumour
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initiation, aggressiveness or susceptibility. Interestingly, we also demonstrate that Spy1
can replace c-Myc as a reprogramming factor and increases reprogramming efficiency.
This could suggest that during tumourigenesis, if oncogenes such as So2, Oct4 and Klf4
are present, the upregulation of Spy1 should in fact induce a more aggressive tumour
phenotype, especially through the expansion of the CSC population. In the future, teratoma
formation assays (Abad et al., 2013)using OSKM alone as well as OSKM with Spy1 will
give us a greater understanding of tumour phenotype with regards to Spy1 expression.
It is thought that tumour initiation, progression and/or relapse in the brain could be
a result of NSCs that have escaped the differentiation program following DNA damage,
and permitting the expansion of a dangerous and abnormal stem cell population. It would
be interesting to see how the NSCs in NTA-Spy1 mice would respond to IR in vivo and
whether this could be a mechanism of cancer initiation in the brain. Lastly, we show that
the depletion of p53 prior to UV irradiation of NTA-Spy1 NSCs results in a decrease in
stem cell markers. This suggests that the ability of Spy1 to maintain a stem cell population
following DNA damage relies on the presence of p53. Further investigation will be
necessary to determine what happens to these cells functionally and what fate decisions
they make.
Our results also demonstrated that Spy1 overexpression in NSCs overrides the
DNA the damage response (DDR) following UV irradiation. Irradiated NTA-Spy1 NSCs
maintained a continued proliferative capacity, upheld stem cells marker expression and did
not differentiate following UV irradiation. The DDR is critical to ensure that cells maintain
their genomic integrity in the face of stressors, thereby safeguarding a healthy cell
population. Studies of the DDR to ionizing radiation (IR) in NSCs show that they undergo
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senescence (Schneider et al., 2012; Schneider et al., 2013). Spy1-CDK complexes are
resistant to CKIs found downstream of p53 and this results in increased proliferation even
when cell cycle checkpoints become activated and leads to aberrant cell growth and
division (Karaiskou et al., 2001; McAndrew et al., 2007; McGrath et al., 2017; Porter et
al., 2003). Studies in NSCs following DNA damage also demonstrate that another fate of
these cells is terminal differentiation towards astrocytic lineage and a decline in stem cell
capacity (Acharya et al., 2010; Monje et al., 2002; Schneider et al., 2012; Schneider et al.,
2013) however, we show that Spy1 overexpression in NSCs impedes differentiation and
stem cell markers are maintained. This suggests that a stem cell population persists as a
result of increased Spy1 levels. What remains to be determined is whether this cell
population undergoes any form of DDR or the NSC population continues to proliferate and
pass down damaged DNA to their progeny.
These roles of Spy1aren not necessarily restricted to effects in the brain. Spy1 is
implicated in a host of cancers; it drives symmetric division in other stem cell populations,
shows changes to reprogramming in fibroblasts and globally alters the DDR (Al Sorkhy et
al., 2012; Gastwirt et al., 2007; Golipour et al., 2008; Ke et al., 2009; Porter et al., 2002;
Zucchi et al., 2004).
SUMMARY
To summarize, data in this study supports the hypothesis that Spy1 is an important
reprogramming factor towards the generation if iPSCs by alleviating senescent barriers and
increasing reprogramming efficiency. We also provide evidence to support the hypothesis
that Spy1-mediated mechanisms drive abnormal growth and division in NSCs of the
mammalian brain. We provide evidence for the relevance of this work towards brain
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functions such as learning and memory. Collectively, these results may provide
information potentially regarding cancer initiation, progression and aggressiveness.
Attaining a better understanding of molecular mechanisms that drive abnormal cell growth
and division in reprogramming and NSCs will be invaluable.
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Cell Cycle Dynamics in Glioma Cancer Stem Cells
Ingrid Qemo, and Lisa A. Porter.
Summary
Cancer stem cells, sometimes referred to as tumor initiating cells, play pivotal roles in
tumor initiation, progression, metastasis, resistance to therapy and relapse. Understanding
how these populations of cells expand in response to a host of conditions is critical in
determining effective cancer therapeutics. A defining feature of cancer stem cells is the
ability to switch between modes of quiescence and symmetric/asymmetric division to
protect and conserve the population, this feature is traditionally reserved for normal adult
stem cell populations. Understanding how the core cell cycle machinery responds to
external cues to drive symmetric/asymmetric division vs. quiescence will reveal
fundamental information about how cancer stem cell populations survive and expand. This
chapter will describe methods to study the cell cycle dynamics in brain cancer stem cell
populations and how they compare to the other populations in a tumor.
Key Words: Glioma, Cancer, Stem Cells, CD133, CD15, CD44, Cell Cycle, Flow
Cytometry
1. Introduction
Cancer stem cells (CSC) share many defining characteristics that are traditionally
associated with normal stem cells. Normal multipotent adult stem cells exhibit key
features, including high self-renewal capacity and the ability to differentiate into the
specialized cells in the tissue where they reside (1). Historically, these cells are thought to
divide very infrequently in vivo to preserve their populations, however the rate of division
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is highly dependent on the tissue type and external cues from the external environment
(developmental or stress/injury related) (2-4). When cued to replenish, adult stem cells can
divide either symmetrically or asymmetrically (5,6). Mathematical modelling supports that
symmetric division may occur in response to accumulating DNA damage to protect the
adult stem cell population and that CSC favour symmetric over asymmetric division to
facilitate tumor growth (7-10). Ultimately these decisions depend on the core cell cycle
machinery, how CSC alter the cell cycle to control this balance is an active area of research.
The brain contains neural stem cells (NSC) which possess many similarities to the CSC
population within gliomas, the most common form of brain tumor, referred to as a glioma
CSC (11). Gliomas contain a population of cells that have transiently exited from their cell
cycle (termed quiescent cells) which contribute to their aggressiveness (12), however, the
cell cycle dynamics of this population remain relatively poorly characterised. Normal NSC
and glioma CSC populations express characteristic cell surface proteins, which are useful
in identifying and sorting these cell populations in order to study or enrich them (13). One
of these markers, CD133, isolates populations of glioma CSC that have the capacity to
recapitulate a tumor, and the presence of these cells correlate with patients that have a poor
clinical prognosis (14, 15).
Other markers have been used to study, isolate and enrich glioma CSC, including CD15
(also called SSEA-1 [stage-specific embryonic antigen 1]) (16), CD44 (17, 18), and the
ATP-binding cassette (ABC) multidrug transporters which contribute to chemoresistance
and drug efflux capability (19). Whether any of these glioma CSC markers correlate to
cellular quiescence in vivo, or proliferative capacity in vitro has not been conclusively
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determined and may reveal information about the aggressiveness of select glioma CSC
populations.
This chapter describes the protocols to uncover cell cycle patterns in glioma CSC
populations using various identified CSC markers. The use of CD133, CD15 and CD44
will help reveal different glioma CSC populations, in both establish GBM cell lines and
primary patient-derived GBM tumor cell lines, and allow for comparative analysis of cell
cycle profiles.
2. Materials
2.1 Culturing human SJ-GBM2
1. The human SJ-GBM2 glioblastoma multiforme cancer cell line was
originally obtained from the Children’s Oncology Group Repository (Texas
Tech University Health Sciences Center).
2. SJ-GBM2 cells were cultured in Iscove’s Modified Dulbecco’s Medium
(IMDM; ATCC; cat. no 30-2005) which contains 4mM L-glutamine and
should be supplemented with 20% fetal bovine serum (FBS; Gibco cat. no
12483-020), and 1X ITS (5µg/ml insulin, 5µg/ml transferrin, 5ng/ml
selenous acid) (Sigma; cat. no I3146) at 37°C and 5% CO2.
3. SJ-GBM2 cells were cultured on 100 x 20mm polystyrene cell culture
dishes (Sarstedt; cat. no 83.3902).
2.2 Culturing human primary patient-derived glioblastoma cells

233

1. Primary

human

primary

patient-derived

glioblastoma

multiforme

neurospheres (HBTC 3160) were generously donated from Dr. deCarvalho
at the Hermelin Brain Tumor Center at Henry Ford Hospital.
2. HBTC 3160 cells require DMEM/F-12 50/50 (Corning cellgro cat. no 10092-CV) culture media supplemented with 1X N-2 supplement (Gibco cat.
no 17502048), 20ng/ml epidermal growth factor (EGF; Thermo Fisher
Scientific cat. no PHG0311), 10ng/ml fibroblast growth factor (bFGF;
Sigma cat. no F0291), 50µg/ml gentamicin solution (Gibco; cat. no15710064), 1X antibiotic-antimycotic (Gibco; cat. no 15240-062); 0.5mg/ml
tissue culture grade bovine serum albumin (BSA; Sigma; cat. no A4919) at
37°C and 5% CO2 .
3. HBTC 3160 cells were cultured in T25 tissue culture flasks (Sarstedt; cat.
no 83.3910.002).
2.3 Flow Cytometry: Cell Preparation and Fixation
1. Dulbecco’s phosphate-buffered saline (D-PBS, 1X) solution without
calcium and magnesium, pH 7.4 was purchased from Thermo Fisher
Scientific (cat. no 14190144).
2. Paraformaldehyde powder (95%) purchased from Sigma (cat. no 158127)
to make a 2% formaldehyde (PFA) solution in 1X PBS.
2.4 Flow Cytometry: Staining and Analysis
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1. Allophycocyanin

(APC)

conjugated

Anti-human

CD133/AC133

(Prominin-1) monoclonal antibody (TMP4) was purchased from
eBioscience (cat. no 17-1338-42) (see Note 2).
2. The Alexa Fluor 555 Mouse anti-SSEA-1 (CD15) antibody (MC480) was
purchased from BD Biosciences (cat. no 560119) (see Note 2).
3. Phycoerythrin (PE) conjugated Anti-CD44 monoclonal antibody [F10-442] was purchased from Abcam (cat. no ab82529) (see Note 2).
4. Hoechst 33342, trihydrochloride, trihydrate – 10mg/ml solution in water
was purchased from Thermo Fisher Scientific (cat. no H3570) (see Note 3).
5. Pharmingen Stain Buffer (BSA) was purchased from BD Biosciences (cat.
no 554657).
6. Axygen 1.5ml eppendorf microcentrifuge tubes were purchased from
Corning (cat. no MCT-150-C).
7. EASYstrainer 70µm sterile cell strainers were purchased from greiner bioone (cat. no 542070).
8. Polystyrene round-bottom 12x75mm BD Falcon tubes appropriate for flow
cytometric analysis (cat. no 352052)
9. The analysis of the cells was preformed using a BD LSRFortessa X-20 flow
cytometer with a BD FACSDiva software (BD Biosciences).
3. Methods
3.1 SJ-GBM2 Cell Preparation Protocol
1. When cells reach 70-80% confluency, remove the media from cell culture
dish and discard it.
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2. Add 3ml of cold Ca2+/ Mg2+ - free D-PBS solution to each cell culture dish,
which will aid in rounding and detaching the cells from the dish. Observe
cells under a bright field microscope until the majority of the layer is
detached (see Note 4). Should take approximately 5 minutes.
3. Gently wash the cell layer and add it to a 15ml conical centrifuge tube. Spin
down the cells at 500x g for 7 minutes at 4°C.
4. Remove the supernatant and resuspend the cell pellet in 1ml Ca2+/ Mg2+ free D-PBS.
5. Add a 1:1 (v:v) ratio of SJ-GBM2 cells to trypan blue solution.
6. Count the number of live cells using a hemocytometer (see Note 5).
7. Spin the cells and resuspend in cold Stain Buffer to get the desired
concentrations depending on which of the surface antigens you will be using
(see Note 6).
3.2 HBTC 3160 Cell Preparation Protocol
1. The cells will be growing as neurospheres in serum free medium in T25
flasks.
2. Add all the contents of the flask to a 15ml conical centrifuge tube. Spin
down the cells at 800x g for 5 minutes at 4°C.
3. Remove the supernatant and resuspend the cells in 2ml cold Ca2+/ Mg2+ free D-PBS solution. Gently pipette to dissociate the spheres.
4. Incubate the cells in cold Ca2+/ Mg2+ - free D-PBS solution at room
temperature for 10 minutes, while gently pipetting every two minutes.
5. Add a 1:1 (v:v) ratio of HBTC 3160 cells to trypan blue solution.
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6. Count the number of live cells using a hemocytometer (see Note 5).
7. Spin the cells and resuspend in cold Stain Buffer to get the desired
concentrations depending on which of the surface antigens you will be using
(see Note 6).
3.3 Flow Cytometry Fixation and Staining
1. Label all BD Falcon tubes, including respective controls and samples for
each cell line (Table 1).
2. For APC conjugated CD133, both the SJ-GBM2 and HBTC 3160 should be
stained with 5uL of antibody in a final volume of 100µl which contains
500,000 cells (see Note 7).
a. Incubate cells for 1 hour at 4°C while gently pipetting cells every 510 minutes to prevent aggregation.
3. For PE conjugated SSEA1 (CD15), both the SJ-GBM2 and HBTC 3160
should be stained with 5µl of antibody in a final volume of 50µl which
contains 500,000 cells (see Note 7).
a. Incubate cells for 30 minutes at 4°C while gently pipetting cells
every 5 minutes.
4. For PE conjugated CD44, both the SJ-GBM2 and HBTC 3160 should be
stained with 5µl of antibody in a final volume of 100µl which contains
500,000 cells (see Note 7).
a. Incubate cells for 30 minutes at 4°C while gently pipetting cells
every 5 minutes.

237

5. After staining for the cell surface antigen, wash the cells twice in cold Ca2+/
Mg2+ - free D-PBS solution. Spin down at 1000 rpm for 5 minutes at 4°C.
6. After the second wash, remove the supernatant and resuspend the cells in
500µl cold 2% PFA in 1X PBS for 10 minutes at room temperature to fix
the cells (see Notes 8, 9, 10).
7. Add 1ml of cold Ca2+/ Mg2+ - free D-PBS solution to each tube and spin
down at 1000 rpm for 5 minutes at 4°C.
8. Discard the supernatant.
9. For tubes that only contain a single stain, resuspend the cells in 500µl cold
Ca2+/ Mg2+ - free D-PBS solution and filter this through a 70µm cell strainer
before adding the filtered contents to BD Falcon tubes.
10. For tubes that need to be counterstained for DNA content, resuspend the
cells in 500µl cold Ca2+/ Mg2+ - free D-PBS solution that contains Hoechst
at a dilution of 1:2000. Incubate tubes for 10 minutes at room temperature.
11. Add 1ml cold Ca2+/ Mg2+ - free D-PBS solution to wash and spin down cells
at 1000 rpm for 5 minutes at 4°C.
12. Discard the supernatant and resuspend the cells in 500µl cold Ca2+/ Mg2+ free D-PBS solution and filter this through a 70µm cell strainer before
adding the filtered contents to BD Falcon tubes.
13. Keep all tubes on ice and protected from light until it is time to analyze them
by flow cytometry.
[Table 1 near here]
3.4 Flow Cytometry Analysis
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1. All flow cytometry experiments were performed using BD LSRFortessa X20 with FACSDiva software. Cell debris was excluded from analysis.
2. The Hoechst (DAPI) dye is excited at 355 nm and its fluorescence emission
is measured at 460-490 nm.
3. The APC fluorochrome is excited at 633-647 nm and its fluorescence
emission is measured at 660nm. A representative analysis of CD133
positive and negative populations in both cell lines showing their cell cycle
profiles is presented in Fig. 1.
4. The Alexa Fluor 555 fluorochrome is excited at 555 nm and its fluorescence
emission is measured at 565 nm. A representative analysis of SSEA1
(CD15) positive and negative populations in both cell lines showing their
cell cycle profiles is presented in Fig. 2.
5. The PE fluorochrome is excited at 488 nm and its fluorescence emission is
measured at 575 nm. A representative analysis of CD44 positive and
negative populations in both cell lines showing their cell cycle profiles is
presented in Fig. 3.

[Fig 1 near here]
[Fig 2 near here]
[Fig 3 near here]
4. Notes
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1. In order to have no product loss, reconstituted EGF and FGF solutions
should not be filtered. This is due to the fact that they may bind to the filters
and there is no way to detect whether they have been rinsed from the filters.
2. Alexa Fluor 555 Mouse anti-SSEA1 (CD15) antibody (MC480) reacts with
both human and mouse samples according to manufacturer’s guidelines.
3. These antibodies come as solutions and should be protected from light.
4. If you are finding that the cells are not detaching, you may alternatively
consider Accutase. However, take care with the enzymatic solutions used,
this is a critical step for flow cytometry and could negatively affect the
expression of surface antigens.
5. For optimal flow cytometry data and analysis you should aim for over 90%
cell viability.
6. Cold solutions as well as staining at 4°C is important in preventing the
internalization or potential modulation of cell surface antigens.
7. All cell surface antigen staining should be performed in a 1.5ml eppendorf
tube and protected from light.
8. The order of staining and fixation varies depending on whether you are
asking questions regarding surface or intracellular antigens. When
analyzing cell surface epitopes, it is best to stain these surface antigens first
and then fix the cells afterwards.
9. Be cautious on the fixation method that you choose. Fluorochromes like PE
and APC are large and may be affected by alcohol fixation. We recommend
formaldehyde fixation.
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10. Fixing cells is an exothermic reaction and therefore you should aim to use
cold fix solution.
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Figure 1. Flow cytometry analysis of cell cycle profiles between CD133 negative (-)
(purple) and CD133 positive (+) (green) populations in SJ-GBM2 glioblastoma multiforme
cancer cells (A) and HBTC 3160 primary patient-derived glioblastoma multiforme cancer
cells (B) and their respective graphs. Percentage of cells in G0/G1 decreases in the CD133+
population as compared to the CD33- population
Figure 2. Flow cytometry analysis of cell cycle profiles between CD15 negative (-) (purple)
and CD15 positive (+) (green) populations in SJ-GBM2 glioblastoma multiforme cancer
cells (A) and HBTC 3160 primary patient-derived glioblastoma multiforme cancer cells
(B) and their respective graphs. Percentage of cells in G0/G1 decreases in the CD15+
population as compared to the CD15- population.
Figure 3. Flow cytometry analysis of cell cycle profiles between CD44 negative (-) (purple)
and CD44 positive (+) (green) populations in SJ-GBM2 glioblastoma multiforme cancer
cells (A) and HBTC 3160 primary patient-derived glioblastoma multiforme cancer cells
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(B). Percentage of cells in G0/G1 decreases in the CD44+ population as compared to the
CD44- population.
Table 1. Controls and samples of flow cytometry experiment. The table shows
important controls and the sample tubes used in this co-staining experiment which are
needed for accurate data analysis for each cell line.

Tube Number
1
2
3

Name
Unstained
Single stain
Single stain

Antibody
No antibody
CD133-APC
SSEA1 (CD15) Alexa Fluor 555

4
5
6

Single stain
Single stain
Double stain

CD44-PE
Hoechst
CD133-APC,
Hoechst

7

Double stain

SSEA1- Alexa
Fluor 555,
Hoechst

8

Double stain

CD44-PE,
Hoechst
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